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Abstract
The majority of women will experience perimenopausal symptoms (Hickey, Davis &
Sturdee, 2005; MacLennan, 2009) with an estimated 20% of those experiencing severe

symptoms (Hickey et al., 2005). Many of these symptoms have the potential to
directly or indirectly affect work performance including hot flushes and night sweats
which are experienced by 85% of perimenopausal women (Baldo, Schneider, &
Slyter, 2003). Symptoms may begin several years before the cessation of
menstruation and may last well into old age (MacLennan, 2009).

This research sought to explore the perceived impact of perimenopausal symptoms on
women in leadership roles: how they managed symptoms; the factors that influenced
their decisions regarding treatment options and their recommendations for women in
similar circumstances. Information was gathered through in-depth, semi-structured
interviews with 17 female leaders. An interpretative phenomenological analysis
(IPA) was employed to identify salient themes from the transcribed narrative. Four
superordinate themes were identified:


Distraction, disruption, discomfort and distress



Soldiering on or taking control



Keeping up appearances



It‟s lonely at the top

Participants reported that contending with the demands associated with a leadership
role while experiencing perimenopausal symptoms was often distracting and for
some, a source of physical and emotional distress which had the capacity to
undermine confidence and work performance. Many reported feeling isolated because
of the demands and status associated with their work. This isolation often restricted
opportunities to gather and share information about symptoms with other women.

The findings provide valuable insights into the experiences of a unique group of
women. These insights inform further research and guide interventions and strategies
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that may assist women in leadership who may be experiencing perimenopausal
symptoms.

In particular, the findings of this study indicate that women leaders and the health
professionals from whom they seek advice and support are often ill-informed about
the onset, nature and management of perimenopausal symptoms. Interventions that
provide information and support in a timely and sensitive manner will benefit all
perimenopausal women and particularly those in demanding leadership roles.
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Chapter One: Background and Context

As women move towards the end of their reproductive lives they enter the
menopausal transition which begins with a change in ovarian function and subsequent
fluctuations in the levels of reproductive hormones. This period is referred to as
perimenopause and is often associated with a range of clinical signs such as irregular
menstruation and a number of adverse symptoms such as hot flushes and disrupted
sleep patterns. Most women will enter the period of perimenopause somewhere
between 35 and 60 years of age (Baldo et al., 2003; Baram, 2005; Cobia & Harper,
2005; Greendale, Lee & Arriola, 1999; Simon & Reape, 2009). The majority of
women will experience their final menstrual period somewhere between 45 and 55
years of age with the average age at menopause of 51.4 years (Simon & Reape,
2009).

The period following menopause is called postmenopause and is characterised by an
absence of ovulation, no further production of progesterone and very little production
of ovarian oestrogen (Baldo et al., 2003; Baram, 2005; Cobia & Harper, 2005; Hickey
et al., 2005; Knotts & Childers, 2009; MacLennan, 2009 ; Simon & Reape, 2009).

The majority of women will experience perimenopausal symptoms, with between
20% and 25% experiencing severe symptoms (Davis, 2003; Hickey et al., 2005).
Symptoms include a range of vasomotor responses such as hot flushes and night
sweats, psychological symptoms including irritability and anxiety, locomotor
symptoms such as joint pains and backache and urogenital changes including urinary
frequency and dry vagina (MacLennan, 2009). Other symptoms reported include a
crawling sensation under the skin, mood swings, depression and concentration
difficulties (Baldo et al., 2003; Cutson & Meuleman, 2000; Eun-Ok, 2006; Smith &
Michalka, 2003).

According to the Australasian Menopause Society (AMS), there are over two million
post-menopausal women in Australia with approximately 80,000 new women
reaching menopause every year. Furthermore, these women account for 40% of all
visits to health care professional (AMS, 2010 a).
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Despite the frequency with which women experience perimenopausal symptoms,
research indicates that many are ill-informed about the onset and nature of symptoms
as well as the terminology used to describe both the symptoms and phases of the
menopausal transition (Lyndaker & Hulton, 2004; Pinkerton & Zion, 2006; Prior,
2006; Twiss et al.,2007).

Research into the impact of perimenopausal symptoms on women in the workplace is
scant. Reynolds‟s papers (1997 & 1999) are among the few substantive reports on the
issue. Furthermore, according to Reynolds (F. Reynolds, personal communication,
September 24, 2007), there has been little interest in the area following her initial
research.
Reynolds‟s studies and those undertaken more recently by Morris and Symonds
(2004), Paul (2003) and Simon and Reape (2009) found that women experiencing
certain perimenopausal symptoms while in the workplace, often perceived these
symptoms to be disruptive and potentially embarrassing. Furthermore, the study by
Simon and Reape indicated that menopausal symptoms had a significant effect on
quality of life, physiological, cognitive and psychological functioning, particularly for
women in professional roles. In addition, studies by Cutson and Meuleman (2000),
and Paul (2003) found that stress, fatigue and other factors associated with both work
and the work environment could exacerbate perimenopausal symptoms such as hot
flushes.

Of particular significance for this study is the age at which women may be
undertaking leadership roles. For example, most Australian women company
directors are reportedly in the 45 to 47 year age group (Burgess & Tharenou, 2002)
and the average Australian board director (male and female) is between 51 and 70
years of age (Kang, Cheng & Gray, 2007). Data from a study of the CEOs of Fortune
500 companies in the United States (Martelli & Abels, 2010) shows that the 76% of
all CEOs in these companies are in the 50-64 year age bracket. With most women
entering the period of perimenopause several years prior to actual menopause, it is
therefore likely that many women leaders in their late 40s and early 50s will be
experiencing perimenopausal symptoms.
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For women in leadership roles, perimenopausal symptoms may be an added burden in
a working environment where women are often poorly represented and face
challenges that may not be experienced by their male counterparts. Women in
leadership roles in Australia are in the minority in almost every sphere of industry.
Furthermore, women become increasingly isolated as they advance to senior
management levels until at the level of Board Director, they are outnumbered by men
at 10 to one (EOWA, 2009). In addition, many aspects of being in male-dominated
environments have been shown to adversely affect women‟s physical and mental
health (Gardiner & Tiggemann, 1999).

For women who experience particularly troublesome perimenopausal symptoms,
there are few effective treatment options. Hormone replacement therapy (HRT) using
oestrogen, either with or without progesterone remains the most extensively studied
and effective treatment of symptoms associated with low or fluctuating hormones
(Knotts & Childers, 2009; MacLennan, 2009). The evidence for HRT‟s efficacy is
well established according to Cochrane reviews of published randomized controlled
trials (Baber, O‟Hara & Boyle, 2003; MacLennan, 2009). In contrast, no
complementary medicines or treatments have been shown to have greater than
placebo effect in blinded randomised controlled trials (MacLennan, 2009).
Furthermore, not only do many of these therapies and interventions have no evidencebase for their claims of effectiveness, many, including the so called bio-identical
hormones, reportedly have the capacity for potential harm (MacLennan, 2009).

HRT was first prescribed commercially in the 1920s ostensibly to provide coronary
benefits and reduce the risk of osteoporosis, Alzheimer‟s disease and overall
morbidity (Knotts & Childers, 2009). Although the benefits of HRT use were
considered to outweigh the risks, a number of long-term placebo controlled,
randomised controlled trials investigating various aspects of women‟s health also
included studies of the risks and benefits associated with the use of HRT. These
studies include the Women‟s Health Initiative (WHI), the Women‟s International
Study of long Duration Oestrogen after Menopause (WISDOM), The Million Women
Study and The Nurses Health Study which has continued for almost 30 years
(MacLennan, 2009).
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In 2002, the release of findings from the WHI study challenged the confidence many
women and their health professionals had in the safety of HRT use. According to
Wren (2009), the study was terminated prematurely due to statistically nonsignificant increases in the incidence of breast cancer and statistically significant
increases in myocardial infarction, thromboembolism and stroke among study
participants. In addition, The Million Women Study, which was undertaken in the
United Kingdom and published in 2003, also found that HRT increased the breast
cancer risk in study participants (Wren, 2009).

Although a number of subsequent reports have cast doubt on the initial findings of the
WHI study, adverse media reports caused many women to reconsider and in many
cases, to stop using HRT (MacLennan, Taylor, Wilson & Myer, 2004; Hickey et al.,
2005; MacLennan, 2009). According to Reape, (K.Z. Reape, personal
communication, February 19, 2010) the change in attitude to the use of HRT has had
a profound impact on women and the implications of this for symptomatic women in
leadership roles remain unclear.

In summary, there are a number of issues which are at the core of this research:


Most women will experience perimenopausal symptoms.



Many women are ill-informed about the nature, onset and effective management
of perimenopausal symptoms.



Perimenopausal symptoms have been shown to cause a range of physical and
emotional symptoms for women in the workplace.



The work environment has been shown to exacerbate the effects of
perimenopausal symptoms.



Perimenopausal symptoms may constitute an added burden for women
contending with certain demands reportedly associated with leadership.



The age at which women are likely to be undertaking leadership roles often
coincides with the age at which many may be experiencing perimenopausal
symptoms.



A loss of confidence in the use of HRT may have left some women leaders with
limited treatment options for problematic symptoms.
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Purpose of the Study

The purpose of this study was to explore the impact of perimenopausal symptoms on
women in leadership roles. It further sought to identify the coping strategies used by
leaders to manage symptoms, their attitudes to treatment options and their
recommendations for supporting other leaders in similar circumstances.

It is envisaged that the information gathered during this study may be used to form
the basis of educational, counselling and occupational health and safety interventions
that may enable women in leadership roles to more effectively recognise and manage
their perimenopausal symptoms. In addition, the findings of this study will enable the
development of future research projects that more effectively target and explore the
issues that are pertinent to this unique group of women.

Research Questions

With consideration of the purpose of the study and based on the seven core issues
outlined above, the following research questions were intended to provide a catalyst
for discussion and to broadly define the scope of the research topic.


What are the perceived effects of perimenopausal symptoms on women in
leadership roles?



What are the coping strategies used to manage symptoms?



What factors influence decisions regarding treatment options?



What are the recommendations for educating and supporting women in similar
circumstances?
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Operational Definitions and Terminology

Leadership role.

For the purpose of this study the term leadership role has been defined as

A role requiring the management, guidance and direction of a workforce (paid
or voluntary) and the responsibility for the development and/or
implementation of policy within the organisation.

This definition was used during recruitment of participants to enable prospective
participants to determine their eligibility for the study.

The following definitions of the terms that are used in this study are from the
Australasian Menopause Society (AMS, 2010 b). As reported earlier, there continues
to be confusion regarding the terminology used to describe aspects of the period of
changing hormonal function that includes perimenopause, menopause and
postmenopause. Many authors use the term menopause to refer to the period of time
which more correctly includes perimenopause, actual menopause and postmenopause. For the purpose of this study the term menopause will be used as defined
below except when cited as a direct quote from a study participant or by another
author.

Hormone replacement therapy (HRT)/hormone therapy (HT).

Hormone replacement therapy (HRT) or hormone therapy (HT) is the use of
hormones as prescribed during the menopause transition and after the menstrual
periods have stopped, to alleviate oestrogen deficiency syndromes such as hot
flushes, mood swings, and vaginal dryness and to prevent or treat longer term
diseases such as osteoporosis.
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Menopause.

Menopause is the final menstrual period and said to have occurred when there has
been no period for one year.

Menopausal transition.

The term menopausal transition will be used when appropriate in this study to
describe the period of changing hormonal function that occurs as women move from
pre-menopause through perimenopause, menopause and eventually into postmenopause.

Oestrogen/estrogen.
Oestrogen is a hormone produced primarily in a woman‟s ovaries. It aids in the
development of female sex characteristics and plays an important role in
reproduction.

Perimenopause/peri-menopause.

Perimenopause refers to the time from the onset of menopausal symptoms through to
the last menstrual period particularly from the onset of irregular periods. It can last
for an average of 4-6 years before the periods finally stop.

Although the AMS has chosen to use the hyphenated peri-menopause the nonhyphenated perimenopause will be used by this author.

Postmenopause/post-menopause.

Postmenopause starts one year after the last menstrual period.
18

Premature menopause.

Premature menopause is considered to have occurred if a women is younger than 40
years of age when she becomes menopausal.

Progesterone.
Progesterone is the natural hormone found in a woman‟s body that helps prepare the
endometrium (lining of the uterus) for implantation of a fertilized egg.

Progestogen.

Progestogen is a hormone which can be natural or synthetic, but has the same effect
on a woman‟s body as progesterone.

Progestin.

Progestin is a synthetic hormone which has the actions of progesterone.

Structure of the Thesis

The thesis structure reflects the qualitative methodology chosen to explore the
research questions.

Chapter One provides an introduction to the research topic and outlines the context in
which the research was undertaken. The core issues that underpin the research and the
four research questions are presented.

Chapter Two reviews the literature considered pertinent to the research topic. This
includes research in regard to the nature and onset of symptoms often associated with
19

perimenopause; an overview of the interventions and treatment options available for
the management of symptoms and the respective research regarding the efficacy of
particular interventions. In addition, research regarding the changing attitudes among
women and health professionals towards treatment options will be presented as well
as research concerning the impact of perimenopausal symptoms on women in the
workplace. The limited literature on the effects of perimenopausal symptoms on
women in leadership roles will also be presented. The literature reviewed includes the
initial research that contributed to the formulation of the research questions and
literature reviewed in response to the implications of the study findings.

Chapter Three outlines the methodology used in this study which includes a
description of the recruitment of participants and the collection, interpretation and
analysis of data.

Chapter Four outlines the findings of the study. This is presented as a narrative
account of the experiences of the study participants, thereby honouring the richness of
the data. The findings are presented as themes and emergent superordinate themes
that represent the commonalities and differences within the reported experiences of
the participants.

Chapter Five includes a discussion of the implications of the four superordinate
themes and the relationship of the findings to the extant literature.

Chapter Six provides a brief overview of the study findings and discusses the
implications of the findings in regard to further research and the development of
effective interventions that may provide advice and support to perimenopausal
women undertaking leadership roles.

Thesis Style and Referencing Format

The style of referencing and citation of sources applied in this thesis is consistent with
that outlined in the 6th Edition of the Publication Manual of the American
Psychological Association (APA, 2009). In addition to the introduction of technical
20

or key terms and labels (as specified by the APA), italicised typeface will also be
used in this document to depict words and phrases quoted directly from the study
participants‟ narrative.
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Chapter Two: Literature Review

Introduction

In this chapter, the published literature pertaining to the nature and onset of
perimenopausal symptoms, psychosocial and cultural issues and approaches to
symptom management is reviewed. Research regarding the impact of
perimenopausal symptoms on women in the workplace and in particular, women in
leadership roles is also reviewed.

The Nature and Onset of Perimenopausal Symptoms

The majority of women will experience perimenopausal symptoms (Hickey et al.,
2005; MacLennan, 2009) with an estimated 20% of those experiencing severe
symptoms (Hickey et al., 2005). Although not all women have problems during
perimenopause, some may experience symptoms they find distressing. The onset of
perimenopause is often associated with clinical signs such as less regular menstrual
cycles and vasomotor symptoms such as hot flushes and night sweats (Bradley,
2005). Most women will enter the period of perimenopause somewhere between 35
and 60 years of age (Greendale et al., 1999; Baldo et al., 2003; Baram, 2005; Cobia &
Harper, 2005; Simon & Reape, 2009) with the average age at actual menopause of
51.4 years (Simon & Reape, 2009).

According to MacLennan (2009) perimenopausal symptoms may begin several years
before the cessation of menstruation and may last well into old age. He divides
symptoms into four main groups: vasomotor, including hot flushes and night sweats;
psychological (e.g. irritability and anxiety); locomotor (e.g. joint pains and backache)
and urogenital (e.g. urinary frequency and dry vagina). Other symptoms reported
include sleep disruption, exhaustion, a crawling sensation under the skin, mood
swings, depression and concentration difficulties (Baldo et al., 2003; Cutson &
Meuleman, 2000; Eun-Ok Im, 2006; Smith & Michalka, 2003).
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In addition to the symptoms associated with fluctuating hormones, the loss of ovarian
function and subsequent decrease in oestrogen levels may have long-term
consequences. These may include an increasing risk of cardiovascular disease,
osteoporotic fractures, dementia and reduced cognitive function (MacLennan, 2009;
Wren, 2009).

Although hormone levels become more stable as a woman enters postmenopause and
many of the symptoms such as hot flushes and night sweats abate, the low levels of
oestrogen may continue to have an effect on women‟s health and well-being for many
years and even into old age (MacLennan, 2009). In addition, a number of symptoms
such as certain urogenital problems may become more problematic in the years
following menopause (Doyle, 2006).

Recognition of Symptoms

Although the majority of women will experience perimenopausal symptoms, research
suggests that many women are not well informed about the age at which symptoms
may begin or the nature of symptoms that may herald the onset of perimenopause
(Baldo et al., 2003). Lyndaker and Hulton (2004) reported that “despite a
proliferation of health education materials” (p. 340), many of the women (aged 30 to
50 years) in their study, failed to recognize symptoms they experienced as being
associated with perimenopause.

Recognition of symptoms was also less likely, according to Boughton and Halliday
(2008), when women entered perimenopause earlier than they or their health
professionals expected. They found that the misdiagnoses of symptoms frequently
caused the women in their study to experience a period of distress and uncertainty. In
addition, study participants often thought they were imagining their symptoms or that
they were losing their sanity. Broughton and Halliday also reported that health
professionals frequently attributed symptoms that occurred outside the expected time
frame for the onset of perimenopause, to a psychiatric basis. They say that this lack of
recognition of symptoms may put some women (particularly those experiencing early
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perimenopause) at a disadvantage in regard to seeking appropriate support and thus
availing themselves of effective treatments.
Lyndaker and Hulton (2004) also say that health care providers need to be “better
educated on the frequency and severity of perimenopausal symptoms and how these
symptoms affect their clients” (p.341). They reported that the results of their study
indicate that “education and anticipatory guidance should begin with women in their
30s” (p346). Furthermore they say that the “challenges of perimenopause justify
further study, because the complaints of the women in perimenopause are real and
must be taken seriously” (p346).

In addition to the lack of awareness regarding the nature and onset of perimenopausal
symptoms, research indicates that there is often confusion regarding the terminology
used to describe and define this time of a woman‟s life. Pinkerton and Zion (2006)
say that given the “biological and social significance of menopause, it is remarkable
that the language used to describe this event and its associated symptoms is
inconsistent” (p. 135). Similarly, Prior (2006) says that “ordinary women and official
statements confuse and conflate perimenopause – the long, complex, life phase of
higher and chaotic estrogen levels – with the low and stable estrogen levels of
menopause” (p. 323). She says that the average woman uses the term menopause to
refer to any changes experienced during midlife and into old age.

Another misconception, according to Prior (2006) is the belief that the period of
perimenopause is associated with an oestrogen deficiency. Prior says that although
hormones fluctuate at this time, oestrogen levels may actually rise during
perimenopause, resulting in a range of symptoms including sore and often nodular
breasts and mood swings. Perimenopause she says, begins in women with regular
menstrual cycles who may begin to notice changes in the duration of cycles, breast
tenderness, sleep disturbances and unusually heavy periods. She suggests that this
lack of understanding may lead women to incorrectly assume that they are suffering
from conditions such as fibromyalgia or chronic fatigue syndrome as a way of
explaining the mood swings and low energy they may be experiencing. Reflecting on
both her personal and professional experience of perimenopause, Prior suggests that
the “ lack of, or mis-information we as women receive deprives us of self24

knowledge, alienates us (further) from our bodies, and leaves us both diseased and
dependent” (p. 327).

The attribution of unrecognised symptoms to other causes is also discussed by Twiss
et al. (2007). They suggest that when women experience symptoms that are not
usually associated with the menstrual cycle such as joint aches, they may attribute
these to other conditions and this may lead to misdiagnosis.

Furthermore, according to Pinkerton and Zion (2006), in addition to the confusion
about menopausal symptoms, women are also confused about symptom management
and treatments. This confusion they say, makes it difficult for women to communicate
effectively with the health professionals they consult. It is not surprising therefore
that being well informed about symptoms and treatment options has been shown to
result in an easier menopausal transition (Baldo et al., 2003).

Diagnosing Perimenopause

In regard to the diagnosis of perimenopause, the Australasian Menopause Society
(AMS, 2008 a; AMS, 2010 d) recommends that doctors do not prescribe blood tests
for hormone levels because they are unreliable at this time. They recommend that
doctors counsel women about their clinical symptoms and provide advice about the
risks and benefits of treatment options. They say that although menstrual cycles may
become less regular prior to the final menstrual period which heralds actual
menopause, this is not always the case. Many women may continue to have regular
periods even though they are experiencing the fluctuating hormone levels associated
with perimenopause. Furthermore they say that the symptoms experienced during
perimenopause and prior to actual menopause may be the most distressing.

Minkin (2006) also discusses the problems associated with the diagnosis and
management of perimenopause. She says that while the diagnosis of the menopausal
patient is relatively straightforward because it is determined retrospectively following
12 months absence of menstruation, perimenopausal women may continue to have
regular periods while experiencing symptoms of hormonal fluctuations. In addition
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she says there is a false perception which is often promoted on daytime talk shows,
that the menopausal transition is something that occurs overnight. The reality for
many women she says is often a protracted process of hormonal fluctuations and the
accompanying symptoms.

Symptoms Frequently Associated with Perimenopause

Vasomotor symptoms.

Among the most recognizable, disruptive and highly researched symptoms of
perimenopause are the vasomotor symptoms such as hot flushes and night sweats.
Although the cause of such symptoms has not yet been determined, Alexander and
Moore (2007) propose that they are precipitated by a reaction in the brain to
fluctuating hormone levels. These symptoms affect 70% to 85% of women (Baldo et
al., 2003; Rymer & Morris, 2000) and according to Freeman et al. (2001) hot flushes
are the main reason women in mid-life seek medical care.

Hot flushes are generally reported as a sudden sensation of warmth that may radiate
outwards from a central point such as the chest. This sensation may last from seconds
to an hour and is often accompanied by perspiration, tachycardia, anxiety, irritability,
palpitations, breathlessness, a feeling of faintness, a rise in body temperature and
even a sense of panic (Baldo et al., 2003; Cutson & Meuleman, 2000; Hickey et al.,
2005; Reynolds, 1999). The severity of hot flushes increases with stress, fatigue and
other stimuli such as high ambient temperatures, coffee and alcohol (Berendson,
2002; Cutson & Meuleman, 2000; Hunter, 2003). Night sweats may also be
experienced by women having hot flushes but can arise independently (Hickey et al.,
2005)

Politi, Schleinitz and Col (2008) say that the period of time in which hot flushes may
be experienced is a median of 4 years. For many, hot flushes do not persist for more
than about a year after the actual menopause, however, about a third of women may
continue to have hot flushes for five years or longer (Hickey et al., 2005) with around
10% experiencing flushes 12 years after menopause (Crandall, 2008).
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Sleep disruption.

According to Baber (2009) sleeplessness is twice as likely during perimenopause.
Hudson (2004) attributes sleep disturbances in perimenopausal women to anxiety,
vasomotor symptoms (night sweats) and the effect of hormonal changes on brain
neurotransmitters. In addition to the disruption caused by night sweats,
perimenopause may affect sleep quality in a number of ways including sleepdisordered breathing which is secondary to sleep apnoea and menopausal insomnia
(Polo-Kantola, Saaresranta & Polo, 2001). According to Phillips et al. (2008),
hormonal changes are strongly implicated in the doubling of the rate of obstructive
sleep apnoea observed in post menopausal women.

In a study by Thurston, Blumenthal, Babyak & Sherwood (2006), self-reported data
from women suggested that there is a relationship between hot flushes experienced at
night as night sweats, sleep problems and subsequently, impairment of psychological
functioning. They also found that more night-time hot flushes were detected by
physiological monitoring than were reported by the women themselves. Other
evidence for an association between changing hormonal levels and sleep disruption
comes from studies of the effects of HRT on sleep quality. Phillips et al. (2008)
reported that three cohort studies showed a reduction in the risk of sleep apnoea in
postmenopausal women taking HRT. Pinkerton and Zion (2006) also cite the results
of clinical trials that indicated a link between sleep quality and certain hormones.
They reported that both sleep and quality of life were improved by the use of lowdose continuous combined oestradiol and norethisterone (progesterone). Similarly,
Hudson (2004) says that oral HRT has been shown to decrease sleep disordered
breathing, improve night-time restlessness and awakening and relieve vasomotor
symptoms. She says that “women may experience sleep disturbance during the
perimenopause transition and menopause itself, especially those who do not take
hormone replacement therapy (HRT)” (p. 154).
Polo-Kantola et al. (2001) say that “severe sleep disturbances may lead to major
impairment of daytime functioning and quality of life” (p.446). In addition, they say
that the problem is often overlooked by both doctors and their patients. Mahoney
(2005) also suggests that sleep problems can significantly diminish quality of life in
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perimenopausal women and that this problem should not be overlooked. Furthermore,
Arigo, Kloss, Kniele and Gilrain (2007) found an association between
perimenopausal women‟s beliefs about the implications of having a disrupted night‟s
sleep, anxiety and subsequent reduced quality of life.

Other research links reduced duration of sleep and disturbed sleep to a range of health
and psychosocial issues. These include an increased risk of cardiovascular disease
(Godfrey, Nagwa & El-Badri, 2009) and problems with cognition and depression
(Hudson, 2004). A study by Blackwell et al. (2006) found that objectively measured
disturbed sleep rather than total sleep time was consistently related to poorer
cognition. Another study linked sleep deprivation with a decrease in night-time levels
of the hormones ghrelin and leptin which regulate appetite and energy balance. The
authors say the subsequent disruption in energy balance may explain prospective
weight gain in insomnia sufferers (Motivala, Tomiyama, Ziegler, Khandrika & Irwin,
2009)

Urogenital symptoms and psychosexual problems.

Oestrogen maintains and supports the vaginal epithelium, maintains vaginal pH,
enhances vaginal lubrication and prevents dyspareunia (painful intercourse) as well as
playing a role in maintaining sexual receptivity ( MacBride, Rhodes & Shuster, 2010;
Rani, 2009).

According to MacBride et al. (2010), vulvovaginal atrophy (VVA) is a condition
which is associated with falling oestrogen levels and characterised by a number of
symptoms including vaginal dryness, soreness, stinging, spotting due to small tears in
the thinning vaginal lining, urinary frequency and urge incontinence. Although this
condition may occur at any time in a woman‟s life it is more prevalent in
postmenopause, affecting between 30% and 50% of women (Doyle, 2006; MacBride
et al., 2010). Furthermore, symptoms such as those affecting the reproductive system
and the psychosexual effects of perimenopause may indirectly affect wellbeing and
quality of life (Cobia & Harper, 2005).
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The decline in vaginal blood flow and changes in vaginal pH due to the fall in
oestrogen levels also predispose women to an increased likelihood of infections and
inflammation (MacBride et al., 2010). Doyle (2006) says that in addition to the
increased risk of fungal and bacterial infections, the urogenital atrophy that results
from reduced oestrogen levels can also predispose women to incontinence. She
suggests that these conditions all have the potential to impact on women‟s health and
wellbeing and subsequently their work performance. Furthermore, unlike many of the
other symptoms associated with perimenopause, vaginal symptoms, urinary
frequency and stress incontinence may actually increase after menopause (Doyle,
2006).

It is significant according to Doyle (2006) that only 25% of women experiencing
urogenital symptoms seek medical advice despite the prevalence of these symptoms.
Many women, she says, simply assume such symptoms are an irreversible part of the
ageing process. MacBride et al. (2010) also discuss women‟s reluctance to report
urogenital symptoms. They say that women are more inclined to raise concerns about
vaginal discharge and urinary frequency while being reluctant to report vaginal
itching, soreness or pain on intercourse. They suggest that there may be a number of
reasons why women do not report certain symptoms including embarrassment, the
belief that such symptoms are unimportant or the fact that they may be treating the
symptoms themselves.
Kingsberg (2009) also discusses issues associated with women‟s embarrassment
about discussing certain urogenital symptoms. A number of studies are cited which
indicate that embarrassment is a major obstacle for women particularly in regard to
reporting issues associated with sexual function. In addition, according to Kingsberg,
a survey found that 68% of women were concerned that they would cause their doctor
to be embarrassed if they were to raise such issues. These concerns may have been
well founded according to data cited by Kingsberg from a survey of almost 2000
health care professionals who admitted that their own embarrassment was an obstacle
to their initiating any discussion about sexual health. According to Kingsberg (2009),
issues associated with sexual dysfunction were unlikely to be discussed if it was left
to the patient to raise the subject. She makes the following comment:
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Lack of physician-patient communication is a major contributor to the under
diagnosis of sexual dysfunction in women. Without proper recognition of these
problems, women affected by FSD (female sexual dysfunction) remain
untreated and experience adverse consequences that undermine their
relationships and quality of life. (p. 524)

This issue is also discussed by Doyle (2006) who says that “with proper screening,
detection and management of this condition, clinicians have an opportunity to
positively affect the quality of life in this growing segment of the population” (p. 34).

Low libido is also an issue for women during perimenopause and in postmenopause
according to MacLennan (2009). He suggests that a number of psychosocial factors
including issues associated with the having elderly parents, adolescent children,
problems with relationships and changes in body image, may contribute to waning
libido. He suggests that sexual counselling and certain hormone therapies may be
helpful for some women.

Although both oral and transdermal HRT can reduce many of the urogenital
symptoms associated with peri and post-menopause, between 10% and 40% of
women continue to experience urogenital symptoms and may benefit from the use of
vaginal oestrogen preparations (Doyle, 2006; MacBride et al., 2010).

In regard to the use of HRT in the treatment of problems associated with sexual
functioning or declining libido, Lovett (2003) says that transdermal HRT (skin
patches) may be more effective in promoting orgasm than oral HRT. He explains that
orally administered HRT first passes through the liver and this affects the levels of
androgens and testosterone which subsequently affect the woman‟s sexual response.

30

Unusually heavy or irregular periods.

Changes in the duration and frequency of the menstrual cycle occur in approximately
half of all women by the age of 45.5 years and in 95% of women by the age of 50.8
years (Bradley, 2005). Heavy or irregular periods around the time of perimenopause
may be associated with fluctuating hormonal levels and alternating ovulatory and
anovulatory cycles according to Hale, Manconi, Luscombe and Fraser (2009).

Around 70% of perimenopausal women will have lower than usual menstrual flow at
around this time; 12% a sudden cessation of menstruation and about 18% an increase
in the flow and frequency of menstruation (Bradley, 2005). Garside, Britten and Stein
(2008) found that women frequently reported a range of concerns associated with
irregular or heavy periods. These included concerns about spotting and a subsequent
reluctance to socialise or wear certain clothing at this time.

A further consequence of prolonged episodes of heavy or frequent menstruation may
be anaemia due to the increased blood loss (Garside et al., 2008). This may in turn
cause cardiovascular problems, fatigue and loss of stamina, impaired cognitive
function and sexual dysfunction as well as a reduction in the woman‟s overall quality
of life (Szromba, 2009).

Irritability, anxiety, low mood and depression.

The relationship between the hormonal changes associated with perimenopause and
depression remains controversial. Although the AMS (2008 b) says that moderate to
severe depression is no more common at menopause than at any other time, they
concede that hormonal changes may contribute to moodiness.

A number of researchers are however, more confident about the link between
hormonal changes, low mood and depression. Soares (2003) states that research data
strongly suggests an increased risk of depression in perimenopausal women and a
relationship between hot flushes and depression even in women with no prior history
of depression. Similarly, Cobia and Harper (2005) cite numerous studies that indicate
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a relationship between changing endocrine function during perimenopause and both
major and minor depression. They also say that the cause of perimenopausal
depression is different from depression experienced in other circumstances and may
also differ in both presentation and response to treatment.

Miller (2006) says that studies indicate an increase in depressive symptoms in
perimenopausal women with one longitudinal study reportedly showing
perimenopausal women at a significantly greater risk of clinical depression than those
who had not yet entered this life stage.

Soares and Almeida (2001) reported a prevalence rate of 49.5% of psychiatric
morbidity among endocrinologically confirmed perimenopausal women (aged 40-58
years). In a later study Soares and Zitek (2008) say that the fluctuating oestrogen
levels during the menopausal transition can often precipitate symptoms of anxiety and
depression. This period they say constitutes a period of vulnerability and time of
increased risk of developing mood disturbances and depression. Furthermore they say
that there is recent evidence that women face an increased risk of developing
depressive symptoms during times of fluctuating reproductive hormones such as
premenstrually, during and after pregnancy and during the menopausal transition.
They suggest that emotional and physical changes associated with perimenopause and
early postmenopause, could lead to a “significantly impaired functioning and poorer
quality of life” (p.336).

Much of the evidence for a link between hormonal fluctuations and mood is derived
from studies of the effects of HRT. Morrison and Tweedy (2000) cite a number of
studies suggesting that HRT and in particular oestrogen, may improve some aspects
of psychological and cognitive function with the exception of major depression.
Another researcher, Miller (2002), found that 68% of study participants who were
given oestrogen replacement therapy (ERT) had a remission of their depression.

Although Stephens, Pachana and Bristow (2006) say that the research regarding the
relationship between oestrogen and mood is equivocal, they claim that the use of
HRT in non-depressed women has been associated with an improvement in mood.
Cutson and Meuleman (2000) also say that oestrogen therapy improves mood and
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dysphoria, and suggest this may be mediated through its effect on the metabolism of
serotonin in the central nervous system.

Further evidence for a link between perimenopause and depression is provided by
Oishi, Mochizuki, Otsu and Inaba (2007) who also assert that the serotonergic system
is involved in perimenopause and that serotonin levels are lower in women
postmenopause than in those who have not yet entered perimenopause.

Robinson (2001) looked at mood disorders and psychiatric illness during
perimenopause. The role of oestrogen and progesterone in regulating mood, and
cognitive function and the possible role of oestrogen in protecting against the
development of schizophrenia was discussed. According to Robinson:
.
The Domino Theory postulates that low mood, irritability and decreased
concentration may occur as a result of the hormone-sensitive physical
complaints that often accompany menopause. Sleep disturbances secondary to
night sweats, and irritability, discomfort and decreased self-esteem due to hot
flashes, may lead to psychological symptoms that can be confused with major
depressive disorders. (p. 178)

In addition, Robinson (2001) cites an earlier study by Jaszmann, Van Lith and Zatt
(1969) which she describes as comprehensive. This study included 3000 women aged
40 to 60 years and found that “complaints of mental imbalance, fatigue, depression
and irritability were most common in women who were still menstruating, reaching a
peak in women who could be considered immediately premenopausal” (p. 177).

In another study, Ryan, Carriere, Scali, Ritchie & Ancelin (2008) investigated
whether there was a link between lifetime hormonal factors and depression in later
life. They found that an earlier age at menopause was associated with a greater risk of
depression in later life, but only for those women with a lower level of education. A
number of factors were postulated to contribute to discrepancies associated with the
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relationship between hormonal exposure and depression including the route of
administration of exogenous oestrogen (patches versus pills). They concluded that
there should be further investigation to determine which hormonal interventions may
be used to treat certain sub-groups of women for late-life depression.

Changes in cognitive function.

Of particular relevance to women undertaking cognitively demanding work (such as
leadership roles) is the postulated relationship between oestrogen and aspects of
cognitive function. For example, according to Dohanich (2003), research shows that
oestrogen and progesterone influence the electrical, biochemical and structural
properties of brain neurons involved in learning and memory. Similarly, Cutter,
Norbury and Murphy (2003) say that research indicates that oestrogen affects brain
function in a number of ways including brain ageing, glucose metabolism and aspects
of neurotransmitter function. Furthermore, Lebrun et al. (2005) say that study
findings indicate that endogenous oestrogens may have a protective effect against the
cognitive decline usually associated with ageing.

Changes in cognitive function observed following the initiation of hormone therapy
offer further insight into the relationship between oestrogen and cognition according
to a number of researchers. For example, Tierney (2000) suggest that for women with
low blood serum levels of oestrogens, taking even low doses of the hormone may
have cognitive-enhancing effects. Similarly, Hogervorst, Yaffe, Richards and Huppert
(2006) consider it biologically plausible that cognitive decline in postmenopausal
women may be avoided by maintaining high levels of oestrogen. This hypothesis
gains further support with Lokken and Ferraro‟s (2006) study in which they found
that postmenopausal women using HRT significantly outperformed postmenopausal
women who were not using HRT on a number of tests designed to evaluate aspects of
cognition.

Similarly, Miller, Conney, Rasgon, Fairbanks and Small (2002), claim that the
postmenopausal use of oestrogen is associated with improvement in mood and
performance on tasks of fluency and working memory. A study by Stephens et al.
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(2006) also indicated that oestrogen may enhance verbal memory in women between
the ages of 40 and 60. More recently, Greendale et al. (2009) cite the Study of
Women‟s Health Across the Nation (SWAN) which assessed a number of aspects of
cognitive functioning in a group of 2,362 women over several years. The study found
that the problems with memory and cognition that develop during perimenopause
may be more annoying than disabling and appear to resolve once women reach
menopause.

According to Greendale et al. (2009) women often experienced a decrease in
cognitive performance during perimenopause at which time they were not able to
learn as well as they had in premenopause. This decrement disappeared in
postmenopause suggesting a time-limited effect. They also found that while initiating
HRT prior to the final menstrual period had beneficial effects on cognitive function,
initiation of treatment at a later time had a detrimental effect. In particular they found
that scores of verbal memory and processing speed increased during early
perimenopause but levelled out or declined during late perimenopause.

There continues to be wide debate about the relationship between oestrogen, mood
and cognitive function. For example, Henderson and Sherwin (2007), suggest that
further research is needed to determine the efficacy of oestrogen therapy in improving
cognitive function.

Regardless of the controversy surrounding this issue, Greendale et al. (2009) say that
around 60% of women report problems with learning and memory during
perimenopause. Luetters et al. (2007) while also acknowledging that around 60% of
perimenopausal women perceive that they have memory problems, claim to have
found no association between menopause transition and various tests of cognitive
performance. These claims are challenged by Stephens et al. (2006) who suggest that
a number of studies which found equivocal or no effects of exogenous oestrogen
were focussed on older women. They suggest that exogenous oestrogen may enhance
verbal memory in younger mid-life women (40 to 60 years of age) while having little
effect in older women.
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The differential between the effects of HRT on younger versus older women is
referred to as the “critical window hypothesis” by MacLennan (2009, p.120). He
explains that although HRT undertaken at, or close to the time of menopause, has
been shown in observational studies to produce cognitive benefit, hormone therapy
does not reverse cognitive decline in older women who may already have cognitive
deficits prior to undertaking HRT.

Sherwin and Henry (2008) also discuss the critical period hypothesis, postulating a
number of possible factors that may contribute to the different cognitive effects of
oestrogen when administered to older versus younger women. They suggest that brain
ageing, which may include a number of factors such as a decrease in brain volume,
neuronal size, neurotransmitter system changes and a reduction in dendritic spine
numbers may inhibit any possible neuroprotective effects of exogenous oestrogen on
the brain. They also suggest that the route of administration and type of HRT may be
a factor.

A study by Ryan et al. (2009) also investigated the relationship between hormone
therapy, cognition and dementia while focusing on the type of therapy, time of
initiation of treatment and duration of treatment. They concluded that although
current hormone therapy was associated with better performance in certain areas of
cognitive function, this association was dependent of the duration and type of
treatment used. They also reported that they did not find evidence of a critical period
for initiation of HRT saying that therapy did not need to be started close to
menopause to benefit cognitive function in later life.

In addition to investigating the effects of HRT on cognitive function, a study which
also investigated the benefits of physical activity in older women, found that
cognitive performance was enhanced in physically active older women using HRT.
The researchers also found however, that physical activity improved cognitive
function irrespective of HRT use (Etnier & Sibley, 2004).

Finally, in addition to possible changes to cognitive function and mood, mild forms of
psychosis during perimenopause are relatively frequent according to Huber et al.
(1999). This association between hormonal changes and mental health is supported by
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Robinson (2001) who suggests that it is the loss of the protective effects of oestrogen
that may be related to the slight increase in the incidence of schizophrenia in women
around the time of menopause.

Other Consequences of Reduced Oestrogen Levels

Although the changing hormonal levels experienced during peri and postmenopause
are often associated with symptoms that may or may not be recognised by the woman
herself, there are other long-term consequences associated with diminished oestrogen
levels. These include an increased risk of cardiovascular disease, osteoporotic
fractures, diminished cognitive function and dementia that may not initially produce
symptoms (MacLennan, 2009).

Cardiovascular disease.

According to Wren (2009), women experience less cardiovascular disease than their
male peers and this protection continues until around 10 years after menopause due, it
is thought, to the residual protective effects of oestrogen on the cardiovascular
system. Wren says that clinical studies indicate that when HRT is initiated within a
few years of menopause women continue to have between 40% and 60% less risk of
hypertension and myocardial ischaemia although he says there is a two to three fold
increase in the risk of thromboembolism.

Dementia.

According to Godfrey, Nagwa and El-Badri (2009) dementia is the fifth leading cause
of death among women and among the most feared of diseases. They say that the
lifetime risk of developing dementia is one in seven for men and one in five for
women. Although a number of factors are implicated in the development of dementia,
the authors say that the role of oestrogen in delaying the onset of dementia may be
associated with the demonstrated, potent antioxidant effects of oestrogen on the
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mitochondria. They say that for perimenopausal women who are able to use HRT,
there may be a positive effect on mild to moderate dementia.

An earlier but comprehensive long-term study which was conducted over 22 years
and involved almost 9000 women (the Leisure World cohort), found that oestrogen
users had a significantly reduced risk of Alzheimer‟s disease and related dementia
compared to nonusers and there was a significant reduction in the level of that risk
with both increased dose and duration of use (Paganini-Hill & Henderson, 1996).
Birge (2002) as cited in Meisler (2002) says that there is strong data suggesting that
oestrogen, when given in perimenopause can delay the onset of Alzheimer‟s disease
by 50% to 60%.

Furthermore, according to Wren (2009), the relationship between the age at which
hormone therapy is commenced and the efficacy of such treatment was also relevant
in regard to the management of dementia. He says that the women in the WHI study
group were all over 65 years of age when they entered the study and appeared to have
little benefit and even an increased risk of developing dementia when HRT was
commenced at this late stage. He says that clinical studies have shown that beginning
oestrogen therapy at or soon after menopause actually reduces the risk of dementia.

Osteoporosis.

Falling oestrogen levels during perimenopause and following menopause change the
normal regulation of bone mass, resulting in an increase in the rate of bone loss
(Vibert, Kompis & Hausler, 2003; Wren, 2009). This may result in osteopenia which
is characterised by a sub-normally mineralised bone and subsequently, osteoporosis
which is associated with weakened bones that fracture easily (AMS, 2010 c).
According to the AMS, the average woman loses up to 10% of bone mass during the
first five years following menopause. In addition, they say that about half of all
women over 60 years of age will have at least one fracture as a result of osteoporosis.

Lifestyle factors such as undertaking weight-bearing exercise, avoidance of smoking
and excessive alcohol and the use of calcium and vitamin D3 supplements can reduce
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bone loss and improve bone health (AMS, 2010 c; Godfrey, Clifford & Rosen, 2008).
For women at risk of, or with diagnosed osteoporosis however, HRT was the
preferred treatment prior to the release of the WHI findings (Canderelli, Leccesse &
Miller, 2007). Although HRT continues to be prescribed when considered
appropriate, other treatment options are now being promoted for postmenopausal
women to reduce their risk of osteoporosis. These include a class of drugs called
biphosphonates, as well as selective oestrogen receptor modulators (SERMS) and
tibolone which have been shown to be at least as effective as HRT in preventing
osteoporosis. As with the use of HRT however, these drugs may also have risks and
side-effects in some women (Canderelli et al., 2007).

Changes in metabolism and weight gain.

Although studies of midlife women consistently show an increase in body weight, it
is unclear whether this is related to ageing or the hormonal changes associated with
perimenopause (Lovejoy, 2009). Lovejoy says however, that studies do indicate that
there is a change in body composition around menopause with menopausal women
having lower lean body mass and higher fat mass. In addition, Lovejoy says there is
an increase in abdominal fat distribution which has been associated with an increased
risk of metabolic diseases such as diabetes as well as an increased cardiovascular risk.
Furthermore Lovejoy says, studies indicate that post-menopausal women using HRT
have less abdominal fat.

Psychosocial, Ethnic and Cultural Issues

Current research into the psychosocial impact of perimenopause on women is scant.
A number of earlier studies focussed on issues including the medicalisation of
menopause (Huffman & Myers, 1999) and reproductive life stages (including
menopause) to the exclusion of social and psychological factors which were
considered to play an equally significant role in women‟s experience of midlife
(Lippert, 1997).
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McKee and Warber (2005) cite Hunter (1993) who showed that multiple psychosocial
factors including physical health, social situation, stressful life events and beliefs
about menopause, may predict a menopausal woman‟s reported quality of life.
Similarly, Dennerstein, Lehert and Guthrie (2002) reported changes in women‟s wellbeing during the menopausal transition. They found that negative mood declined and
women‟s well-being improved as they entered the later stages of the menopausal
transition and that a number of psychosocial factors including marital status, work
satisfaction and number of concerns and adverse life events also had a significant
effect. Furthermore they say that because the bodily changes associated with
menopause are intrinsically linked to gender and reproduction, the experience of
symptoms is “inevitably imbued with social and cultural meanings concerning what it
is to be female, to be an older woman” (p. 191). Binfa et al. (2004) also found that
psychosocial factors affect menopausal symptoms and identified a link between the
intensity of symptoms, biological predisposition and a history of premenstrual
syndrome.

Li, Holm, Gulanick and Lanuza (2000) investigated the changes in the quality of life
(QOL) ratings of women during perimenopause. They found that psychosomatic
complaints were more frequently reported than vasomotor complaints (such as hot
flushes) and were more positively related to QOL indicators. They concluded that
managing psychosomatic symptoms may be important to improving QOL for women
during the perimenopausal period. Gita and Kuh (2006) also reported that a number
of factors affect women‟s quality of life during the menopausal transition. They
concluded that although the experience for most women is complex, it is not
necessarily “overwhelmingly negative” (p. 93).

A number of comprehensive studies have provided information regarding the
psychosocial factors associated with women‟s experience of perimenopause. An
example is the Study of Women‟s Health Across the Nation (SWAN) which was
initiated in 1994 and had over 3000 mid-life women enrolled across the United States.
Data gathered during this study provided Santoro (2004) with information in regard to
the impact of ethnicity, culture and socioeconomic status on menopausal women. She
found that although ethnicity was strongly related to the experience of symptoms and
the health status of women, socioeconomic status was a confounding factor because
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the representatives of different ethnic groups were selected from communities with
varying socioeconomic circumstances. The study provided support for the findings of
other smaller studies which indicated that smoking, socio-economic status and
racial/ethnic factors influence the age at which women reach actual menopause and
the way in which they experience symptoms.

Anderson, Yoshizawa, Gollschewski, Atogami and Courtney (2004) compared the
midlife experiences of Australian and Japanese women. They found that the
experience of menopause was different for each group. The Australian women
reported significantly more vasomotor symptoms such as sleeplessness and night
sweats while the Japanese women reported more psychological and somatic
symptoms including nervousness, panic attacks, difficulty concentrating and feeling
unhappy or depressed.
Hunter (2003) suggest that “menopause is very much associated with negative beliefs
and images in western societies, and concerns about hot flushes representing visible
signs of menopause can be distressing if these beliefs are taken on board” (p. 189).
The concept that it may be women‟s interpretation of the physical symptoms of
menopause, in particular those related to vasomotor symptoms such as palpitations
that may exacerbate their experience is discussed. Hunter suggests that this negative
perception of symptoms may result in feelings of anxiety, irritation, low mood or
embarrassment.

More recently, a study by Marvan, Islas, Vela, Chrisler and Warren (2008) looked at
the stereotyping of women at various stages of their reproductive lives. They say that
in the majority of Western cultures, women do not look forward to menopause. They
cite a number of studies that suggest that women fear a loss of status as well as
physical attractiveness at this time. Their study of women in Mexico and the United
States found that survey respondents stereotyped menopausal women as irritable and
moody and used the term “old” to define menopausal women. They suggest,
however, that this is not always the case, with women in some Asian countries
reportedly having a more positive view of menopause.
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Finally, according to Boughton and Halliday (2008), women experiencing premature
menopause (before age 40 years) encounter particular psychosocial problems. Their
study (as reported earlier) found that participants were distressed when, on many
occasions, the health professionals from whom they sought a diagnosis and
explanation for particular symptoms, were inclined to discount the possibility of
perimenopause based on the woman‟s young age. This reportedly resulted in a
tendency for symptoms to be attributed to psychological rather than physiological
factors and the women consequently experienced the stigma often associated with this
type of diagnosis.

Treatments and Management of Perimenopausal Symptoms

Complementary and alternative medicines (CAMs) and other alternative
therapies.
A report by MacLennan et al. (2002) found that “alternative” or “natural” therapies
for hot flushes were used by 52% of Australian women with an estimated expenditure
of $2.3 billion per year. According to a more recent report by MacLennan (2009)
around 60% of women self-medicate or seek alternative therapies to relieve their
symptoms and 20 to 30% of women between the ages of 50 and 60 use HRT.

Although non-pharmacological treatments such as acupuncture and behavioural
interventions may offer some benefits (Hickey et al., 2005; McKee & Warber, 2005),
Hickey et al. (2005) say that there is a paucity of clinical research data available to
confirm this. MacLennan (2009) says that it is “very important to differentiate the
common temporary placebo effects of most unproven therapies for menopausal
symptoms from the prolonged and statistically and clinically better results of truly
effective therapies” (p. 114). Furthermore, MacLennan reports that a systematic
Cochrane review indicated a placebo effect of 58% for hot flushes and night sweats
compared to a 90% effect with combined (oestrogen plus progesterone) HRT.

Some of the treatments for which there continues to be inconclusive evidence
regarding efficacy and safety include vitamin E, black cohosh, liquorice root and the
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use of naturally occurring plant hormones or phytoestrogens (Cutson & Meuleman,
2000; Hickey et al., 2005; Hunter, 2003; MacLennan 2009).

Other non-pharmacological treatments and interventions have been shown to have a
positive affect on the health of perimenopausal women. For example, MacLennan
(2009) says that, in regard to reducing the risk of osteoporotic fractures, an increased
calcium intake and vitamin D supplements (when necessary) may assist in slowing
bone loss and thus reduce the risk of osteoporotic fractures. In addition, he says that
exercise has been shown to reduce the risk of osteoporotic fractures by improving
balance and slowing postmenopausal bone loss as well as reducing the number and
intensity of hot flushes and improving women‟s quality of life.
The so called “bioidentical” hormones that are compounded by pharmacists are
promoted as a more natural alternative to conventional HRT. According to Eden,
Hacker and Fortune (2007), these products typically contain three oestrogens
(oestrone, oestradiol and oestriol), progesterone and androgens such as testosterone
and DHEA. They are usually provided as creams or as troches (tablets or capsules) in
doses supposedly tailored to individual requirements. It is a concern according to
Eden et al., that these products are not regulated by the Therapeutic Goods
Administration and there is no evidence of safety or efficacy. This lack of regulation
has recently prompted the AMA to request that such products be subject to similar
safety warnings as those applied to other pharmaceutical products (Hickey, 2009).

In addition to criticism regarding the lack of regulation, MacLennan (2009) says that
“claims that testing a woman‟s saliva to „tailor‟ such products are completely
unsubstantiated, are pseudoscience and lead to inappropriate prescriptions” (p.115).
He makes the following comment regarding the promotion of certain products and
therapies:

It is morally wrong and scientifically and medically unsound to advocate and
purvey therapies that at best only have a placebo effect. This policy will
eventually cause the distrust in the doctor-patient relationship, may lead to
unexpected or unrecognised side-effects, will delay the use of effective
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therapies, exploit the gullible, waste the health dollar and will not have longterm benefits. (p.121)

Evidence based therapies.

Non-hormonal therapies.

In addition to hormone-based therapies which may include preparations containing
oestrogen, progestins and other hormones such as testosterone in various
combinations, there are a number of other pharmaceutical medicines that are used to
treat certain perimenopausal symptoms. For example, according to Speroff, Gass,
Constantive and Olivier (2008), desvenlafaxine which is a serotonin-norepinephrine
reuptake inhibitor significantly reduces the number and severity of hot flushes in
postmenopausal women.

The effectiveness of such medications is questioned however by MacLennan (2009)
who says that a number of pharmaceutical medicines including selective serotonin or
noradrenaline re-uptake inhibitors (SSRIs) which are primarily used for treating
depression are only marginally more effective than placebo in reducing the severity
and frequency of vasomotor symptoms. In addition, there are a number of side-effects
reportedly associated with the use of SSRIs include sexual dysfunction (Baldwin,
Hutchinson, Donaldson, Shaw and Smithers, 2008) and an increase risk of bone loss
and subsequently, osteoporotic fractures (Rosen, 2009; Saag, 2007). Furthermore, in
regard to the use of serotonergic antidepressants, McIntyre et al. (2005) found that
following the release of the WHI report in 2002, “a significant decrease in the number
of HRT prescriptions was associated with a statistically significant increase in
prescriptions of serotonergic antidepressants “(p.57). They suggest that this indicates
that antidepressants are being prescribed for the management of both psychological
and physical symptoms of perimenopause which were previously more commonly
controlled with the use of HRT.
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Other products including clonodine and gabapentin also have a slightly better than
placebo effect on vasomotor symptoms according to MacLennan (2009) but may also
have side-effects that could reduce long-term compliance. Other compounds
including selective oestrogen receptor modulators (SERMS) have been used to either
mimic or block the action of oestrogen in different tissues. These compounds include
Tamoxifen which is used as an adjuvant treatment for oestrogen-receptor positive
breast cancers and Raloxifene which is used to manage postmenopausal osteoporosis
(AMS, 2010 c; Davis, 2003)

Hormonal therapies (HRT or HT).

The terms hormone replacement therapy (HRT) or hormone therapy (HT) refer to the
treatments used to manage the symptoms associated with peri-menopause, and postmenopause and the long-term consequences of oestrogen deficiency (AMS, 2010 b;
MacLennan, 2009). Therapies are available in both oral and transdermal preparations
and include oestrogens only; oestrogens plus progestogen or combinations of
hormones including oestrogen, progestogens and testosterone. Tibolone is another
form of hormone therapy used for treating menopausal symptoms such as hot flushes,
vaginal dryness and bone loss ( MacLennan, 2009). According to Hickey et al.
(2005), tibolone “is a synthetic prohormone with weak oestrogenic, progestagenic,
and androgenic actions” (p. 414). This androgenic effect they say, may improve
sexual function in some women but may also have an unfavourable effect on HDL
cholesterol and triglycerides.

HRT has been used for the past 70 years to relieve a number of perimenopausal
symptoms and improve the quality of life for menopausal women (Wren, 2009). In
addition, Wren says that HRT‟s effectiveness in treating the symptoms associated
with fluctuating oestrogen levels is well documented. Wolfman (2005) says HRT is
more than 85% effective in treating vasomotor symptoms such as hot flushes and
Hickey et al. (2005) say that HRT reduces vasomotor symptoms in perimenopausal
and postmenopausal women by 90% and 65% respectively. According to Baber et al.
(2003), Cochrane reviews of published randomised controlled trials have clearly
established the evidence for the efficacy of HRT.
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The Risks and Benefits of HRT

There have been a number of long-term placebo controlled, randomised controlled
trials such as the Women‟s Health Initiative (WHI) and the Women‟s International
Study of long Duration Oestrogen after Menopause (WISDOM) that have included
research into the risks and benefits of HRT use. Some studies such as The Nurses
Health Study have continued for almost 30 years (MacLennan, 2009).

According to Wren (2009), concerns about the long-term safety of HRT resulted in
the initiation of the WHI study which was intended to run for over eight years but was
stopped after five years. This early termination he says, was due to statistically nonsignificant increases in the incidence of breast cancer and statistically significant
increases in myocardial infarction, thromboembolism and stroke among study
participants. Similarly, another large cohort study, The Million Women Study, which
was undertaken in the United Kingdom and published in 2003 also found that HRT
increased the breast cancer risk in study participants (Wren, 2009). According to
Wren, not all the WHI results however, indicated an increase in negative outcomes
with HRT use. Wren says that the study also found that there were statistically
significant reductions in hip fractures and colorectal cancers.

More recent analysis of the new data from a number of studies including WHI has
changed the risk:benefit ratio for the majority of women who begin HRT close to
actual menopause (MacLennan, 2009). In 2004, the results of the second arm of the
WHI trials were published. These results showed that women receiving oestrogen
without progestogen had a reduction in the incidence of breast cancer, osteoporosis
related fractures, stroke and myocardial infarction (MacLennan, 2009; Wren, 2009).
These findings suggest that progestogens may play a role in the increased incidence
of breast cancers in women using HRT which contains both oestrogen and
progestogens (MacLennan, 2009). The results also found benefits associated with
HRT use for women less than 60 years of age (Holloway, 2009).

The critical therapeutic window hypothesis that has been suggested in regard to the
effects of HRT on cognitive function may also apply to the cardioprotective effects of
oestrogen (MacLennan, 2009). According to MacLennan, the benefits of HRT on the
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cardiovascular system appear to be dependent on the continued responsiveness of
vascular oestrogen receptors to exogenous oestrogen. He says that when administered
around menopause, HRT appears to reduce the progression of atherosclerotic plaques
although existing plaques may actually be disrupted when HRT is administered many
years after menopause, often with adverse effects.

According to MacLennan (2009) and Wren (2009) neither the WHI nor the WISDOM
trials studied women who represented the normal users of HRT. Both say that the
majority of study participants were women who had commenced HRT up to 14 or 15
years after menopause. They also say that many had pre-existing health problems
including hypertension, diabetes and elevated cholesterol. In addition, 50% of
participants were past or current smokers; 34% were obese and 35% were overweight
(Wren, 2009).

Carroll (2008) also highlights discrepancies within the WHI study in regard to the age
of the study participants. She says that recent sub-analyses and pooled meta-analyses
of the findings of the WHI trials supports the premise that initiation of therapy
between the ages of 50 and 59 puts women at a lower risk of cardiovascular events
than those initiating therapy several years postmenopause. Carroll reports that
compared with the placebo group, the number of women in the 50 to 59 age group
experiencing cardiovascular events subsequent to using HRT was in the range of zero
to one additional case per 1000 women per year of hormone use. This she say, defines
such events as rare.

According to MacLennan (2009), hormone therapies are the most effective and best
researched interventions for the management of both menopausal symptoms and the
longer-term consequences of oestrogen deficiency. He says that Cochrane systematic
reviews show HRT‟s effectiveness in reducing vasomotor symptoms and urogenital
symptoms such as vaginal dryness and painful intercourse. In addition, he says that
both the WHI and WISDOM studies showed a significant reduction in sleeplessness
and joint pain as well as an improved sexuality and overall health-related quality of
life with the use of HRT.
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Other benefits of HRT include the prevention of fractures associated with
osteoporosis which is both cost-effective and relatively safe according to MacLennan
(2009), if initiated in osteoporotic women before the age of 60 years. Furthermore,
MacLennan says that combined HRT has also been shown to be associated with a
small decrease in bowel and uterine cancers and (as mentioned earlier) a cognitive
benefit when initiated close to menopause. He maintains that the use of appropriate
hormone therapies does not increase the risk of any major disease in women who
commence therapy close to the time of menopause and continue therapy for up to five
years.
Wren (2009) also discusses the benefits of oestrogen. He states that “when begun
within 5 years of menopause in healthy women, oestrogen-based HRT results in far
greater benefits than adverse outcomes” (p. 321). He says that there is substantial
objective evidence for the benefits of HRT which include reducing distressing
menopausal symptoms, risk of osteoporotic fractures, dementia and colorectal
cancers. In addition, he says HRT improves wellbeing and quality of life as well as
improving aspects of urogenital health and subsequent sexual enjoyment, maintaining
cardiovascular health and increasing longevity. Adverse effects he says include a
doubling of the risk of thromboembolism with oral HRT and promotion of the growth
of pre-existing breast tumours.

Another study (Paganini-Hill et al., 2006 as cited in Wren, 2009) looked at data from
the Leisure World cohort study which was conducted over 22 years and involved
8801 women. Findings indicated that those women who commenced using HRT at
menopause and continued for the remainder of their lives, had fewer adverse events
and lived longer than women who did not use HRT.

As discussed earlier, other research indicates the benefits of HRT for improving
mood in perimenopausal women. Robinson (2001) discusses the benefits for women
with mild or no depressive symptomology in using physiological doses of oestrogen
(p. 180). Ancelin, Scali and Richie (2007) report that 69% of experts recommended
HT (HRT) as the first-line therapy for “first episodes of mild and moderate
depression occurring at perimenopause, with antidepressants being recommended as
the second option” (p. 481).
48

Similarly, Miller (2002) cites Soares et al. (2001) that transdermal ERT (estrogen
replacement therapy) is an effective antidepressive treatment in perimenopausal
women with depressive disorders. In addition, McIntyre et al. (2005) say that
although the mechanism by which oestrogen might attenuate depressive symptoms is
unknown there are a number of reports of the “putative antidepressant effects of
HRT” (p.57). In addition, Kotz, Alexander and Dennerstein (2006) also reported on
studies which found that oestrogen improved general well-being in some groups of
surgically menopausal women.

Canderelli et al. (2007) provide an overview of the current research on the use of
HRT. They conclude that in addition to alleviating certain perimenopausal symptoms,
HRT, when used in the first five years following menopause, may be useful in
preventing some comorbid conditions including type II diabetes, cardiovascular
disease, osteoporosis and colorectal cancer.

In 2007, citing what they considered to be incorrectly extrapolated data from the WHI
studies, the International Menopause Society called for a revision of the current
guidelines on prescribing HRT. They said that the safety profile for the use of HRT
for women up until the age of 60 years is favourable and should not preclude women
from using HRT when considered appropriate (Pines et al., 2007).

MacLennan (2009) makes the following comment regarding the changing guidelines
regarding the use of HRT and subsequent risks and benefits:

Recent analysis of new data from WHI, other RCTs and observational and
animal studies have now unified much of the HRT data, changed the risk:
benefit ratio for the large majority of women who commence HRT for
symptom control around menopause and given cause for the guidelines to be
reviewed and changed. (p. 121)
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Recently, the North American Menopause Society (NAMS, 2010) published their
Position Statement on the use of oestrogen and progestogen in postmenopausal
women. They provided the following statement:

Recent data support the initiation of HT around the time of menopause to treat
menopause-related symptoms; to treat or reduce the risk of certain disorders,
such as osteoporosis or fractures in select postmenopausal women; or both. The
benefits-risk ratio for menopausal HT is favourable for women who initiate HT
close to menopause but decreases in older women and with time since
menopause in previously untreated women (p. 242).

Several smaller studies also indicate that HRT has benefits for a range of conditions
that are associated with low oestrogen levels. For example, Hederstierna, Hultcrantz,
Collins and Rosenhall (2007) found that postmenopausal women who were using
HRT had better hearing than those who were not and Cook, Bass and Black (2007)
found that active women using HRT had less tendon abnormalities than non-users.

Finally, there are issues regarding the routes of delivery of hormone therapy in regard
to the safety and efficacy of such treatments. Carroll (2008) discusses the risks and
benefits of transdermal HRT as compared to oral therapy. She says that in Europe,
transdermal oestrogen therapy has been the dominant prescribing practice for
decades. In contrast, oral oestrogen therapy is the most commonly prescribed in the
United States. Of particular significance according to Carroll is the need for oral
oestrogen to be administered in supraphysiological levels to achieve therapeutic
levels of circulating hormone. She says that between 60% and 90% of oral oestrogen
is metabolised in the liver while transdermal oestradiol avoids this and achieves more
consistent blood oestrogen levels. Furthermore, she says that oral oestrogens are more
likely than transdermal to cause side-effects such as sore breasts and break-through
bleeding which is often associated with the discontinuation of therapy.
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Changing Attitudes to the Treatments and Management of Perimenopausal
Symptoms

Despite the evidence for the efficacy of HRT, the confidence in this treatment
previously enjoyed by many women (and their doctors) was reportedly compromised
by the release in July 2002 of the findings of the Women‟s Health Initiative (WHI)
study (Heinemann et al., 2008; Hickey et al., 2005; Kauffman, Castracane & van Hook,
2005; MacLennan 2009; Simon & Reape 2009; Wren, 2009).

According to Wren (2009), the release of the WHI report which indicated adverse
effects associated with the combined oestrogen and progestin trial, had a dramatic
negative effect on the prescribing habits of health professionals. Wren says that
“because of these negative findings, many health professionals stopped prescribing
oestrogen-based hormonal therapy, and women were bewildered by the conflicting
information regarding the safety of HRT” (p. 321). Similarly, Simon and Reape
(2009) say that following the negative publicity associated with the WHI report,
many women now avoid pharmacological treatments preferring to either put up with
symptoms or try unregulated alternative therapies. Holloway (2009) also says that
these negative findings led to an increase in confusion amongst women, the media
and the medical professionals who have subsequently become more reluctant to
prescribe HRT.

Several studies show the extent of the fall in HRT use following the negative
publicity regarding HRT. In Australia, a study conducted by MacLennan et al. (2004),
found that subsequent to the publication of the WHI report there was a two thirds
drop in HRT use within the authors‟ study population. Similarly, Hickey et al. (2005)
investigated the attitudes of doctors and their patients to HRT and found that a
substantial number of Australian women had stopped using HRT following the
release of the WHI report, because of their concerns about side-effects. In the year
2000, 38.8% of Australian women in their fifties were using registered conventional
HRT according to MacLennan, Gill, Broadbent and Taylor (2009). The level of use
declined to 11.8% in 2008 with another 4% using non-registered hormonal products.
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Kauffman et al. (2005) suggest that there is now “an atmosphere of unease and
trepidation” (p. 592) around the issue of HRT use. He says that “widespread concern
over safety issues persists among many physicians and menopausal women despite
the fact that estrogen therapy is unparalleled in the treatment of such symptoms” (p.
592). Furthermore, according to MacLennan (2009, September) misinterpretation of
the WHI findings resulted in misinformation and a degree of hysteria that has
subsequently placed symptomatic perimenopausal women at a disadvantage.

A number of authors refer to the role of the media in promulgating and maintaining
negative attitudes towards HRT use. Alexander and Moore (2007) say that the
media‟s reporting of the WHI report caused concern regarding all forms of HRT. As a
consequence, according to Kauffman et al. (2005), women (and their GPs) continue
to be influenced by the WHI findings and “a willing media searching for another
medical scandal “ (p.592). Furthermore, Simon and Reape (2009) suggest that
“although initial findings (of the WHI study) received widespread, at times
sensational, reporting in the popular media, less dramatic updates have received less
attention and media coverage” (p.75).

McIntosh and Blalock (2005) and Simon and Reape (2009) also found that the media
reports about the WHI study had a strong impact on women‟s attitudes to HRT use.
McIntosh and Blalock found that women who changed their HRT use after hearing
such media reports were significantly less likely to trust the information given by
their doctors about HRT. Conversely, Ness, Aronow, Newkirk, McDanel and Morley
(2005), found that women in their study continued to use HRT for a number of
reasons despite the negative publicity.

Women are ill-informed about the risks and benefits associated with HRT use
according to Simon and Reape (2009). In their study of the menopausal experiences
of professional women, they found that a number of women incorrectly identified the
risks associated with HRT use. They highlighted the fact that this lack of clarity about
the benefits and risks associated with HRT use existed despite these women being
highly educated and successful and visiting their healthcare professionals on a regular
basis.
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Several studies have endeavoured to identify factors that may differentiate HRT users
from non-users. For example, Twiss et al. (2007) reported that HRT users were more
likely than non-users, to engage in health-promoting behaviours such as using
calcium supplements, exercising and having mammograms. Bosworth et al. (2005)
also investigated the factors that influence women‟s decisions about the use of HRT
and found that the way in which women responded to the adverse findings was
influenced by a number of factors. Within their study sample, women were less likely
to discontinue using HRT if they had an increased understanding about HRT, were
confident, had mental health symptoms, had had gynaecological surgery and held the
perception that menopause is a natural process. In addition, they found that having an
increased understanding about the risks associated with HRT use, mood symptoms,
vasomotor symptoms, and having had gynaecological surgery were associated with a
greater likelihood of initiating HRT use. The researchers said that their findings
indicate the importance of physicians discussing the use of HRT with their patients,
especially in light of the recent findings.
Other studies have also focused on the factors that may influence women‟s decisions
regarding the use of HRT and other therapies. Heinemann et al. (2008) had
fortuitously investigated women‟s opinions about the use of HRT just prior to the
release (in 2002) of the WHI findings. The study was therefore considered by the
authors to provide a benchmark of attitudes towards HRT use from which to measure
changes since 2002. The study included over 10,000 women aged between 40 and 70
years, from nine countries across four continents. They found that for most “everusers” of HRT in their study, the relief of hot flushes, night sweats and insomnia were
rated as the most important reason for commencing therapy. Prevention of
osteoporosis was rated second. In addition, they found that as well as the relief of
symptoms, the absence of an increased cancer risk was also considered desirable.
Factors such as possible cardiovascular benefits, improvement in well-being and
protection of bone density were less highly ranked in regard to decisions about HRT
use. Furthermore, women who said they were afraid of hormones in general, believed
HRT use to be unnatural or that there were natural alternative preparations available
were frequently from the more developed countries and held underlying negative
attitudes towards HRT use.
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In addition to the confusion amongst women in regard to the risks and benefits
associated with HRT use, Simon and Reape (2009) report that health care
professionals may also lack an understanding of the pertinent issues. They found that
primary care physicians overestimated the risks associated with HRT as much as 67%
of the time. Other research (Kauffman et al., 2005) also reported changes in the
attitudes of doctors subsequent to the negative publicity about HRT. They found that
following reports of adverse findings, many medical practices in the US were
requiring patients to sign informed consent disclosure forms before being prescribed
HRT. They described this practice as puzzling given that it was not applied to the
prescription of many commonly prescribed extended-use drugs and the oral
contraceptive pill which they said carry greater risks.

Holloway (2009) also discusses the change in attitudes among health professionals in
regard to the use of HRT. She suggests that both women and health professionals may
use the confusing information about the risks and benefits of HRT selectively
depending on their personal beliefs. In addition, she says medical practitioners may
now be reluctant to prescribe HRT because the information available to them is both
confusing and contradictory. Similarly, Twiss et al. (2007) say that the ramifications
following the release of the WHI findings are that many healthcare providers are no
longer prescribing or recommending HRT to symptomatic women. Instead, they are
waiting for symptoms to become more distressing or for the woman to raise the issue
herself.

Finally, MacLennan (2009) discusses the effect of the change in attitude to the use of
HRT. He says that many women inappropriately stopped using HRT after the adverse
media reports in 2002 and makes the following comment in regard to this:

Ironically many women who experienced menopause after 2002 may have
missed a therapeutic window for cardioprotection and possibly cognitive
benefit and also suffered unnecessary menopausal symptoms if they avoided,
or their advisors denied them, the option of HRT. (p. 121)
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Sources of Information and Support for Perimenopausal Women

In Australia, the role of educating women and health professionals about the onset,
nature and treatment of perimenopausal symptoms has been undertaken principally by
the Australasian Menopause Society (AMS). The AMS may be described as the peak
medical body in Australia, promoting best practice in regard to the management of
issues associated with the health of mid-life women. The organisation‟s website
(www.menopause.org.au) provides information for health professionals and the
general public as well as links to other pertinent websites. According to the AMS:

The need to understand the various problems of the menopause, and their
management is a major issue to doctors, politicians, health care workers, and
the community; particularly when it is realised that women are not only living
longer, but that their numbers are increasing at a disproportionate rate (AMS,
2010 a)

Notwithstanding that the AMS is a vital source of information it is unclear to what
extent this information is accessed by women or health professionals. There is a
paucity of recent research into the current sources of information for women
regarding treatment of perimenopausal symptoms. According to Bosworth et al.
(2005), health care providers need to be aware of the pivotal role they play in
influencing the decisions of women in regard to the use of HRT and alternative
treatments for perimenopausal symptoms. He says he believes this is of greater
importance following the release of the WHI report in 2002 and that health care
providers should take the time to discuss matters of concern regarding HRT use with
their clients.

Twiss et al. (2007) recommend that health professionals allocate more time to the
education and assessment of perimenopausal women and the provision of information
that is accessible and consistent and empowers women to make decisions about their
health and choices regarding HRT use. They cite a number of studies that indicate
that women who are not well informed about HRT are less likely to use it.

55

Experiencing Perimenopausal Symptoms in the Workplace

There is a paucity of literature regarding the impact of perimenopause on women in
the workplace. Although not recent, a study by Reynolds (1999) is quite
comprehensive and her findings may still be pertinent. She claims that women‟s
experiences at work generally, have been largely neglected by researchers and that
even less is known about the impact of menopausal problems on women in the
workplace. Reynolds suggests that hot flushes may become more problematic when a
woman is trying to manage “particularly challenging or anxiety-provoking tasks (such
as meetings or tasks requiring attention to fine details)” (p. 358). She also found that
some women reported having problems with aspects of cognition such as learning or
concentration during hot flush episodes.

Although Reynolds acknowledges that her study has clear limitations she raises a
number of issues that she suggests warrant further investigation. In particular, she
discusses the need for more research into the impact of the social stigma that she
asserts is associated with being identified as menopausal. She suggests that women
who may be reaching higher levels in their organisation, may at times be concerned
that their poise and authority may be compromised by having their menopausal status
exposed due to having hot flushes in public situations.

This sense of vulnerability continues to be an issue for women, as highlighted in a
study by Morris and Symonds (2004) who interviewed women in clerical and
administrative jobs within large organizations. They found that the women in their
study reported that a number of symptoms such as hot flushes and unexpected heavy
bleeding increased their sense of vulnerability and embarrassment.

A study by Simon and Reape (2009) appears to be one of few to date that focuses on
the perimenopausal experiences of professional women. The authors say that the
majority of women they surveyed reported physical and/or emotional symptoms
which many believed significantly affected their personal and professional lives. In
particular they found that night sweats, insomnia and hot flashes (flushes) were the
most disruptive to the participant‟s professional lives and proved to be the most
bothersome menopausal symptoms. In conclusion they say that “menopausal
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symptoms can have a significant effect in the workplace. Physicians should be aware
of the frequency and impact that menopausal symptoms can have on patients‟ lives
and discuss the appropriate options available for treatment of these symptoms” (p.
76).

Finally, in addition to the impact of perimenopausal symptoms on women in the
workplace, there is evidence to suggest that work and the work environment may
exacerbate perimenopausal symptoms. A comprehensive report (Paul, 2003),
commissioned by the Trade Union Congress in the UK, identified a number of issues
of concern to women experiencing menopausal symptoms at work. In this study, 500
union safety representatives were asked to survey members about their experience of
perimenopausal symptoms. Respondents reported that many of the symptoms
commonly associated with perimenopause had been exacerbated by work or working
conditions. These included hot flushes (53%), headaches (46%), tiredness and lack of
energy (45%), sweating (39%) and menopause-related aches and pains (30%).
Concerns raised ranged from practical issues such as being required to wear uniforms
that did not cater for fluctuating body temperatures, to problems associated with the
embarrassment and stigma that were felt by many to be associated with being
menopausal.

Women Leaders in Australian Workplaces

At the core of this research is the coincidence of the age at which women may
experience perimenopausal symptoms with the age at which they may be undertaking
leadership roles. For example (as previously reported) the average age at actual
menopause is 51.4 years and many women will enter perimenopause several years
prior to this. Burgess and Tharenou (2002) say that most Australian women board
directors are between 45 and 47 years of age while Kang, Cheng and Gray, (2007)
found that the average board director was between 51 and 70 years of age. The most
recent report by the Australian Government Corporations and Markets Advisory
Committee Report on Diversity on Boards of Directors (March, 2009) showed that
the average age of board directors (male and female) was 53 years. In each of these
reports, the years in which women are likely to be undertaking leadership roles such
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as board directorships, include the years frequently associated with the menopausal
transition.
Women‟s participation in the Australian workforce is monitored by the Equal
Opportunity for Women in the Workplace Agency (EOWA) which is an Australian
Government agency consulting with Australian employers. In addition to a number of
educational and other initiatives, EOWA conducts an annual census of Women in
Leadership. According to the EOWA Census figures from 2008, women in leadership
roles are in the minority in almost every sphere of industry. Furthermore, women
become increasingly isolated as they advance to senior management levels until, at
the level of Board Director, they are outnumbered by men at 10 to one and at the level
of CEO, at 49 to one within the ASX200 companies (EOWA, 2009).

Furthermore, the 2008 census figures for the Australian Stock Exchange top 200
companies show a slight decrease in participation rates since the 2006 census
(EOWA, 2009). In 2006, there were 8.7% of board positions held by women and 12%
of executive managers were women. The report says that the number of positions for
women on boards has not kept up with the increase in overall board seats. In
executive management positions, they report that the numbers of women has also
decreased and there is a continuing decline in the pool of women in executive
management positions. In addition, the report says that the majority of women
continue to be in support positions rather than in line positions which purportedly
provide the experience considered essential for achieving top corporate positions. The
report also says that the increase in women holding line positions seen in previous
Census takings has not been sustained.
The decline (across all indicators) in women‟s participation in leadership roles is
discussed by McPhee and Smith (2009) in the forward to the (2009) EOWA Census
report. The authors highlight the decline in the proportion of women to men on
corporate boards and in executive leadership roles since 2006. They say that in this
regard, Australia has now fallen behind the United States, United Kingdom, South
Africa and Canada. One explanation that they say may account in part for this
decrease in women‟s participation is the growth in male-dominated industries (such
as mining and engineering). They say this only highlights the gender segregation
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within the Australian workforce and the problems women encounter in advancing
within such industry sectors.
The failure of women to gain leadership positions within Australia‟s top ASX200
companies despite the implementation of a number of strategies aimed at improving
the gender balance at this level was the subject of research by Nesbit and Seeger
(2007). They reviewed the activities of thirty Australian organisations across three
distinct industry groups (Finance and Insurance; Construction and Engineering;
Health and Community Services) in regard to the actions taken to support and
enhance women‟s participation in management roles. The following remarks were
made in regard to their findings:

While overt gender discrimination was generally reported to be a matter of the
past, indirect obstacles, relating to both organisational culture and wider social
values, still seemed to be in existence preventing women from reaching the top
levels of their organisations in equal proportions as men. Until these broader
social values are challenged and dealt with the extent that organisational efforts
for enhancement of women in management will continue to advance very
slowly. (p. 21)

In the absence of recent Australian research, a study by Martelli and Abels (2010)
explored a number of demographic variables within the population of CEOs of the
Fortune 500 companies in the United States. They found that although there was an
increase in the number of younger CEOs (between 40 and 44 years of age), the
average age of CEOs had remained constant for a number of decades at 55.1 years of
age. Female CEOs however, were less well represented within the younger age
brackets being on average older than their male counterparts. The authors concluded
that women needed to work harder and attain higher levels of experience and
education than their male counterparts, in order to be elected to CEO positions.
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Of particular relevance to this study are the ramifications for Australian women
leaders working in male-dominated environments. The continued underrepresentation of women in leadership roles in Australia suggests that the findings of
an earlier study by Gardiner and Tiggemann (1999) which indicated that being in
male-dominated environments can adversely affect women‟s physical and mental
health, may still be relevant. They describe three postulated consequences for women
in these circumstances which they say have the potential to increase stress levels.
These include stereotyping, exaggeration of differences and increased visibility. In
particular they say, increased visibility is associated with being one of only a few
women amongst a majority of men. This they say can be particularly stressful for a
woman if she feels she is being constantly watched and therefore under more pressure
to perform and to perform better than her male colleagues. The authors suggest that
this may also result in a sense of a loss of privacy for these women.

Another issue for women leaders involves the way they may be judged in regard to
the style of leadership they employ. Gardiner and Tiggemann (1999) say that when a
woman leader employs a more feminine style of leadership it may “make her even
more visible and exaggerate differences between herself and men even more, thereby
leading to increased negative reactions” (p. 302). They cite a conclusion reached by
the American Psychological Association (Amicus Curiae Brief, 1991) which may
continue to have relevance in more recent times:

Sex stereotypes place women in a double bind situation. If they adopt
stereotypically masculine styles of leadership that may be required for that
particular job, they are considered to be abrasive or maladjusted. However, if
women utilize stereotypically feminine styles, they are considered less capable
and their performance may not be attributed to competence. (Gardiner &
Tiggemann,1999, p.304)

Furthermore, according to Gardiner and Tiggemann (1999) the style of leadership
adopted by women working in male-dominated organisations tends to be more similar
to that employed by men and conversely more interpersonally orientated when
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working in female-dominated environments. In addition, women‟s tendency to
employ an interpersonally orientated leadership style was seen to be decreased when
in a male-dominated environment. This they said supported the findings of a cited
study by Eagly and Johnson (1990) which found that women “adopted more typically
male styles in order not to lose authority and position” (Gardiner & Tiggemann,1999,
p. 301).

Isolation is another issue for women working in mostly male-dominated workplaces
according to Gardiner and Tiggermann (1999). They suggest that this isolation from
other women and also from the predominantly male peer group may reduce
opportunities to access both formal and informal support which may also increase
stress levels. They conclude that their findings support the more general claims of a
number of other researchers, that the work stressors experienced by women leaders
are greater than those experienced by men. Much of this stress they say reportedly
comes from being isolated, overworked and more visible than men. In addition they
acknowledge that many of these stressors also apply to women leaders in femaledominated industries. An exception they say, relates to the issue of discrimination
where male colleagues are seen to be treated more favourably and are perceived to
have greater career opportunities.

More recently, Eagly (2007) suggests that in male-dominated environments, women
find it difficult to develop helpful relationships and gain access to influential
networks. The issue of exclusion from influential networks and opportunities to
develop the kind of camaraderie that men take for granted at this level is also raised
by Eldridge, Park, Phillips and Williams (2007). They reported that some women said
they were reluctant to share personal issues or be as casual with colleagues as were
their male peers. Another issue raised by Eldridge et al. (2007) concerns the paucity
of strong mentorship for women in senior roles when compared to their male peers.

Eagly (2007) also proposes that women in highly masculine domains have to contend
with a greater range of criticisms and expectations than their male colleagues. She
says in conclusion that “given these hurdles, advancing up a highly male-dominated
hierarchy requires an especially strong, skilful, and persistent woman. She has to
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avoid the threats to her confidence that other people‟s doubts and criticisms can
elicit” (p. 6).

Summary

The literature reviewed in this chapter provided the basis for the development of the
research questions and directed the conduct of the study. The following chapter will
address the rationale for the selection and implementation of the research
methodology subsequently chosen as the most appropriate approach to explore the
phenomenon of perimenopausal symptoms in the lives of the women leaders who
participated in this study.
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Chapter Three: Research Design

Introduction

Research regarding perimenopause and the menopausal transition has most often
focussed on the physiological effects of fluctuating hormones. Consequently, studies
in this area have generally used quantitative approaches in the measurement and
evaluation of data. Although qualitative approaches have been used to explore various
psychosocial and cultural issues associated with the menopausal transition, relatively
few studies have employed qualitative approaches to explore the broader impact of
perimenopausal symptoms on women‟s lives. Fewer still have investigated how such
symptoms may affect women in the workplace and in particular, women in leadership
roles. A narrow focus on the numerically measurable effects of perimenopausal
symptoms is unlikely to provide the kinds of insights that may enhance our
understanding of how working women in positions of responsibility experience and
manage this time of their lives.

It is evident within the literature that perimenopause has often been seen primarily as
a medical issue and therefore researched using approaches traditionally favoured
within the medical sciences. Although research using quantitative approaches is
appropriate in many instances, qualitative approaches provide a different perspective
and offer opportunities to explore the ways in which people experience phenomena
within their lives. In this regard, a number of health care professionals have raised
their concerns about the lack of good qualitative research within the medical sciences.
For example, Malterud (2001) suggests that the use of qualitative research methods
could improve the quality of medical research. She makes the following comment:

Medical research needs diversity. We need to prevent methodological
separatism and supremacy if the field of medical knowledge is to be expanded,
not just strengthened or divided. Responsible application of qualitative research
methods is a promising approach to broader understanding of clinical realities.
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No research method will ever be able to describe people‟s lives, minds, and
realities completely though, and medical doctors should be reminded that
scientific knowledge is not always the most important or relevant type of
information when dealing with people. (Malterud, 2001, p. 489)

More recently, Clarke (2009) discussed the value of applying qualitative approaches
in health care research. She says that health professionals need to develop a deeper
understanding of the experiences of clients, colleagues and carers and of the
relationship between their practice and the health and wellbeing of clients.

Qualitative approaches by their very nature explore the way people make sense of
their experiences. The information gathered using qualitative research can only add to
our understanding and thereby enhance the way health professionals interact with
their patients and clients. The rationale for choosing a qualitative research approach
and in particular, interpretative phenomenological analysis (IPA) for this study will
now be discussed.

Qualitative Research
Denzin and Lincoln (2005) describe qualitative research as “a field of enquiry in its
own right” (p.2). They discuss at length the historical and political factors that have
influenced the development and practice of qualitative research over several decades
and offer what they describe as a generic definition:

Qualitative research is a situated activity that locates the observer in the world.
It consists of a set of interpretative, material practices that make the world
visible. These practices transform the world. They turn the world into a series
of representations, including field notes, interviews, conversations,
photographs, recordings, and memos to the self. At this level, qualitative
research involves an interpretive, naturalistic approach to the world. This
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means that qualitative researchers study things in their natural settings,
attempting to make sense of, or interpret, phenomena in terms of the meaning
people bring to them. (Denzin & Lincoln, 2005, p.3)

Smith (2004) says that qualitative approaches allow researchers to explore, describe
and interpret participants‟ personal and social experiences. In particular he says that
qualitative approaches enable researchers to investigate particular phenomena in a
way that is not restricted by predefined categories or narrow hypotheses.

Although qualitative approaches have gained popularity within a number of health
related areas such as psychology (Smith, 2004), other disciplines have been slower to
embrace this methodology. For example, Ryan-Nicholls and Will (2009) say that
although qualitative research methods are considered to be congruent with the goals
and perspectives of nursing, there continues to be resistance to the use of qualitative
approaches within many areas of medicine and public health. The authors suggest that
the emphasis on evidence-based research often relegates qualitative studies to
“second-class status” (p.70). They cite Morse (2006) who suggests that this may in
part be due to the application of Cochrane criteria which places randomised clinical
trials as the gold standard in research relegating studies using qualitative
methodologies to a non-fundable status.

In addition, according to Ryan-Nicholls and Will (2009) qualitative researchers are
frequently criticised for failing to demonstrate methodological rigour. They cite
Maggs-Rapport (2000) who they say correctly predicted that those with a poor
understanding of qualitative approaches would continue to judge qualitative studies as
failing to meet the standards of rigour that are more appropriately applied to
quantitative research. Furthermore, they say that although there are fundamental
differences between qualitative and quantitative methods, attempts to address such
concern often result in a tendency to evaluate both approaches against criteria suitable
for quantitative research only. Rolfe (2006) and Smith, Flowers and Larkin (2009)
also reject the notion that qualitative research should be judged according to the same
criteria as those applied to quantitative research.
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Ryan-Nicholls and Will (2009) outline some alternative criteria for assessing rigour
in qualitative research. For example, in regard to the concept of truth value or internal
validity, they cite Sandelowski (1986):

The search for truth is much more elusive in qualitative research. In this type
of enquiry, truth value is subject-orientated rather than defined by the
researcher. Truth is found in the discovery of human phenomena or
experiences as they are lived and perceived by subjects as opposed to the
verification of a priori conceptions of such experiences. (Ryan-Nicholls &
Will, 2009, p.72)

The concept of neutrality which is so valued in the conduct of quantitative research is
also discussed in regard to its relevance within the context of qualitative research.
Ryan-Nicholls and Will (2009) say that by its very nature, “qualitative research seeks
the truth by interacting with, as opposed to disengaging from, that which is being
investigated” (p. 73). The disengagement that is required to achieve neutrality in the
context of quantitative research is therefore diametrically opposite to the engagement
and connection required in conducting qualitative research.

A key issue in all research, including qualitative approaches, is the validity of the
methodology. Smith et al. (2009) cite four broad principles as suggested by Yardley
(2000) which they considered to be more appropriate for assessing the quality and
validity of qualitative studies than those designed for quantitative research. Each of
these principles will now be outlined and their application within this study will be
discussed where relevant in the following sections of this chapter.

Sensitivity to Context

According to Yardley (2000) as cited in Smith et al. (2009) demonstrating sensitivity
to context is a hallmark of good qualitative research. This sensitivity may include
consideration of socio-cultural issues, the published literature on the topic and the
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data obtained from the study participants. The conduct of the research interview also
provides an opportunity to demonstrate sensitivity to context through the interactional
nature of the interview process. This can also be demonstrated during the process of
data analysis in so far as “making sense of how the participant is making sense of
their experience requires immersive and disciplined attention to the unfolding account
of the participant and what can be gleaned from it” ( p.180). Furthermore, they say
that sensitivity to context can also be demonstrated through an awareness of the
existing literature both substantive in regard to the topic under investigation and
theoretical as it applies to the conduct of the research itself.

Commitment and Rigour
Yardley‟s (2000) second broad principle, as cited in Smith et al. (2009) refers to the
issues of commitment and rigour. Commitment is said to be demonstrated in a
number of ways including the manner in which the researcher ensures the comfort of
participants during the interview process and attends to what the participant is saying.
Smith et al. (2009) say that there is an expectation that researchers have the skills
necessary to undertake these kinds of interviews effectively. This commitment also
needs to be demonstrated in the manner in which the data from each participant is
subsequently analysed.

Rigour is concerned with the thoroughness of the study. This can be enhanced
through the selection of an appropriate and reasonably homogeneous sample; use of
well conducted in-depth interviews to gather the data and a thorough and systematic
analysis of the data with sufficient idiographic engagement. In addition, the analysis
of the data must move beyond a description of what is said, to an interpretation of the
meaning implicit in the participant‟s narrative. Smith et al. (2009) say that IPA
studies should not only tell the reader something about individual participants but also
something about the themes they have in common with others in the study.
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Transparency and Coherence

According to Yardley (2000) as cited in Smith et al. (2009), transparency relates to
the clarity with which the stages of the research process are written-up on completion
of the study. This may include a description of how participants were selected, how
the interview was conducted and the steps used during the data analysis.

The coherence of the research may ultimately be judged by the reader of the
completed write-up and may relate to the coherence of any argument put forward, the
apparent logic behind the clustering of themes and the way in which any ambiguities
or contradictions are addressed.

Impact and Importance
Yardley‟s (2000) final principle as cited in Smith et al. (2009), is concerned with the
extent to which the particular piece of research is considered to tell the reader
anything of interest, use or importance. Yardley says this ultimately provides a
measure of the real validity of the research.
In addition to Yardley‟s four broad principles (Yardley, 2000 as cited by Smith et al.
2009) the authors suggest the independent audit as a really powerful way to
demonstrate validity in qualitative research. This requires the filing of all data in such
a way that the process can be followed from the initial interviews through to the final
report. They highlight the difference between this kind of audit and the type used to
quantify the analysis of open-ended material. The independent audit they say is
“attempting to ensure that the account produced is a credible one, not that it is the
only credible one” (p. 183). In this regard, the aim is not to produce a single report
claiming to represent the only truth nor necessarily to achieve some kind of
consensus, but rather to acknowledge that there may be a number of possible accounts
that are also legitimate. The concern they say is therefore about how transparently and
systematically the particular account has been produced.
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Interpretative Phenomenological Analysis (IPA)

IPA is a relatively recent approach to qualitative research. The approach originated in
the area of psychology and has more recently been applied to other disciplines within
the human, health and social science fields (Smith et al., 2009). Brocki and Wearden
(2006) described IPA as providing a theoretical foundation and offering a “detailed
procedural guide” (p. 87) for the conduct of research. Furthermore, Smith and
Osborne (2004) say that IPA is an appropriate approach when investigating how
individuals perceive particular situations and make sense of their personal and social
world, particularly when the researcher is concerned with novelty, complexity or
process. They add that within the practice of IPA, research questions are usually
framed broadly and openly and there is no attempt to test a predetermined hypothesis,
but rather to explore an area of concern in a flexible yet detailed way. Furthermore,
within IPA the process of analysis of the raw data is iterative and ongoing and the
overall aim is to provide an interesting narrative account of the emerging themes
(Seamark, Blake & Seamark, 2004).

According to Smith et al. (2009) IPA has been informed by concepts and debates
from three key philosophical areas including phenomenology, hermeneutics and
idiography. The influence of each of these areas on the development and conduct of
IPA will now be discussed.

Phenomenology
Phenomenology is at the core of IPA and is described by Smith et al. (2009) as “a
philosophical approach to the study of experience” (p.11). According to Giorgi and
Giorgi (2004), phenomenology “seeks the psychological meanings that constitute the
phenomenon through investigating and analysing lived examples of the phenomenon
within the context of the participants‟ lives” (p.27).

Smith et al. (2009) describe the contributions of a number of philosophers to the
phenomenological approach including Husserl, Heidegger, Sartre and Merleau-Ponty.
Hursserl, they say, emphasised the importance of focusing on our perceptions of
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experience. This concept was developed further by Heidegger, Sartre and MerleauPonty who they say “ each contributed to the view of the person as embedded and
immersed in a world of objects and relationships, language and culture, projects and
concerns” (p. 21). This descriptive or Husserlian approach which is distinguished by
bracketing or holding in abeyance, the researcher‟s theoretical impositions and preconception was gradually replaced by the interpretative or hermeneutic approach
(Kleiman, 2004; Smith & Osborne, 2004; de Witt & Ploeg, 2006).

Hermeneutics

Unlike the Husserlian approach, the interpretative or hermeneutic approach considers
the researcher‟s conceptions to be integral to his or her ability to interpret the
participant‟s personal world. Smith et al. (2009) describe hermeneutics as a theory of
interpretation concerned with the methods and purposes of interpretation itself. By its
very nature, the interpretative approach provides both the researcher and the
participants with an opportunity to play a role in a “dynamic research process”
(Clarke 2009, p.37).

Idiography

Idiography also exerts a major influence on IPA according to Smith et al. (2009).
They describe idiography as being concerned with the particular in contrast to being
nomothetic or concerned with establishing general laws about human behaviour and
making claims about groups or populations. The authors assert that this idiographic
commitment is demonstrated in IPA firstly through IPA‟s commitment to being
particular about the detail and therefore the depth of analysis, and secondly in its
commitment to understanding particular experiential phenomena from the perspective
of particular people within a particular context. They say that as a consequence of this
“IPA utilizes small, purposively-selected and carefully-situated samples, and may
often make very effective use of single case analyses” (p.29).

70

In regard to the conduct of IPA, Smith and Osborn (2004) say that there is no
definitive way to conduct IPA but rather researchers may adapt their approach
according to the topic under investigation. They summarise the core philosophical
basis of IPA as follows: “IPA has a theoretical commitment to the person as a
cognitive, linguistic, affective and physical being and assumes a chain of connection
between people‟s talk and their thinking and emotional state” (p.52). Furthermore,
Smith et al. (2009) say that “IPA is concerned with the detailed examination of
human lived experience. And it aims to conduct this examination in a way that as far
as possible enables that experience to be expressed in its own terms, rather than
according to predefined category systems” (p.32).

Finally, it is considered pertinent within the context of this study, that the approach
used in IPA is congruent with many of the principles of feminist methodology, as
outlined by Neuman (2003) and Seibold (2000). Seibold describes what she considers
constitutes a feminist research:

A typical checklist of what characterises feminist research is as follows: the
principal investigator is a woman; the purpose is to study women and the focus
of the research is women‟s experiences; the research must have the potential to
help the subjects as well as the researcher; it is characterised by interaction
between researcher and subject and by non-hierarchical relations, expressions
of feelings and concerns for values. (Seibold, 2000, p.151)

The Rationale for Choosing IPA for This Study

This study sought to explore the phenomenon of perimenopausal symptoms as
experienced by women in leadership roles. The intention was to explore this
phenomenon in a way that would enable the participants to provide deeper, personal
insights which may not be generated by research using traditional quantitative
approaches. To achieve such insights it was considered important that data be
gathered in a manner which would be least likely to pre-empt or in any way limit the
scope of the participants‟ responses. Therefore, a qualitative methodology was chosen
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as the most efficacious method for this study. Furthermore, IPA as an interpretive
phenomenological approach was considered the most appropriate because it provided
a framework that enabled the exploration and interpretation of the meaning ascribed
by women in leadership roles in regard to their experience of perimenopausal
symptoms.

Method

Participants and recruitment.

Purposive sampling was used to recruit 17 participants, including parliamentarians,
executives from corporate, government, non-government, not-for-profit organisations
and academic institutions. The method of recruitment ensured a degree of
homogeneity among study participants in regard to their experience of the
phenomenon being explored (Seamark et al., 2004; Smith & Osborn 2004; Guest,
Bunce & Johnson, 2006; Smith et al., 2009). The approach is also consistent with
IPA practice and the aforementioned commitment to ensuring rigour within the
study. Furthermore, Neuman (2003) says that purposive sampling is appropriate
when the researcher wants to recruit individuals from a “difficult-to-reach,
specialized population” (p.213). Due to both the nature of the research topic and the
leadership status of the prospective participants, the population targeted within this
study could well be described in this way.

According to Smith and Osborn (2004) decisions about sample size in studies using
IPA are based on a number of factors. These included consideration of the time
constraints; level of commitment of the researcher and the richness of the data
obtained from the interviews. Although Smith and Osborn maintain that there is no
right sample size, they suggest that the analysis of larger data sets may result in the
loss of “potentially subtle inflections of meaning” (p. 54). According to the broader
literature on IPA studies, as reviewed by Brocki and Wearden (2005), participant
numbers in IPA studies varied from one to 30. Smith et al. (2009) suggest that
historically, qualitative researchers opted for larger sample sizes in order to avoid
criticism from their quantitative colleagues. They say that as more studies are
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published and the approach gains a level of maturity, sample sizes are falling. They
recommend that between four and 10 interviews may be sufficient for a study at
professional doctorate level.

Due to the sensitive nature of the study topic, it was considered important to recruit
participants in a manner which protected them from being identified as
perimenopausal. It was therefore decided that publicly advertising the study either
within the community or workplace would be inappropriate. Rather, a less direct
recruitment process was used whereby individuals within the realms of the
researcher‟s professional networks were asked to approach colleagues or friends who
were deemed to be in leadership roles (as defined for this study) and who they
thought might be interested in taking part in the study. Potential participants were
then invited to contact the researcher if they were interested in receiving further
information about the study. This initial approach also resulted in a snowballing
effect whereby prospective participants subsequently informed others within their
networks about the study.

It is important to note that a great deal of consideration was given to the process of
recruitment in regard to the risk of causing offence by approaching someone who
may not have considered herself to be perimenopausal. Those asked to approach
others all professed to being mindful of this and agreed to undertake the task with
great sensitivity. To the knowledge of the researcher no one was offended by being
asked to participate and this was a tribute to those involved in helping in the
recruitment process and also to the women who subsequently volunteered to
participate.

The women who subsequently expressed an interest in participating in the study were
provided written material including: information about the study as required by the
UNDA Ethics Committee (Appendix B); information regarding the terms used in the
study (Appendix C); a Symptoms Checklist (Appendix D). The symptoms checklist
was a composite of checklists used by the Keogh Medical Centre (adapted with
permission, Dr Natalia Kowal, November 16, 2007) and the Australasian Menopause
Society (AMS, 2008 a). The decision to provide this information to potential
participants was based on research by Lyndaker and Hulton (2004) as outlined in the
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previous chapter, which found that women often fail to recognise certain
perimenopausal symptoms. It was intended therefore, that the provision of this
information would enable potential participants to more accurately determine their
eligibility for inclusion in the study. The checklist was also used as a catalyst for
discussion of symptoms during the interview.

The 17 leaders who subsequently agreed to take part in the study all signed the
Consent Form (Appendix A) as required by the UNDA Ethics Committee, completed
the interview process and provided information for the study.

Data collection.

Qualitative data were gathered through audio-taped, in-depth, semi-structured
interviews.
Smith et al. (2009) describe the qualitative research interview as “a conversation with
a purpose” (p. 57). Smith and Osborne (2004) say that the semi-structured interview
method is considered the exemplary method for IPA. They assert that this form of
interview allows greater flexibility and enables the interviewer to go into novel areas
and thus produce richer data. In addition, they say this approach acknowledges the
participant as the perceived expert in the telling of their story. According to Reid,
Flowers and Larkin (2005), one-to-one interviews enable interviewer and respondent
to “work in flexible collaboration, to identify and interpret the relevant meanings that
are used to make sense of the topic” (p. 22).

Rubin and Rubin (2005) use the term responsive interviewing rather than in-depth
interviewing to highlight the interactive nature of the interview process which they
also say should generate a depth rather than a breadth of understanding. They
emphasise the importance of recognising the mutuality of the relationship between
the interviewer and interviewee as conversational partners. The main goal of
responsive interviewing, they say, is to achieve a deep understanding of what is being
studied and they describe the process of achieving this as follows:
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Research design and questioning must remain flexible to accommodate new
information, to adapt to actual experiences that people have had, and to adjust
to unexpected situations. The researcher creates future questions based on what
he or she has already heard, requiring the researcher to analyse interviews
throughout the project rather than just at the end. (Rubin & Rubin, 2005, p 35)

As discussed earlier, in-depth interviews also enable the researcher to engage with the
participant in a manner that contributes to the rigour of the research process. Smith et
al. (2009) describe a good in-depth interview as essential to IPA. Furthermore, they
say that “unless one has engaged deeply with the participant and their concerns,
unless one has listened attentively and probed in order to learn more about their
lifeworld, then the data will be too thin for analysis” (p. 58).

As an experienced mental health counsellor, this researcher applied the skills of
active listening, paraphrasing and prompting to ensure that each participant had the
opportunity to relate her story openly and in a manner that contributed to the
exploration of the research topic. The interviewer was mindful however, of the need
to avoid taking on the role of counsellor within the interview process. When
appropriate, at the conclusion of the interview the researcher discussed particular
issues of concern that had been raised in the interview and provided information
about further sources of advice and support.

Smith et al. (2009) recommend that an interview schedule be prepared in order to set
a loose agenda for the interview process and to enable the researcher to think more
deeply and explicitly about the content and scope of the interview. Furthermore,
Smith and Osborn (2004) say that consistent with the concerns associated with an
approach such as IPA, the interview schedule should provide a guide to the
interviewer rather than dictate the course of the interview. They say that this enables
the interviewer to feel free to probe interesting issues raised by the participant and
follow areas that are of interest or concern to the participant.
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All interviews were undertaken by the researcher in an environment that ensured each
participant‟s comfort and privacy. According to Kleiman (2004), undertaking the dual
role of collection and analysis of data enables the researcher to achieve the richest
appreciation of the rendered descriptions. In addition, it was considered that having
only one interviewer would ensure optimum consistency in data collection. The place
and time of the interview were decided by the participant.

Smith et al. (2009) highlight the importance of establishing rapport with participants
if meaningful data is to be obtained. Given the sensitivity of the research subject,
establishing rapport through perceived (and genuine) empathy was considered
essential to the research process. The researcher‟s gender, age, and both personal and
professional experience of perimenopause was considered vital to the development of
the level of rapport considered necessary to gain participant‟s confidence and elicit
open dialogue. Rubin and Rubin (2005), cite Aston (2001, p. 147) who asserts that
personal disclosure is essential in that it increases the comfort levels of the participant
and facilitates a degree of “trust and mutuality”.

Following initial introductions to facilitate mutual rapport, the symptoms checklist
was used as a catalyst for discussion. Participants were only prompted to discuss a
particular symptom they had checked if they did not spontaneously do so. If there was
any reluctance to discuss a checked symptom the issue was not pursued. Prompts
were only used if it was considered that the participant‟s narrative had not addressed
the research questions. In most cases, discussion of specific symptoms led to
revelations about the broader issues associated with the experience of perimenopause,
coping strategies, attitudes to treatment options and the implications of this in regard
to the participant‟s role as a leader. Finally, if not spontaneously mentioned,
participants were prompted in regard to providing their recommendations for other
women in similar circumstances (Research Question Four).

Within this study, data analysis began with the transcription of each interview.
Following initial analysis of the 17 interview, it was decided that little would be
added to the research findings by conducting further interviews. Charmaz (2004)
describes the point at which it is considered that no new insights would be gained by
gathering further data as category saturation.
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Data analysis.

According to Smith et al. (2009) there is no single approach to data analysis in IPA,
but rather a degree of flexibility and a clear focus on exploring participant‟s attempts
to make sense of their experiences. They describe data analysis in IPA as follows:

IPA can be characterized by a set of common processes (e.g. moving from the
particular to the shared, and from the descriptive to the interpretative) and
principles (e.g. a commitment to an understanding of the participant‟s point of
view and a psychological focus on personal meaning-making in particular
contexts) which are applied flexibly, according to the analytic task. (p.79)

Consistent with IPA practice, the process of data analysis in this study began with the
interpretation of individual transcripts. This process was begun following each
interview as recommended by Rubin and Rubin (2005). According to Smith and
Osborn (2004) the central issue is to explore the meaning ascribed to the participant‟s
experiences and to try to understand the content and complexity of these meanings
rather than to measure the frequency with which they occur.

The qualitative data management package NVivo 8 was used to assist with the
development of a number of superordinate themes as outlined by Smith and Osborn
(2004) and Larkin and Griffiths (2004). In this regard, where the authors recommend
the use of left and right hand margins on individual transcripts to record emerging
themes, NVivo8 provided the option of transferring identified themes directly into
free nodes and subsequently tree nodes which are coded to enable linkage back to the
passage within the transcribed narrative. This provides a high level of transparency
within the study, enabling the accuracy and context of the data to be easily checked
and thereby further contributing to the rigour of the study as outlined by Smith et al.
(2009).

According to Smith and Osborn (2004) a number of factors influence the selection of
themes rather than simply their prevalence within the data. These factors include the
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richness of particular narrative that may highlight a particular theme and the way in
which a particular theme may relate to other aspects of an account. Utilizing NVivo 8
to manage the data, the process was therefore conducted as follows:


Individual transcripts were read and re-read in order to identify any comments
made by participants that were considered to be related to the research questions.
All the resulting data (excerpts from the participants‟ narrative) were included as
findings of the study. This process was iterative and produced a number of themes
that included the terms used by the participants to represented their experiences
and concerns.



This process was continued with each transcript.



After the process of identifying themes was completed, emerging clusters of
themes were identified. This process involved the categorising and re-categorising
of themes in an explicitly interpretative process that reflected both commonalities
and differences in the data from individual transcripts.



Connections between themes were identified and reassessed in relationship to the
original transcripts. The emerging clusters of themes were subsequently labelled
and represent the four emergent superordinate themes.



Emergent superordinate themes were then analysed with the findings
subsequently presented in Chapter Four.



Finally, a discussion of the findings with linkage to the extant literature is
presented in Chapter Five.

Transferability of the Study Findings

As discussed earlier, qualitative research has often been judged according to criteria
more appropriate for judging quantitative approaches. For example, Malterud (2001,
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p. 486) discusses the concept of transferability saying that the findings from analysis
of qualitative data may only constitute “descriptions, notions, or theories” (p. 486)
which are applicable within a specific setting and not to the population at large. As
with most research using qualitative approaches, the intention of this study was to
explore the lived experiences of the women in the study group in order to develop a
greater understanding of the phenomenon under investigation. The findings from the
study are not intended to be transferable to other populations but may however be
used to inform the direction and nature of further research including that which
employs quantitative approaches.

Ethical Considerations

There were a number of ethical considerations that were required to be addressed
prior to and during the undertaking of this research. These considerations will now be
outlined.

Informed consent.

It is a requirement of the University of Notre Dame Australia Human Research Ethics
Committee (HREC) that those engaging in research involving human subjects obtain
informed and voluntary consent from respondents prior to their participation in the
study. In accordance with these requirements, signed Consent Forms (Appendix A)
were collected from each respondent and respondents were provided with pertinent
information about the study (Appendix B; Appendix C).

As participants in this study were English-speaking adults in leadership roles, all were
able to provide informed and voluntary consent as required by the HREC. However,
as the research methodology involved one-on-one interviews on a subject
(perimenopause) about which participants may have been sensitive, participants were
advised of their right to withdraw consent during the interview and to review, edit or
erase the recording or transcript of the recording of the interview prior to its inclusion
in the study.
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Confidentiality and anonymity.

According to McHaffie (2000), as cited in Walker (2007), research involving face-toface interviewing makes participant anonymity impossible. Confidentiality will be
protected, however, in a number of ways as described earlier and as required by the
HREC. Neuman (2003), cites Singer et al. (1995) who found a “modest”
improvement in responses to highly sensitive topics when researchers assured
participants about confidentiality. To ensure that participants achieved this level of
assurance, the issue of confidentiality was discussed prior to the commencement of
the interview.

Honesty and trust.

It was anticipated that approval of this project by the HREC would provide
participants with some reassurance regarding the legitimacy of the research and the
obligations of the researcher to behave in an honest and trustworthy manner. Beyond
this, if the researcher‟s approach had failed to elicit the trust of the participant it was
considered unlikely to promote the rapport required for the transaction of information
considered to be of value to the research. To develop and maintain the level of trust
that was required in order to elicit meaningful data, it was considered essential to
promote a sense of transparency about the research process. In this regard, the
concept of consent as “an ongoing transactional process” (Walker 2007, p. 41), was
pertinent because if a participant had lost trust in the researcher at any stage in the
process, she may have chosen to withdraw her consent and her data would have been
lost to the study. This did not occur and all participants indicated that they had been
comfortable with the interview process with many adding that they had found the
experience both informative and enjoyable.

Reciprocity.

Once a participant had (as required by the HREC) been duly informed about the
nature of the research and the obligations of the various parties involved, it was
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anticipated that her decision to take part indicated that she considered the project had
some merit. Beyond the expectation that her involvement may in some way be able to
contribute to the greater good, it was conceivable (and certainly the desire of this
researcher) that through her participation in the study, a participant may gain a greater
awareness of the issues surrounding perimenopause. It was also anticipated that as
well as gaining some personal benefit, participants may subsequently be better able to
support female colleagues and women under their management and perhaps influence
occupational health and safety policy around this issue within their workplace.

Intervention and advocacy.

It was considered appropriate to explain to the participant that there was implicit in
the interaction some duty of care that required the researcher to terminate the
interview and refer the participant to the appropriate service (counsellor or
occupational health service provider) if information revealed during the interview had
raised concerns about the wellbeing of the participant or another party. The researcher
did not undertake the role of counsellor or advocate and was prepared to encourage
any participant making such a request to seek the appropriate service to meet their
needs. The need for this action did not arise during any of the interviews.

Beneficence and non-maleficence.

Walker (2007) says that beneficence and non-maleficence are among the most
fundamental ethical principles applicable to research. The use of semi-structured
interviews and IPA was considered the most efficacious methodology for this study
as it enabled the researcher to develop the rapport considered necessary in order to
elicit candid responses from the participants. It was acknowledged however, that
given the nature of the research topic, this approach may have (under the HREC
guidelines for assessing level of risk), constituted highly personal interviewing using
an intrusive technique. As discussed above, the subject matter of this research may
have been considered highly sensitive by many of the study participants and it was
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therefore essential that participants were encouraged to feel comfortable with the
researcher and confident about confidentiality.

Siebold (2000) discusses the problems associated with the revelation of highly
personal information by participants during an interview in which an empathetic
relationship is established. This relationship, although likely to be conducive to the
gathering of information pertinent to the research, can also become problematic if the
interviewer is recruited into the role of counsellor. Care was taken to ensure that the
interviewer maintained the role of researcher and was prepared to terminate the
interview if it was felt the needs of the participant were not being met, or were being
compromised in any way by the interview process.

Mitchell and Lovat (1991) discuss the concept of non-maleficence in the context of
its association with the maxim “above all, do no harm”. In regard to this research, the
intention of the researcher was to ensure that the interview process was of some
benefit to the participants, and to be vigilant in ensuring that no harm was done to
participants as a result of the interaction. As discussed above, an interview would
have been discontinued if it had been considered that the process was having a
negative impact on the participant. To ensure the participants were able to enhance
their understanding of the issues under discussion, at the completion of the interview,
participants were directed to the website of the AMS (www.menopause.com.au) for
information about perimenopause, support services and a list of AMS trained general
practitioners in their vicinity.

The issue of power.
O‟Leary (2005) discusses the need for researchers to “recognise the political nature of
research and to manage the position of power afforded the researcher (p.43).” It was
expected that the issue of power would be less problematic in this study because the
participants were in leadership roles and thus less likely to be at risk of feeling
intimidated by either the researcher or the interview process. It was evident during
each of the interviews that the participants, by virtue of their job roles, were in
positions of power and authority themselves and therefore unlikely to feel intimidated
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by the researcher. In addition, the fact that the researcher was also a woman and of
similar age who revealed having had personal experience of perimenopausal
symptoms appeared to further preclude any possibility of participants feeling that
they were in any way at a disadvantage.

Reflexivity.

According to Walker (2007), the most critical ethical obligation of a researcher
conducting qualitative research, is to interpret the experiences of others in the most
faithful way possible. Reflexivity refers to the concept of acknowledging that the
actions and decisions of the researcher will affect both the meaning and context of the
participant‟s experience. In this regard, research is seen as a joint enterprise between
researcher and participant (Ashworth, 2004; McBrien, 2008). Although there is some
debate in the literature about the extent to which a researcher should reflect on his or
her biases and prejudices and how these may affect the rigour of the study (McBrien,
2008), the interpretive approach considers the researcher‟s conceptions to be integral
to his or her ability to effectively interpret the participant‟s personal world (de Witt &
Ploeg, 2006; Smith & Osborne, 2004). Within this study, the interview method
selected, the conduct of the interview and the process used in the analysis of the data
ensured that the best effort was made to provide an authentic representation of the
lived experiences of the participants.

Summary

This researcher used qualitative research methodology faithfully to explore the
phenomenon of perimenopause and its effects on women in leadership roles. Every
aspect of the study including the recruitment process, interview method, data
collection and analysis were designed to ensure that the experiences of the
participants would be explored in a meaningful and respectful manner with
consideration of the sensitivity of the study topic. The generosity of the participants in
talking frankly about a very personal matter was greatly appreciated. Their stories and
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valuable insights, which represent the study findings will be presented in the
following chapter.
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Chapter Four: Presentation of Findings

Introduction

The aim of this chapter is to present the findings of the study in a manner consistent
with the methodological approach outlined in Chapter Three. The presentation of the
findings as superordinate themes represents the final stage of the process of data
analysis which began during the interviews. This process continued as each
transcribed interview was subsequently read and re-read until a number of pertinent
themes emerged. These themes and the emergent superordinate themes constitute the
findings of the study.

As discussed by Smith et al. (2009), superordinate themes represent a construct that
evolves through a process of exploring connections, patterns and differences in the
data. From the time of interview until the final distillation of emergent themes into
superordinate themes, the process is iterative and there may be a number of equally
valid ways to represent the participants‟ experiences. Providing extracts of the
participant‟s narrative as it contributed to each of the themes enables the reader to
follow the process of analysis as it evolved for the researcher and subsequently
informed the development of the constructs that represent the four superordinate
themes. According to Smith et al. (2009), this process also contributes to the rigour
and transparency of the study as outlined in the previous chapter.

Conventions Used in the Reporting of Findings

A number of conventions are used throughout the chapter to ensure consistent and
clear presentation of the data. These conventions are as follows:


Direct quotes from participants are indented and in italic typeface. No attempt has
been made to correct grammatical errors.
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Italic typeface is also used to denote the use of words or phrases from the
participants‟ narrative when these are cited within the researchers accompanying
comments.



The beginning and end of individual quotations are identified by a forward slash
/…/. Separate quotes from different parts of the same interview may be grouped
in one paragraph if considered appropriate.



The use of square brackets [ ] within direct quotes indicates the researcher‟s
additions. Additions are only used when they are considered necessary to reduce
confusion and ensure clarity of meaning and context for the reader.



The insertion of (…) within direct quotations is used to protect the identity of
participants or organisations.



The insertion of ….. indicates that the intervening text (such as small talk) is
considered irrelevant to the context and meaning of the quote.

To ensure the anonymity of participants, coding of quotations which enables direct
reference to its location within a specific transcript has been removed from this
document as it is considered that linkage of several quotes from one individual may
enable identification of that individual. The master document, which is retained in a
secure location by the researcher, includes these codes and may be made available if
required for verification of authenticity or clarification of the context of quotations.

Presentation of Findings
The presentation of findings commences with a brief report of participant‟s comments
regarding the symptoms checklist, followed by the findings associated with the four
emergent superordinate themes. Responses to Research Question Four (What are the
recommendations for educating and supporting women in similar circumstances?) are
then reported. The chapter concludes with the presentation of other pertinent issues
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raised by the participants that did not relate directly to the research questions but were
considered pertinent to the research topic.

Participants’ comments regarding the symptoms checklist.

As discussed earlier, a number of symptoms may be associated with the hormonal
fluctuations that characterise perimenopause. Although many of these symptoms may
be experienced at any time of life, there is often a change in the frequency or intensity
of the experience of a particular symptom that indicates that a woman may be
perimenopausal. Symptoms checklists such as the list used in this study are often used
by health professionals to assist in assessing whether a woman is likely to be
perimenopausal.

For the purpose of this study, the symptoms checklist was not intended to be a
definitive list of possible perimenopausal symptoms but rather as a guide to
participants in assessing their perimenopausal status and subsequent suitability for the
study. The list was also intended as a catalyst for discussion about the experience of
those symptoms. A number of participants raised their concerns about aspects of the
checklist and the nature of some of the symptoms listed. Their comments follow:

One leader indicated that her response to the checklist may be variable over time.

/ I think that's what's interesting is that that's a big list and..... at times I could
tick all of those. /

A number of participants questioned the legitimacy of attributing particular symptoms
to perimenopause when they believed that life circumstances at the time could have
been responsible for changes they were experiencing.

/ When I looked at these symptoms I thought, which part of the symptoms is
associated with menopause and which part is associated with starting a new
and very challenging job at the time? /
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/ I don’t think it was particularly different. I usually wake up and worry about
the world, anyway..... I do remember not sleeping well, but that could have
been work or it could have been anything. /
/.....I think all those things certainly occur, but I don’t know that I would
directly apportion them just strictly to menopause. That’s why I sort of really
didn’t tick them because most of them are probably more of once again an
ageing process or a time in your relationship when it sort of changes. /

A number of participants reported finding the checklist useful as a prompt or
reminder about symptoms that they may have experienced in the past.

/..... I would have, perhaps thought of that but not necessarily...../

/..... it's a useful list because.... it makes you think..... particularly when it's not
currently happening..... /

For some the list was reportedly helpful as a way of identifying symptoms they may
not otherwise have associated with perimenopausal changes.
/ .....when I was ticking these boxes..... I thought ‘I never would have put that
down’, but that was actually a lot about how I was feeling...../

/ .....definitely that sort of crawling under the skin; until I saw that symptom
there I would never have linked it. /

/..... probably if you'd asked me to list, or what are the things..... I would have
said the temperature, the hot flushes, the other bits and pieces, but not anything
else...../

/..... actually it's only now reading that.....//..... that makes me think, putting that
together, actually in terms of looking at the list. /
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One leader said she had not been aware of the difference between perimenopause and
menopause until she read the definitions provided before the interview.

/ I didn't actually realise what the definition of menopause was until I read
your information sheet, but I hadn’t come across the perimenopause period as
being the period when you probably experience a lot of the symptoms before
menopause rather than menopause being when all the symptoms sort of start
springing up. /

A number of leaders made general comments about when they first noticed changes
that they believed heralded the onset of perimenopause. These comments follow:

After being asked when she had first experienced perimenopausal symptoms, one
leader responded

/..... probably over the last 12 to 18 months, like a lot of these things they sneak
up on you, reasonably unexpectedly in some sense in that I think, for me, fairly
gradual so there wasn't any big event where I could go ‘God! that's when it
all..... my body really started to fall apart'.....it's more, I've noticed it and then
you put two and two together and go like ‘Oh God! I guess this is what it's all
about'. /

Another leader expressed some doubts about whether the changes she experienced
during her 40s were associated with perimenopause.
/ For me, those things I think all possibly started around my 40’s, early 40’s,
and I don’t know whether that is perimenopausal or not, but I think that in my
early 40’s was when my life changed, so I sort of put it more down to, well, I
have thought about it more in line with that ./

One leader reportedly experienced perimenopause a little later than most women and
her symptoms were sporadic.
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/ I probably started about three years ago, so I would say..... I was probably a
little later than most people, about 53. I would get a spate of sort of hot flushes
over a period of a number of weeks and then they would stop and I wouldn’t
get anything for about two or three months, and then it would sort of start
again. And then progressively, I think as I have got older-they seem to be more
frequent. However, I have noticed recently that I’m probably not getting as
many. /

Erratic periods heralded the onset of perimenopause for another leader.

/ I think I was probably in my late 40s when I first experienced the symptoms,
the menopause symptoms, the pre-menopausal stuff, and it was with very
erratic periods. /

The next section will focus on the four emergent superordinate themes and their
constituent clusters of themes.

The following table is included to provide an outline of the relationship between the
emergent themes and superordinate themes.
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Table 1
Emergent Superordinate Themes and Their Constituent Themes

Superordinate Theme One: Distraction, disruption, discomfort and distress


Disturbed and interrupted sleep



Hot, sweaty and red in the face



I mourn the loss of my libido



Don‟t wear white!



Irritable, anxious, feeling low



A bit more forgetful, less on the ball



Erratic, loony, emotionally driven extreme behaviour

Superordinate Theme Two: Soldiering on or taking control


Just get on with it!



Time out



Seeking support



I like my doctor



I just don‟t like taking tablets



I‟m dead or I‟m on HRT

Superordinate Theme Three: Keeping up appearances


Fronting up and putting on a bit of a face
Show your weakness and you are lost!
Superordinate Theme Four: It‟s lonely at the top
No one to talk to
A no-go-zone
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Superordinate Theme One: Distraction, Disruption, Discomfort and Distress

All participants reported experiencing some degree of distraction, disruption,
discomfort or distress associated with perimenopausal symptoms. Participants did not
always choose to talk about symptoms they had checked on the list. Gentle prompting
was used to initiate discussion if a checked symptom was not raised by the
participant. If the participant indicated a reluctance to enter into further discussion,
the issue was not pursued. In addition, some participants discussed symptoms that
were not on the checklist but which they believed were related to the hormonal
changes associated with perimenopause.

Disturbed and interrupted sleep.

Leaders described changes in sleep patterns that they believed were associated with
perimenopause. Many of those experiencing sleeplessness also reported experiencing
night sweats. Only one leader checked night sweats without also checking
sleeplessness. Despite the frequency with which both symptoms were reported
together, disrupted sleep was not always attributed to night sweats. A number of
leaders were unable to identify the cause of their disrupted sleep.

/..... some times I'll fall asleep for a couple of hours and then I'm awake. But
there's also times when I just don't feel sleepy and I may go to bed feeling tired
but I just can't sleep and then you fall asleep at four o'clock and the alarm goes
off. /

/.....the night sweats where they have come maybe three nights in a row, and I
have had to get up and disturb my sleep and all that sort of stuff..... /
/.....I wasn’t waking up in a wet bed. A lot of women lie in this pool of sweat;
no, that wouldn’t have happened, but I would wake up a lot of times in the
night. /
/ I will sleep and I will go off, but if I don’t, I sort of can be an hour, an hour
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and a half, before I can go to sleep, and then waking during the night and not
being able to go to sleep. /

Some leaders specifically commented on how their sleep quality had changed.
/ I’ve had interrupted sleep now every night for three years or four years,
whereas before I would go to bed and I would sleep and I would wake up. /

/ ..... sleeplessness only in the last 2 months //..... and I'm an extremely good
sleeper, never actually wake up and noticed that. And it's not every day but on
occasion I'll wake up and it'll be 3 o'clock in the morning and I'm awake and
that's it but then I'll go back to sleep. But it's quite unusual for me to have that;
it's just been in the last couple of months. /
/ I don’t sleep as well now as I used to, and I think probably certainly since the
menopause symptoms started I will wake on the average probably two or three
times a night for no particular reasons. I guess I put it down to being a
menopausal symptom. Generally I’m quite a light sleeper anyway, but I will
just wake. / As a general rule I do [go back to sleep], unless I’ve got a lot on
my mind for work because that is when the activity in the mind starts.// But,
yeah, I’m nowhere near as good a sleeper as I once was and I find that after,
say, six, six and a half hours I find it a struggle to sleep beyond that amount of
time. /

/ I was waking up at 3.00 in the morning, getting up and doing some work, even
sometimes going into the office and then coming back home for breakfast,// I
was under enormous pressure, and I think it was all happening around about
that time..... that’s when the sleeplessness would have started, but then it would
have gone on for the next couple of years. /

Finding the term crawling feelings under the skin on the checklist provided one
participant with a description of a sensation she had experienced and which she found
had disturbed her sleep.
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/..... definitely that sort of crawling under the skin; until I saw that symptom
there I would never have linked it. /I tend to wake up with a feeling that is not
quite itchiness because it is not that you can scratch it and make it go away,
but there is a definite irritability that then makes me quite cross, I have to say
because you find trouble going back to sleep and you have to just say, ‘Ignore
it, ignore it.’ It is a bit like a mosquito bite or something. /

A number of participants talked about the association between their disrupted sleep
and night sweats.
/ I would say probably more in the last six months I’ve woken up a number of
times at night covered in sweat and no reason for that, which is most
unpleasant. I remember women describing how awful it is and they are
absolutely right. I mean, your hair is wet, the pillow is wet and it is just awful. /

/.....the major thing for me would be the, the night sweats and the hot flushes,
and I'd say the hot flushes aren't bad in terms of what I've read about or heard
others talk about, but the night sweats are full-on and I guess just generally
sleeping less well than I used to...../

/ I would say that in the, the last, probably six months or so, six to nine months,
some of that sleeplessness is associated with, like, like actually waking up
because I'm really sweating and just being uncomfortable, particularly in
winter; throw the doona off and then half an hour later you're scrabbling
around trying to find the doona again. So that sort of interrupted sleep and a
bit of just hearing the clock chime every hour. /

/ I have had a number of them [night sweats] where they have literally woken
me up and I’m just absolutely drenched and feeling very uncomfortable. I just
sometimes sort of get out of bed and virtually change just to get back to sleep,
because sometimes I’ve woken and think, ‘Oh, I feel really wet’ and I would
just like to roll over and go back to sleep again and I just can’t. /
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One leader made a distinction between sleeplessness and having an interrupted
night‟s sleep because of hot flushes.
/ I wasn’t sleepless, but it is just that your bloody hot flushes wake you up in the
night. You know, it wasn’t that I wasn’t sleeping; it is just that you have an
interrupted night’s sleep and you get fed up with it. /

Another leader found a number of things disrupted her sleep.

/ You might get up because you had to go to the toilet or because you are hot,
and often it is both. /

One leader talked about having a recurrence of her sleeplessness more recently after
coming off HRT.
/.....the only thing that is still with me is I don’t sleep. Sleeplessness is a real
issue.//If I go to bed at 10, I’ll wake up at 11.00 and wide awake and then I
only seem to doze from then on. I mean, occasionally I take a Temazepam or
something, half of one, just to try and knock myself out, but even that doesn’t
work./

Interrupted sleep reportedly caused a number of participants to be anxious or
concerned.

/ I mean I'd wake up and I still do this sometimes, and I can't go back to
sleep//..... and you know you're just awake for hours and hours and
hours.//.....you can get into a cycle of just being anxious about not being able to
sleep.//.....yeah well I mean the busier I am the more I know it happens...//.....
more things are on my mind and you know I think that's true whether you're
menopausal or not menopausal.....//..... that was probably the worst,
sleeplessness, and I still have some sleeplessness now...../

/ I just get to the point where I am just so exhausted that I just lie in bed and
go, ‘Just bloody well go back to sleep!’ /
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/ I guess most of the time my main concern is I’m waking up three or four times
in the night. /

In contrast, one leader believed that it was her anxiety that was the cause of her
disrupted sleep.

/.....it was anxiety that would wake me at night, and I keep reading about stress
and what have you, and work was stressful. Work seems to have always been
stressful and yeah, waking up with work churning through the brain and all of
that sort of stuff..... /

A number of participants talked about the impact of their disturbed sleep on their
ability to function optimally during the day.

/..... it caught up with me on me on occasions, and there were several occasions
when around lunchtime I just had to shut my door and just put my head down,
like a nanny nap, and I would be fine. /
/..... if he had called a meeting at 1.00 o’clock, I knew that I would be dozing
off..... this didn’t happen every day, but there were days when I just thought,
‘I’ve just got to put my head down for five minutes’ and then I was fine. /

/.....certainly I think the nights when that has happened [sleeplessness], I do
wake up and the next day feel quite tired, and I’m sure that has had an effect on
my working day. /

Participants talked about being unusually tired or exhausted. One attributed this
directly to hormonal changes and resorted to using HRT to manage the symptom
while another attributed her tiredness to interrupted sleep.

/..... the thing that really did impact me at work was unusual tiredness. I did go
through a period of hardly being able to get out of bed, like not even being able
to put your foot out of the bed in the mornings because you're just so tired and
might have even slept well at night and that's what pushed me into HRT for a
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little while. The unusual tiredness was debilitating, was most debilitating.//.....
it's not just a lack of sleep tiredness, it's right in the core of your bones. You're
just like ‘ I can't get up, I can't do this’- and I'm a very high energy person so
not being able to get up......// I was not able to function really, I was so tired
and that made it difficult at work. /

/..... just tired exhausted....//.....I try to manage that by not getting too tired and
exhausted so if I've had a couple of nights of, of really bad sleep, trying to go to
bed early and of course you know that doesn't really guarantee anything. /

Another leader who had previously experienced chronic fatigue talked about her
concern that symptoms she was experiencing may have heralded a relapse of this
condition.

/ I had chronic fatigue.....and I had that same sort of malaise coming over me
again. I thought I had better go back and just check. ..... she [the GP] did blood
tests and hormonal level checks and all that sort of stuff and it all came back
perfectly. /

Hot, sweaty and red in the face.

The majority of participants reported experiencing hot flushes. Although a number of
those subsequently began using HRT they were able to talk about hot flushes
experienced in the time prior to or after ceasing the use of HRT.

In addition to the distraction associated with having a hot flush and her concerns
about whether her face was red, one leader talked about feeling sweaty and dirty as a
result of the changes in her body temperature.

/ I'm going clammy inside my clothes and trying to sit in a meeting and look
like I know what I'm talking about and all I'm thinking about is. ‘my God! is my
face red?' and I’m feeling dirty ‘cause you feel sweaty and that isn't very
pleasant......//..... didn't feel fresh. It's like when you've been for exercise and
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you're sweaty and the first thing you want to do is get in the shower and I kept
feeling like I needed a shower and I..... they weren't even bad, really, really
bad for me. But to be sitting 'round the table discussing something highly
important and you have to start speaking and your face went red would be.....
it's bad enough just feeling it coming on it's like ‘Oh far out'. /

The experience of having a hot flush while in a meeting was reportedly both
uncomfortable and a distraction for one leader.

/ I can feel them when it is happening. I just feel this sensation coming,
overwhelming, over the body, and I think, ‘Oh my God! Here I go breaking
out.’ I can feel the redness coming through the face, but generally in most
cases it probably only lasts for about 30 seconds and then the feeling goes
away, but during that period of time, gee, I have a great desire to pull the
clothing off. / It is a distraction, yeah, and sometimes I think your power of
concentration sometimes goes. /

She then describes how she tries to ignore the sensations she is experiencing while
wondering what people are thinking.

/I just try and stay reasonably sort of calm and just sort of let it go. Where I do
find it a little bit difficult is if I’m in the middle of a meeting or I’ve got staff
that work with me and we are sitting in a meeting and I can feel this happening
and I just try to as much as possible just sort of ignore it and just continue on,
but sometimes it is a bit difficult and I do think what are the other people
thinking that are in the meeting or something with me? So, from that
perspective, not so much embarrassment, but I do feel a little
uncomfortable...../.....focused on what is actually happening to your body./

Two leaders discussed their concerns regarding the possibility of others
misinterpreting their physical response to a hot flush (sweating, flushing or apparent
discomfort) as nervousness or a negative or unfavourable response to an issue under
discussion.
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/..... often our board meetings were making decisions about funding, and you
would be sitting there and you are quite calm about the conversation that was
occurring, but there you would be sitting and going red and sweating and they
are thinking, ‘Oh (participant‟s name) doesn’t agree with us on this decision.
Isn’t that interesting?’ /And they would say, ‘so, (participant‟s name), despite
what you think, we are going to make this decision.’ And you would think, ‘I
don’t disagree with you’ but there you are sweating and red in the face. The
body language was telling them otherwise, or I would be looking so black in
the face, so black and tense and black, just sort of getting through the pain or
whatever I was having, that they would be thinking, ‘Oh gosh,(participant‟s
name) doesn’t approve of this decision again’..... and it wasn’t associated with
that at all. It was just you just trying to..... /
/ At times when I’m sitting up at a table where it is very official and I’m about
to present a talk or something like that, then I get a bit self-conscious about the
fact that I’m going bright red or I feel that I’m going bright red, whereas I
probably aren’t, because I can’t see myself, but I get very hot then. And some
people will then misinterpret that as me being nervous, whereas I’m not
nervous when I speak, but I get hot. So I find that it is only when I’m doing
public speaking that I feel at all self-conscious about it. /

Although working provided a distraction for one leader, the air-conditioned
environment of the office exacerbated her hot flushes.

/ I also think that probably working sort of full-time my days are occupied with
other things, so I’m not sort of dwelling on it. The only thing is I do find that
probably when I do have hot flushes it does occur much more so in an office
environment when you are in air-conditioning. If I’m at home on the weekend I
rarely ever have one because I’m really active. I’m either out in the garden or
I’m out walking or I’m doing things around the house and that activity just
dissipates it. /
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A number of leaders discussed the strategies they used for managing the fluctuations
in body temperature associated with hot flushes or night sweats. Many of these
involved changes to the way they dressed or the type of clothing they wore.

/ I take clothes off. //..... I have layers. ... my jacket is taken off all the time now.
If I’m going to some function, I will always have a jacket. In the last year I’ve
just not even bothered to take the jacket because I just know that it is going to
be off more than it is going to be on. So I’ve modified slightly what I wear just
so I can get the layers of! /
/..... being more sensitive to temperature and to heat and it’s wanting to ensure
that I've got more control over my environment. The way I manage that is much
more layer dressing and those sorts of things. /

/ I rarely wear jumpers without something underneath 'cause I know at some
stage I'll have to peel something off. /
/..... having to sort of think about ‘what will I wear?’ more than I did. I look at
some fabrics and I think 'Oh you've got to be kidding’ This program I'm doing
next week, they said, 'Oh we're providing a shirt and a jacket thing for all of
the team members' and I said, ‘what use is this for a menopausal woman?’/

In addition to changing the way she dressed, one leader had another strategy for
keeping cool.

/..... [the] realisation that you only ever wear summer pyjamas these days and
that you have to have a foot flapping around outside the bed to try and do some
temperature control and those sorts of things. /

Humour was frequently used by women who experienced hot flushes in public
situations to reduce their own and other‟s possible embarrassment.

/.....it [hot flush] happens to me at board meetings. I chair about four
committees and, at times, I’m sitting there stripping off. I deal with it by
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making a joke of it. I’m very open about it. / /I just take it as a huge joke and I
laugh and everyone laughs with me. Sometimes people will then turn and admit
to it if there are any other women in the room, but blokes.....I just kill myself
laughing about it and so it relieves the pressure on them too. //By laughing at
myself and stripping off and then putting things back on, I don’t care and they
don’t care then. They get over it. They have all got wives. They have all got
people who are going through it. /
/ I’m quite comfortable with making probably more of a joke of it ‘Oh God, we
are going through a hot flush stage’ or as my husband refers to it as ‘a power
surge’. /

One leader who often worked in male-dominated environments said she believed
using humour with men helped her and the men involved to feel more comfortable
about the issue. She likened this approach to the tactics she might use to deal with
bullies.

/ I used to work almost exclusively in a male domain. I now sit on one board
that is all men, about eight men or nine men around the table and me. I have
some that are now mixed boards with men and women, and I chair a board that
is all women. It is interesting if you make a joke of it, men will cope with it as a
joke. It is like how you deal with bullies is you make a joke of it and they back
off. I use humour for lots of things and it works pretty well for this as far as I
can see. /

She provides further insight into how she would broach the subject with her male
colleagues.
/ I call them my power surges. I just brush it aside. I say, ‘Excuse me! I’m
having a power surge.’ I just take the jacket off and the men will have a little
grin, and then I put the jacket back on and someone might say, ‘Oh you are
cold again, are you?’ So they get used to it and they know me well enough.
They can have a little dig back and they know I’m not going to take offence. /
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One leader felt she could be open with her younger female colleagues without it being
used against her.

/..... the colleagues that I work with are predominantly female. Most of them
are younger than me but by the same token, you can talk about things and joke
and laugh, but in a way that isn't then used against you. /

Another leader who worked in predominantly male environments did not feel she
needed to conceal the fact that she was having a hot flush.

/ I worked always with men. So I was always very open about how I was
feeling. So if I had hot flushes, I wouldn’t have tried to sort of pretend they
weren’t existing. I would have said, ‘This is how I am now.’ I would have been
quite open about it. /

For other leaders, the degree of openness depended on the situation and who was
present.

/ It would have depended who I was meeting with. A lot of the meetings were
with outside bodies. It would depend. If it were men that I knew and would
manage it, I mean, hopefully I would do it differently now, but then I probably
didn’t...../

When asked how she thought she had managed at the time:

/ I think I probably would have just sipped on my water and just sat quietly
until they [the hot flushes] just went past. I think I have memories of having
meetings with other health professionals in meetings where I obviously would
say something and everybody would have a bit of a laugh or ‘I can’t wait until
it happens to me’ and so on and so forth. I certainly didn’t acknowledge it at
the meetings with the outside people. /

Other leaders were also more inclined to reveal that they were experiencing a hot
flush in certain circumstance but not in others.
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/ I wouldn’t necessarily say ‘Oh gosh I'm having a hot flush!" if I was in a
meeting, where as if I was with my women colleagues I’d go ‘Oh bloody hell! /
/ I've stopped saying 'is it hot in here or is it just me?' .and they'd all go ‘.no, no
it's not hot in here'. I've decided that this is not a good question to ask. /
/ I would admit sometimes to other women that ‘I’m really hot, it must be that
time; I’m just going to go and disappear’ but only to people that I trusted. /

One leader described her observations about how she would feel and how she thought
other people may react when a woman was experiencing a hot flush in a public
situation.

/ I always feel a huge amount of empathy because typically the rest of the
people in the room would be mainly male and they are not quite sure how to
deal with it, but I think most women have dealt with it with quite good
humour.//… they have been a bit self-effacing about it and tried to get through
the moment. They certainly haven’t wanted to draw attention to it, so they have
just made a little quip and everyone has got on with it. To the guys’ credit, I
actually can’t think of when guys have sort of squirmed. They just tried to
pretend it wasn’t happening. /

I mourn the loss of my libido.

Although many participants checked less sexual feelings and the majority of
participants checked at least one urogenital symptom (dry vagina; uncomfortable
intercourse; urinary frequency; loss of bladder control), there was little reference
made by participants to these issues during the interviews. When prompted, some
participants appeared reluctant to enter into discussion about these issues and the
subject was not pursued in these circumstances.

One leader expressed her concerns about her declining libido quite simply:
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/ I mourn the loss of my libido. /

Another participant who was experiencing problems in her private life was unsure
whether her declining libido was in fact due to hormonal changes.

/ I sort of put that down to why I am ticking boxes like depression, less sexual
feelings, no feelings, because you are dealing with this very traumatic
situation//..... the, less sexual feelings, I mean, I’ve been married (...) years, so I
just assumed that that is all part of that process. //.....the more you lose those
feelings, the harder it is to get them back but......//..... it is a concern I think, but
I try and rationalize it, ‘Why is it a concern?’ It could be environmental
reasons more than physical reasons just yet. /

When prompted to discuss having ticked dry vagina one leader talked about her
surprise at the change in her physical responses.

/.....that's [dry vagina], well painful! Just one of those things that I think was, a
surprise for me and not something that I'd particularly thought about even
though, you know, I'd had the blood test that had said 'oestrogen levels were
dropping' and so I knew all of those things were happening..... that came as a
bit of a surprise in terms of my body not responding how it had responded in
the past. /

One leader questioned whether the problem was stress related.

/ I started using HRT cream, a topical cream, and the reason for that was
because I did have a dry vagina at the time, but whether that was caused by the
stress, I don’t know.//Or whether it was just a stage I was going through or
what; but, anyway, she [the doctor] said, ‘Use this cream. Don’t go putting it
up your vagina.’/

Another talked about using over-the-counter products to manage the problem.
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/ It’s a manageable problem from my point of view. Over the counter stuff from
the chemist is fine. It’s not something that is causing me a great deal of grief. If
it was, then I’d talk to the GP about it because, at the end of the day I’m fine
with all of that. /

The problem of dryness began post-menopause for one leader and had recently
caused her to seek medical advice and treatment.

/.....that all happened post-menopause really I think. // I think probably a lot of
the things are post-menopause.//When it stopped; all those things like the
dryness were certainly part post-menopause.//..... it has happened more
recently..... I’ve been again to see a GP. //.....she certainly prescribed things to
help with.....//..... things that help with the moisturizing, keeping it damp. /

Two leaders talked about a change in urinary frequency:
/ I found myself in strange cities going, ‘So where is the toilet?’ And just having
that sense. Sometimes I actually ran back to the hotel with this sort of sense
that my bladder was full, but it actually wasn’t.//..... just really being in this
foreign environment made me very anxious of how much I was going to the
toilet. /

/ Some days you just think you need to go to the toilet like regularly in terms of
passing water and such.....//.....maybe over the last 4 or 5 months, I've noticed
some difference and then occasionally it just seems, it can be worse. /

Don’t wear white!

Heavy or irregular periods were a source of concern for a number of participants.

One leader described how her periods, which had often been heavy, became even
more problematic at the time of perimenopause.
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/.....very heavy periods, such terrible periods. I remember having some
shockers// I had one really particularly severe time where I had terrible tummy
cramps and very, very heavy bleeding.....she [the GP] realised it was part of
menopause and put me on the treatment.//I used to have heavy periods, but not
these dreadful cramps and muscle pain and bloating and flooding, and all that
sort of thing. /

Extended periods of bleeding were attributed to an increase in stress levels for one
participant. This reportedly caused her added inconvenience and concern because it
meant her GP would insist on her being screened in order to eliminate other possible
causes of the bleeding.

/..... a couple of times when I was about to go overseas, I would have
essentially, periods that would last 6 or 7 weeks, so I'd go and get that checked
out and what I worked out in conjunction with the doctors is that it was
associated with my stress levels in terms of trying to get everything done and
get on a plane 'cause it's like, 'hang on a minute', 'this happened last time I
went away’. And so the blood tests came out of a, probably a more thorough
screening in terms of ' is something going on here? /

Erratic periods were a concern for a number of participants.

/.....erratic and you just had to have protection on. That was how I felt, because
you just never knew quite what was going to happen. /

/ A couple of years ago when my periods were, were finishing and they were
very erratic and could be quite heavy..... that in many ways was probably more
concerning..... just that whole thing of ‘if I've got to be in the (....) room for 3
hours, will I be OK? ‘Don't wear white’ you know those things. /

/ I'm one of those people where in terms of periods where I could virtually set
my watch by them. From the time they started when I was 15, I mean, literally,
almost to the time of day, it was just ridiculous. So now they're slightly less
predictable, only that I'm not sure which of 3 or 4 days of the week things
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might start and they're heavier.//I guess it's heavy enough that if I was in a
meeting that ran more than a couple of hours, it would probably......I'd start to
worry...../

Irritable, anxious and feeling low.

Many leaders reported an increase in their experience of irritability and mood swings.
One participant likened the experience to the changes that would be associated with
the menstrual cycle.

/ I think, irritable, probably mood swings, the things that really we would
probably attribute to hormonal before our period and that sort of thing. /

Another participant reported that she had not associated her mood swings with
perimenopause at the time when they had occurred, but had attributed her behaviour
to the demands of her everyday life.
/ I certainly wouldn’t have gone to the doctor and said, ‘Look, I’ve got this
irritability and mood swings.’ I probably would have put it down to trying to
manage family, house, work, and all of that. /I would think I probably excused
it in those ways. /
Interrupted sleep patterns reportedly affected one participant‟s mood. She also
noticed that she was less tolerant than she had been and believed that her family may
have borne the brunt of this change in her temperament.

/ I think the irritability is somewhat to do with the sleep, but I also find a bit
older I get, the less patient I get. I was always someone who was able to let
things go through to the gatekeeper, and now I just pick everyone up on every
little thing. // I have always worked hard. I have always worked full time when
the children were small, so I suppose they are used to me just sailing through
that and now I’m at the point where I get very grumpy very quickly. /
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Similarly, another participant mentioned her concerns that it was her family that bore
the brunt of her mood swings and changes in temperament. She believed however,
that she was generally able to manage her behaviour while in the workplace.

/ I think as far as the work goes I used to just put on a face and go like mad at
work, and then a lot of the irritability and the mood swings and things came out
at home. /All of that happened with the family instead of at work, although I’m
sure the work colleagues also copped some of the mood swings and things as
well, but I don’t think it ever was so bad that it affected my work in that people
would comment or anything. /

She then describes how the changes in her mood and temperament lasted for some
time.

/ I had many years of mood swings. I certainly remember mood swings, going
into tempers and things, mostly at home again. I do remember that going on for
some time. //..... that last few years. I think that was when it was particularly
bad, and the mood swings were particularly bad. /
Travel and being away from home affected one participant‟s moods.

/..... when I think back on it, I noticed, for example, if I travelled away from the
home situation, you would notice the irritability and shortness on travel, the
mood swings. /

Having an interrupted nights sleep and a busy schedule contributed to one
participant‟s irritability.

/ I think that [disrupted sleep] does lead to some of the irritability, because by
the time I’m cooking dinner at 7.30 or 8.00 o’clock at night, I have been up,
well, sometimes since 3.00. /

A lack of awareness about the cause of her symptoms reportedly contributed to one
leader‟s inability to manage the situation effectively.
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/..... irritability. This bit about irritability, unloved feelings, mood swings. I
think I've sort of put really, all into one, and that was the bit that..... I don't
think I managed well 'cause I didn't recognise what was happening. /

In contrast to the experience of others, one leader said she felt she had fewer mood
swings in the absence of her normal monthly cycle.
/ I certainly don’t feel as though there has been any real change in moods or
anything like that. My husband might think differently; I don’t know. But I
don’t necessarily feel it. If anything, I think the moods are probably more
balanced because the hormonal sides of things with the swinging are not quite
there with the cycle. /

Although a number of participants checked anxiety, not all chose to raise the issue
during the interview. None indicated that they were certain about the cause of this
symptom although all had noted a change in the way they experienced anxiety.

/ The anxiety. I do remember the anxiety and the first anxiety attack I had.
Whether it was to do with menopause or not, I don’t know. It started out feeling
contented and pleasurable, and it was as though something in my brain said,
‘Well, we can’t have that, can we?’ Bang! And I would get this anxiety attack. /

/ I worked with (company name) who was dreadful with its women, and it was
so hard on me. That pushed me into being anxious anyway. I had no peers I
could relate to and all that sort of thing. So I wasn’t a natural presenter and
those sorts of things, so any anxiety I did feel would have aggravated the
anxiety that people knew I felt and therefore I wouldn’t have discussed it. I
would have been shy about it, because it would have gotten worse than usual. /

/ I seem to get much more anxious these days, and I notice the anxiety on things
like your driving is not as good. I’m a cyclist, and I’m really spooked now by
cycling. I’m so un-brave, you wouldn’t believe it. /

A number of participants noted depression on the checklist. One professed to being
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uncertain about what constitutes depression and to what extent her symptoms were
related to hormonal fluctuations.
/ I have had times where I’ve just been a bundle of tears, but it is not often at
work. It has to be fairly significant. // The sadness is probably the thing that
would be the one that would most.....//..... depression, I assume I am depressed
at times. I mean, I haven’t been clinically diagnosed, but there are times when I
find it just really, I just..... I don’t know what depression is, to be honest with
you. I have ticked the box, but, you know, at a point where I just don’t want to
talk to anybody. I just feel really low, and I’m not that kind of person. I mean,
I’m in (a public role) for God’s sake! But I do feel downtrodden a little bit with
my home situation, yeah, so I’m assuming it must be depression. Now, whether
that is linked to hormones, it quite well.....And I certainly know mid-cycle now,
two weeks out from my period, I want to kill somebody. /

Another described how her mood could change suddenly and without warning. She
also described feeling less happy and content around perimenopause.
/ It was a lovely day, the sun, the birds, and I was thinking, ‘God, this is good’
and Bang! I thought, ‘Where did that come from?’/ / I would wake up in the
morning feeling somewhere below baseline in terms of feeling happy and
content and everything. /

Two other leaders reflected on how they had experienced feeling low and how this
had been the catalyst for using HRT.
/ I don’t normally feel low. I wouldn’t say depressed, but low. I kind of wake up
in the morning and I’m bright and I’m kind of chirpy. I can remember driving
to work and thinking, ‘Oh gosh, I feel low.’ It was that kind of feeling. // I don’t
know how long that went on for, but I think it was probably quite a while. I
mean it might have been, I don’t know, nine months or maybe even close to a
year, but just that sort of low feeling. /
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She went on to talk about how a conversation with a female friend subsequently lead
to her use HRT to alleviate her low mood.

/..... we were talking about the menopause and the changes and our feelings
and this feeling of lowness, and she said, ‘Look, I went onto hormone
replacement therapy and the very next day I woke up and I felt different. I felt
back to my old self.’ I don’t know whether it was because she implanted that
idea in my mind that I was going to do it too, but it happened.// So that was my
experience and that certainly lifted the depression- that depressed feeling...../

The other leader described her low feelings as resembling permanent PMT.
/ I had these symptoms which were, I don’t know, feeling low, teary. I would
like to say depressed, elements of depression, but you don’t even know what
really. You are just feeling like PMT, like permanent PMT. That’s how I
remember describing it. /
Having a disrupted night‟s sleep due to a skin irritation (which she later attributed to
perimenopause) while trying to cope with the demands of young children caused one
leader to feel depressed.

/ ... that can bring on a lot of depression because I would be walking the floor
scratching myself and thinking: 'it's day light and the first little person [child]
in my life is going to be awake soon. How are we going to get through this
day?’/

Another leader attributed strange and emotional feelings to having had a
hysterectomy.

/ I was feeling strange, teary and all of those sorts of emotional feelings and I
assumed that was because I had had a hysterectomy, because the only thing I
knew about a hysterectomy was the word came from hysteria which meant ‘Oh
my God! I’m feel I’m not a woman anymore, I’m going a bit sad’ and so on. So
that’s what I assumed. /
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Two participants noted having unloved feelings. Both talked about having been
unaware of these feelings at the time and only able to recognise the experience
retrospectively.

/.....the bits that I didn't, that I don't think I picked up were, a little bit of feeling
unloved and a little bit of mood swings...../

For one woman, this recognition only came about when she undertook HRT and
things improved for her.

/ I was feeling very unloved and overburdened, unnecessarily I thought. /
/.....one of the things I noticed most in that relationship was that I was trying to
blame him [her husband] for me feeling down..... that sort of ‘well it's his fault’
and unloved and I just thought then afterwards, 'how unfair' when things
improved for me. /

A bit more forgetful and less on the ball.

Although a number of leaders indicated that they had noticed changes in memory or
concentration, there was often uncertainty about whether these changes could be
attributed to hormonal fluctuations.

One put her loss of memory down to being slack.

/ I seem to have loss of memory, but who knows why, whether it was just
because I am slack. /

Another blamed her forgetfulness on her age.

/ I guess at my age, I mean we all forget things and sometimes I get bothered
by thinking now, 'what was that person's name?' and I'm driving home from a
function and I think, ‘yes well of course, that's his name.’/
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Forgetting a particular word was frustrating for one participant.

/.....and that's more, just frustrating when you, just sort of stop for a moment
and you might just forget that particular word that you were actually going to
say and then just come back to it a second later of something, but it's just
glimpse of 'oh gee, what was I going to say?’ /.

Writing things down helped one leader cope with her memory lapses.
/ I find that I’m a little bit more forgetful and I have to be really conscious of
writing things down. ..... or I will have a conversation with somebody and then
have to think about what the conversation was five or six days ago, and I’m
thinking, ‘Oh, what was it that was discussed?’ and I have to really think it
through probably more so than it just coming to mind quickly. I don’t know
whether I can attribute that to menopause or whether it is just the ageing
process overall. /

She related her experiences of working with younger people and finding that she did
not perform as well as they did. She again questioned whether this was related to
menopause or ageing.

/..... in terms of concentration, I was less on the ball, particularly when I was
doing my Masters and doing it in group exercises with people who were
considerably younger than me, probably 20 years younger. I think it would take
me probably longer to actually sort of think things through and get on top of it
and so forth than someone who was 30 or 35 or even 40. // I probably had to
put a little bit more thought and effort and so forth into it, but whether that is
just menopause or whether it is the ageing process...../
One leader however, provided a very descriptive account of changes in her cognitive
function which she confidently attributed to perimenopause.
/.....in that period, those couple of years, I couldn’t think. My brain was..... I
always used to say when I had bad PMT it was like there was a magnet pulling
at my brain. That was the feeling that I used to have, through that PMT and
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through that menopause bit untreated, that’s how it felt, permanently like that.
Therefore, with this happening it was just full. There was no room for thought.
I could function, but I couldn’t think. / /..... in fact I would say there was no
strategic thinking. /

Erratic, loony and emotionally driven extreme behaviour.

A number of participants mentioned symptoms that they believed were associated
with perimenopause that were not specifically mentioned on the checklist. These
symptoms were often reportedly related to changes in emotional reactions that the
participant considered uncharacteristic. Frequently participants said that they only
gained insight into the change in their behaviour retrospectively.

One leader described her reactions and behaviour around this time as erratic and
reflected on her lack of insight at the time.

/ I don't think I recognised at the time it's only in retrospect that I sort of see
things and the most particular element of that was I think I was much more
erratic, emotionally erratic and..... it's only now, or some years after all that
happened I thought, 'crickey! I was all over the place about how I was
feeling/..... in particular some erratic behaviour around a particular male at
the time which when I look back on it, ‘why was I behaving like that? Why was
I feeling like that?’ because .I didn't recognise at the time that it was connected
to my sort of stage in life. It was just so sort of un me about the way that I was,
behaving / I think it was some years later that I was able to think, 'Oh God .....'I
think that’s probably why.....’ I think that impacted on my life more than
anything. I'd also say that, at the time that I had the most symptoms, I was the
general manager of (company). /

She talked further about how useful it may have been if someone had been able to
draw her attention to the change in her behaviour at the time it was occurring.

/..... it's only now when I look back and think 'God that was very erratic
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behaviour’ and I'm not really erratic, normally, and I really was erratic, up
and down and all over the place. So whether it got better or not, I don't think I
knew that there was something that needed to get better.//I suppose, if I could
wind the clock back it would have been helpful if somebody had been able to
put a mirror up in front of me and say, 'hey, you’re, this seems like, it doesn't
seem like you, do you think it could have anything to do with menopause?' and
I think that might have stopped me in my tracks to think, ‘wow! That isn't like
me.’/

Others also noticed more subtle changes in their emotional response to situations
during this time.

/ I mean it wasn't horrendous, or I wasn't flying high one minute and in the
depths of despair the next. I was just very much, a lot more emotional, cry
easily and do a little bit of poor (name) occasionally I've had a few 'poor
(name) days', during that period. /

One leader described her behaviour at the time of perimenopause as loony.

/.....my major symptoms were all emotionally related. And that was at the same
time that I had just been promoted to be a board director of a large (……)
company. So the two things came together. Well, in fact, the first phase came
when I was just promoted to be a manager of a division and then I was well
and truly realising I was half loony by the time I was made to be a board
director. P8/ I think what I mean is I was literally loony. /

She related an incident which she believed demonstrated how aberrant her behaviour
had become.
/ I walked in there [the doctor‟s surgery] and I picked my ticket up and I turned
around and said to those women, to everybody there, ‘You may think your
ticket is taking you in before me, but I am going before all of you, otherwise
I’m going to be hanging from the rafters!’ And they all just put their heads
down and people let me go in and I was the next one in, even though they were
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all before me. So, you know, that’s how loony, because I really felt like I could
jump off a bridge, type thing. /

She continues with other descriptions of what she calls her emotionally driven
extreme behaviour.

/ I would do one of two things: I would cry or if I felt really strongly about
something I would shout and scream.// Yes, the permanent PMT state, you
know, totally irrational and a bitch. // Yeah, I think that is exactly it, extremes,
you know, emotionally driven extreme behaviour. /

Another participant attributed her loss of courage to hormonal changes.
/ I have lost my courage and all that sort of thing, and I’m sure that is
hormonal. I’m sure I haven’t got quite such a wimp just because I’ve got old. /

Two participants talked about how other people were able to recognise the change in
their behaviour at the time it occurred and were able to reflect on this at a later date.

/ I certainly was known; colleagues would tell me, as quite, not ferocious, but
certainly quite determined and quite dogged at work, black was black with me
and white was white and never a dot of grey. I’m sure that was all part of this,
‘I’ve got to get through the day.’ /

/ One particular friend still makes remarks when she meets friends of mine,
‘Oh, you want to see what she was like at that time.’ But what she always says
is that I was totally demanding and could go hysterical, scream and yell and
rant and rave, but it was never personal...../

The same leader reflected on how she believed she managed to deal with issues at the
time albeit somewhat irrationally.

/ So, you know, there is an element of you, of me, or of one that you can still
keep your.....There is a line that you still don’t go over. Actually, I probably
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wanted to tell them they were useless or whatever, but I dealt with the issues
still even though I did it irrationally or, you know, over the top. /

Another leader also talked about being less rational at the time and described how she
managed to minimise the affect of this in her interactions with others.

/ I kept my workload down to a minimum and my contact with people down to a
minimum, so that I knew that I was stable when I was talking to people,
because I found that I wasn’t quite as rational. /

One participant questioned whether her decision to leave her job was related to
hormonal fluctuations that she had not recognised at the time.
/..... the general thought of ‘I’m going to leave all this’ was such a relief, and I
wonder if that was because of the hormonal stuff. I really do. I mean I used to
enjoy my work and I enjoyed it to the end because it was stimulating, and I still
like mixing with stimulating people and that sort of thing, but, you know, the
thought of all this managing all these people. Perhaps blokes get fed up with it
as well, I don’t know. /

After initiating HRT, one leader said she was able to reflect back on her pre HRT
behaviour.

/ I really noticed it, [the change in behaviour following HRT] but no one ever
said because they didn’t know what was happening. I think the board of
directors was very pleased with me and I think their view was that I grew into
the role. That’s what they used to say, ‘Oh, you’ve really grown into this role’
whereas, they never referred back to ‘you know you were a blabbering idiot.’
But I can remember the manager saying to me once in one of these situations
where I was beside myself, ‘You are so mercurial of mind; this idea one day
and that the next.’ I can remember thinking, ‘Mm, mercurial of mind, well, that
is not me. Usually I’ve got my view and that is it.’ I didn’t react to it; I just
remember thinking, because he was right. /
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For one leader, a lack of insight into the possible role of fluctuating hormones as the
cause of a change in her behaviour was seen as a possible factor in her marriage
breakup.

/.....my marriage also broke up around that time. He was a lovely man, but
retrospectively I totally realise it was this whole thing...... I was a pain in the
arse to live with and I didn’t understand and he didn’t understand and no one
ever told us anything. So we didn’t even know that..... Luckily, five or six or
seven years later we ran into each other and had a little chat about it and
realised, both of us, that that was what it was. So, that was all in that whirlwind
thing happening, the permanent PMT state, you know, totally irrational and a
bitch. // I definitely am a hormone affected person, HAP. That could be a new
acronym, couldn’t it? /

Superordinate Theme Two: Soldiering On or Taking Control

Participants chose different strategies to manage perimenopausal symptoms. In many
cases, leaders indicated that their decisions to either soldier on or to take control of
symptoms reflected their general philosophical approach to managing difficult issues
encountered within their personal or professional lives. Attitudes to perimenopause
and the use of medication also reportedly influenced decisions about treatment
options. Participants, who chose to soldier on, often reported using behavioural
strategies, lifestyle changes and natural approaches to symptom management. Others
indicated a preference for taking control of their symptoms, with some choosing
interventions such as medically prescribed hormone therapy.

Just get on with it!

A number of leaders described a just get on with it approach to their management of
symptoms.
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/ Depression, mood swings, some people go along like this. I’m not one of
those people. /

/ I probably have quite a strong work ethic and just sort of get on with things
and life is very much in that sort of mould. /

/ I have sort of been the achiever. I have always pushed myself out of my
comfort zone, so it is a matter of just getting on with it and dealing with it. So
that is my personality. /
/ I haven’t found anything I didn’t feel I couldn’t manage. I’m a very sort of
mind over matter type person. /
/ I’ve got a pretty, pragmatic approach...../
/ I mean, I think I’m sort of a,’ get on with it’ sort of a person.//‘No nonsense,
get on with it’, and I’m sort of a bit like that even now, you know, ‘just get on
with it’. /

/ I think as far as the work goes I used to just put on a face and go like mad at
work, and then a lot of the irritability and the mood swings and things came out
at home..... /

/ I probably fairly actively manage a fair bit of that stuff, so if I do think 'I'm
feeling anxious' I'll actually work through and I'll say ‘ Well OK. What's
happening? Why? What do I need to do about it?’ /
One leader‟s belief in herself as a motivated person caused her to hesitate in regard to
seeking professional advice about symptoms.

/ I have thought seriously about going to someone and I have actually made
some enquiries, but I’m not at the point yet where I have done that, and I
suppose the reason I haven’t is because, you know, going in and trying to
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explain it all, and I keep thinking to myself, ‘You are a motivated person; you
can get a handle on this and do it yourself.’/
Another leader‟s sense of professionalism reportedly motivated her to avoid taking
sickies even when she wanted to run away.

/ In my work place I am very professional and kind of separate myself mentally,
I think. So I haven’t had issues where I have been a cot case and had to take
days off and so forth. I have wanted to run away at times, but I think because
I’m so disciplined in my work place that I don’t take sickies...../

A positive outlook about ageing reportedly motivated another leader to survive
wonderfully during perimenopause.

/ Look, I think part of it is just that whole issue of ageing, and my thing has
always been that you should look after your health and, you know, survive
wonderfully./

A number of leaders talked about how their determination to cope during this time
often had ramifications for themselves and others.

One leader described how she was determined to push through her symptoms until
she realised she could get help.
/ I mean, with all three roles, you can’t have off days.//.....you get really busy
and so engrossed in what you are doing or trying to achieve or whatever, and
you just keep pushing and you think you can push through these things, and
then sometimes you realise you can get help. /

Another leader reflected on how she later recognised that she had become more
matter of fact about things at that time of her life. She also talked about her
determination and how she pushed herself through things.
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/ I think I became more matter of fact about my work and things. I didn’t spend
a lot of time on the social interactions and those sorts of things. I really just got
into my work and just got it done because I had to get it done.....//Whether that
was work or the situation or whether it is to do with this [perimenopause] as
well, I’m not sure, but certainly.....//It was around that time that I sort of had a
sense that I was certainly a lot more matter of fact about my work//..... again I
think that is part of my personality in a way in that I’m very determined to do
things.//I pushed myself through things...// I was always very organised at
work. I always made sure I was well prepared before I went into things, so that
I had a back-up if I didn’t feel so good......//Rightly or wrongly that was the
way I dealt with it. /

She also talked about how she believed that she lost a lot of the softness during the
time when she was experiencing symptoms. She described how she would hang in
there in order to manage certain situations.
/ Hang in there and just get through it’. I’m sure that was all sort of a part of
that because a lot of the softness went during that period, I think. In retrospect,
I’m sure a lot was the result of the sweats, because you just had to do a job and
you had to get on with it and you had to sit in board meetings, which we had
all the time at (organisation), and feeling lousy but you had to sit there and get
through it. So you just gritted your teeth and got on with it. //..... you would just
do it, heavy flooding and all the rest, you just keep going...../

One woman reportedly preferred to discuss her concerns with her husband rather than
bring it into the workplace.
/ I wouldn’t bring it into the work place. I think probably what I did was I
would have done a lot of talking to my husband and gone through a lot of the
work place issues with him to try to work out solutions or ways forward. If you
ask some of the staff, they might see it quite differently, but I don’t think that it
affected the way I managed, although, you know, I certainly do recall having
hot flushes in meetings and that kind of thing. /
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When asked how she recalled managing having a hot flush during a meeting:

/ I think I probably would have just sipped on my water and just sat quietly
until they [hot flushes] just went past. /

A number of participants talked about the strategies they employed to maintain their
health and well-being in order to ameliorate their symptoms.

Despite a very busy work schedule, exercising and maintaining an active social life
helped one leader cope with symptoms.

/ I exercise. I go to a personal trainer. Most weeks I go 3 times a week. I walk
on the weekend. I really work hard at ensuring I've got a good social life so
that sometimes means that I don't have any nights home at all and I'm involved
in a community group as well.// ..... a lot of that is really deliberate in terms of
a way of making sure that there's some balance; that it does help you deal with
stress because you're having a different set of conversations.....// I'm passionate
about work. I've worked crazy hours and I could easily work more crazy hours.
//..... it's about finding ways of breaking up those things and staying connected
with people who are really important in my life//..... making sure my husband
and I go out for dinner and do those sorts of things are also part, for me, of just
managing it all. /

Maintaining a healthy lifestyle reportedly helped one leader avoid the need to go on
medication.
/ I don’t take anything for menopause and I try to be very active. I’m a person
that exercises quite a lot. // I eat a huge amount of vegetables and exercise and
everything, so that is my way of managing it. To date, I feel as though it really
hasn’t impacted on my life to such an extent that I need to go on medication. /

Another leader believed that yoga and exercise helped her to maintain a healthy mind
and manage her demanding role.

122

/ I do yoga. //..... and I mean certainly some of the yoga assists with the
menopause.....//..... and I do a lot of walking and am just pretty active, so I just
try to manage it in that sense. I think by doing that and having a healthy body, I
think that sort of contributes to having a healthy mind which helps me manage
the workload, because it is quite a demanding role and I do work quite long
hours. /

Time out.

For a number of participants, their executive roles enabled them to be more flexible in
their work arrangements and to use this as a means of coping with or managing
certain symptoms.

/.....it is a very flexible job in that sense..... if I do wake up one day and feel
crappy, 'Oh, I’ll work from home for a couple of hours’ if I haven't got any
meetings on that’s fine. . //.....and there's no one going ‘Where were you? Why
weren't you in....?. and 'This is not good enough. It's just not the way it works.’/

/ I negotiated a nine-day fortnight, a new contract, and I think that was my
way of saying, ‘Hello, I just need one day in a fortnight of my own’, and ‘of my
own’. /

For another leader, this sort of flexibility was not always an option.

/..... there are times when you can hide away a little bit, or just not schedule
meetings for that day if you have got that flexibility and also it is an
environment where it is quite a younger person’s profession to work in./,/ So,
you have got to be fairly active and on-the-ball to be able to manage...../
One leader described how she would take some time out so she wouldn‟t have to test
the waters.
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/ I think that when I felt the hot flush coming I would then think, ‘something is
going on; okay, let’s have some time out.’ And so I would just take some time
out. So I wouldn’t put myself in the situation. So I never really had to test the
waters. // I just accept that you have your good days and your bad days, but
when you have your bad days, you rebook your appointments. /

Seeking support.

A number of participants actively sought information, advice and support as a way of
coping with their symptoms. The degree to which leaders chose to or felt able to
discuss symptoms with significant others varied. Some found advice and support
from relatives, friends, colleagues and medical professionals helpful.
One leader made a general comment about her attitude to seeking and sharing
information.

/ My background is science and being fairly open about.....I know some women
don't like to talk about anything that's personal and those sorts of things, well,
I'm not one of those. I'll ask questions, or someone's read something so I'll read
that or talk about it. I’m quite open to sharing information. /

A number of participants found talking with friends or family members was a source
of both support and information.

/.....friends all around the same group all tend to talk about it and I think the
friends network was really important and I have a number of friends who are
older than me and that was helpful, that was actually very helpful...../
/..... this group is a menopausal support group, that’s what we call ourselves,
and really going along to groups like that can really help.//..... it gives you the
idea that you are not the only person to experience these various symptoms or
to be in that position.//..... and probably my sisters, they probably prompted me.
We researched it, we talked. /
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The experience shared by a friend alerted one leader to the possible cause of
symptoms she had been experiencing.

/ She had obviously gone through the menopause at that stage. She was
working at the time and she had said what her symptoms were. She had
obviously been to her doctor and got the HRT. So I kind of just knew that that
was exactly what was happening to me. So I went to my doctor and I said, ‘I
think I’ve got pre-menopause or menopausal.....’ /

She went on to describe her relationship with a group of peers who provided advice
and support to each other throughout the time of perimenopause.
/ I’ve got this group of friends, a group of women, who I don’t see very often.
Maybe three or four times a year we go out for dinner together. We call
ourselves the MSGs, the menopause support group. It is just a little joke. We
have been doing this for probably about 15 or 20 years, the MSGs! /

Another participant discussed the impact of skin rashes that she experienced at the
time and her realization, after talking to friends, that the problem may have been
related to hormonal changes.

/.....one of the things that nearly drove me over the edge was around that time I
obviously had a major hormonal change, ' cause I came out in enormous
rashes , allergies to what the doctors thought it was to dyes in fabric, but I had
spoken to a couple of other friends who had been put on particular drugs for
that sort of thing and they said 'you know have you ever considered that it's
got to do with the change of life?' .....and I just wonder in retrospect, how many
creams I've put on my skin and what ever, cortisone, when it may have
been...../

Another leader also talked about the value of talking to other women who were of a
similar age and educational level.

125

/ I talk to girlfriends. ..... we have been meeting together for so many years; we
talk about ‘the change’. //.....we were all talking about the change and what to
do and this, that and the other. /.....‘what colour are your tablets? / That was
when we were all turning 50 //..... that group were all, if not academic, well
educated, rational thinkers. /

One leader, who had acknowledged that she was in early perimenopause, said that
seeking information was not a priority. She indicated that she would deal with
problematic symptoms when and if they arose and would then seek advice from
friends.

/ I guess in some ways, it's probably..... a little like when you're pre-adolescent,
you know that it's coming and you kind of think 'oh well, what's it all
about?’..... but until you actually hit it......//..... I'd probably chat to some of my
friends about it as well; find out what they've done. /

A number of leaders discussed the pros and cons of seeking advice and support from
colleagues. One leader described how discussion with female colleagues did occur
but was often limited to a fairly brief and superficial exchange of information and a
show of empathy.
/.....it wasn’t talked about consciously.//.....we would talk about it but just have
a joke about it and not say, ‘Are you seeing a doctor? Have you tried this?’ It
wouldn’t get to that depth. It was just the, ‘Oh gosh! Are you going through
that too? You poor thing!’ That would be the sort of extent of it in a way. /
One leader reflected on how things had changed in the time since she‟d experienced
hot flushes at work. She believed it was now much easier to talk about.
/.....someone's always saying 'Oh, excuse me; I'm having a hot flush’..... it
doesn't matter if there's men there or anything .....// .....somebody will say, 'OH
God! Hot flush! Hot flush!'..... it's much easier to talk about it, it's also, sort of
ten years on too so it's a bit easier to talk about those things, but when I was
working with a young group, it wasn't talked about. /
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Another said she would talk to those in her own age bracket, but that she did not think
younger women would be able to relate to the issue.

/ The girls in my particular department are all in their 20s or early 30s, so they
probably don’t relate. They just think, ‘Oh gosh, she is getting old.’ So I
wouldn’t necessarily discuss it with them, but certainly people around the same
age bracket. /

Another leader believed women colleagues would generally be supportive of each
other.

/ I think most, nearly all the women who work here would have other women
here that they can talk to and some of us would have a lot of those women in
common.....so there's that sort of, quite collegial caring..... even where there's
not necessarily a, like a strong friendship, some of us catch up very regularly
‘cause there's a strong friendship as well. /

A number of leaders also discussed talking to family members and friends about
perimenopausal symptoms.

One talked about the resistance she had experienced when trying to advise her sister
about managing perimenopausal symptoms.

/ I suggested to her HRT but she was negative, feeling depressed and putting
the blame on her husband for all the ills and what ever in the family...../

Another leader who had had a positive experience of using HRT was quite forthright
in her advice to a friend.

/..... she is still not sleeping and this has been going on for years. I said to her,
‘Why don’t you go on HRT?’ ‘Oh it’s dangerous.’ I said, ‘No bloody way!’ you
know. I said, ‘And even if it does mean you are going to drop off the perch a
few years earlier, at least you had a good time and can go out roaring.’/
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I like my doctor.

The relationship leaders had with their doctor or health professional often appeared to
be a factor in regard to their knowledge about and attitudes to perimenopausal
symptoms and treatments. A number of topics were discussed including how
comfortable they felt discussing certain issues; whether information or advice was
offered unsolicited and the nature of the advice given.

Many leaders said they felt comfortable about talking to their GP and confident that
the advice given would be appropriate.

/ I'm comfortable with her. She seems competent, so I'd probably rely on her
advice to quite a great extent.....//..... she [the GP] will actually ask 'Are your
periods still regular?’, when I go through the yearly check up//..... if she thinks
it's normal, I've only got my experience to go on where as, she's got hundreds
of people to compare with so if she was concerned, then I'd think 'Oh well there's something unusual'. /

/ I like my doctor and I've got a lot of confidence in her so if she thought it
[HRT] was a good idea I'd probably give it a go and she's the kind of person
who would probably want to monitor how things were going and see if that
was a suitable treatment or not. /

/ I had a very good female doctor who has unfortunately resigned from that
practice but she was very good in terms of, good level of care, easy to talk
to...../
/..... she was a very good women’s doctor who always was running late because
you would go in and she would spend time with you. /.....when she talks HRT
you would have a long talk about it. /..... you knew that you were getting good
education and you were going to be considered and your feelings were going to
be considered, and you had a say...../
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Although not recommended as a means of ascertaining menopausal status (AMS,
2010 d), a number of leaders talked about their doctor ordering blood testing in
response to their seeking advice regarding symptoms.

One sought advice regarding heavy and erratic periods and was offered hormone tests
and subsequently prescribed HRT.
/ I put up with that for a while and then went to see my doctor, a gynaecologist
or whatever/ I had to have some tests. They do the hormone tests and then I
was prescribed hormone replacement therapy, which I was on for ages. /

/ I was menstruating, and I had to wait for that to stop before they would do
any tests. I don’t think it was done light-heartedly. It was done with a bit of
caution...../

Another leader talked about being concerned that certain symptoms may have
heralded the return of the chronic fatigue she had experienced some years before. She
described how her doctor ordered blood tests in order able to alleviate her concerns.

/.....she did blood tests and hormonal level checks and all that sort of stuff and
it all came back perfectly. /

In contrast, another leader who sough medical advice because of concern about her
symptoms was informed that the tests were not to ascertain her menopausal status, but
to rule out other possible causes of her symptoms.

/ ... 'is this associated with changing hormone level and stress? Is there
something more sinister that's happening underneath here that we need to be
worried about?' So it was in that context that I had the blood tests rather than,
'Am I menopausal or perimenopausal? /
The offer of antidepressants after seeking medical advice for low mood was rejected
by one participant who said she preferred alternative therapies.
/.....she [the doctor] asked did I want antidepressants and I said, ‘No’ and that
was it. We left it at that. I sought alternative therapies. /
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When her female doctor was replaced by a male GP, one participant found she was
less comfortable about discussing some things with him.
/ I’ve not talked to the doctors, mainly because the female doctor has gone and
the guy who's now my GP is someone that I worked with. We worked really
well together and I trust him implicitly as a doctor but I don't need to discuss
some things with him. /

Although she was experiencing symptoms, one leader had not raised the issue with
her doctor.

/..... the doctor that I had been going to for many years retired. The one that
I’ve seen since, no, I really haven’t sort of...../

When asked if her new GP had raised the issue:

/ No, no, not at all. /

Another leader who had been complaining about her waning libido was not satisfied
with her doctor‟s explanation and mentioned her intentions to have the issue clarified
at her next visit.

/ I will ask her because I have been whingeing about this. She [the GP] says,
‘Oh, here is the graph. You are no longer meant to have babies, so you are not
meant to feel sexy at all.’/

After experiencing certain urogenital symptoms, another leader was encouraged to
continue using medication to alleviate the problem and prevent other problems from
developing.
/ I went to a doctor a few weeks back and said, ‘Should I be discontinuing
this?’ She said, ‘That will stop you from getting incontinence and vaginitis and
other infections. /
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The importance of establishing a good relationship with a woman doctor was
highlighted by one participant.

/ I think if women can set up that sort of relationship with a woman doctor and
I say a woman doctor because I think it's far more difficult to do with a male
doctor. /

One leader talked about her frustration after getting what she believed was
unsatisfactory advice form a number of doctors.
/ I was going to the doctors first and they were saying, ‘No, nothing wrong’
and then I’m thinking, ‘Oh I can’t handle the job obviously’. //.....so various
doctors, ‘Yes, no darling you are alright. That’s okay, do you want some pills?
No, I don’t want any pills. I just don’t feel right.’ / On the same day I went to
three doctors. /

She described how she subsequently searched for information at the library

/ I went to the library, then I came across all these things and these symptoms
and this menopause thing, ‘My God! That’s what it is.’ And I understood. I
thought, ‘Okay, fine, I’ve got one ovary. That ovary has packed up. I’m now
menopausal.’ I understood! /

She then went back to see her doctor:

/ I told her what was wrong, what had happened and what I had identified and
she said, ‘No, no, you are too young.’/All day I spent going to doctors. In the
end the last doctor said, ‘Okay, I see what you mean. Yeah, we will have to put
you on HRT’ and then that whole process started...../

More recently, she found that seeking advice about the pros and cons of whether to
continue using HRT was also problematic.
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/ ..... it depends which doctor you see. ..... I had asked doctors every time I go,
‘What do you think? Do you think I’m still okay? I would get one who would
go, ‘Well, you know, you should be off it now. How long have you been on it?
Oh dear!’ And then you would get the other one say, ‘Yeah, look, you know, the
latest thing is, I read something the other day and says, dah-de-dah-de and
these are the pros and these are the cons.’ You know, that’s fine, pros and the
cons and let me make a decision. /

I just don’t like taking tablets.
A number of factors reportedly influenced participant‟s decisions regarding treatment
options. For some their decisions reflected an underlying philosophy about the use of
pharmacological or naturopathic approaches while others professed to being prepared
to make decisions based on what they considered important at that particular time in
their lives. Attitudes and beliefs about HRT as well as advice from significant others
also influenced decisions regarding treatment options.

One leader expressed her view that perimenopause is a natural process.

/.....for me it was just a matter of this is a natural process and you live through
it.//..... and also just an understanding that it is a process that you go through
and having gone through it. //..... move out the other end without continuing it
or extending it by strategies to try and avoid it. /
For many participants, decisions about treatment reflected existing attitudes to using
medications.
/ I’m not great on taking things; I’m terrible. I’m notoriously bad to take
things. I just don’t like putting myself on lots of, you know things. I mean, now
I’m on high blood pressure tablets and I have to take them, so I do take them,
but if it was anything else I probably wouldn’t take them because I ..... //I just
don’t like taking tablets...../
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/ I mean, I’m certainly not hippie-ish in any way, but I think I really pride
myself on the fact that I’m not taking any medications..... my first preference I
think would be what lifestyle and dietary changes I could make and then is
there any sort of herbal or vitamin/mineral based thing, and then I think I
would look at HRT. I would always have all the options explained to me, but
knowing how I’ve dealt with other things, even something like chronic fatigue,
that is the sort of hierarchy I went through. /

Others expressed a similar philosophy to the use of medications.

/ Well, given that I have taken nothing, I probably would be going down the
road of trying to avoid that; very much so. /

/ I only take medication when I really have to. /

One leader specifically discussed her concerns about HRT, the factors that had
influenced her decision not to use this type of treatment and her determination to just
ride it out.

/ I would go onto HRT with a great deal of caution. // I think this is something
that occurs naturally and it happens for a reason. Maybe we don’t understand
what that reason properly is, but it is the reason our systems have evolved to
that point. I’m a great evolutionist and I think the equation can’t be that wrong.
And so I would prefer to ride it out if I can, anyway. / / I am not interested in
HRT mainly because I don’t want another set of drugs to complicate my
current regime. My regime [for a pre- existing condition] works really well and
I’ve been very stable on that regime, so I don’t want to throw anything more
into the system. So I decided that I would try to just ride it out. And it hasn’t
been bad enough; if it got really bad, then I might. /

She describes how her decision not to use HRT was based on medical advice.
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/ I have an endocrinologist for my [pre-existing condition], so I had some
discussions with him on HRT and we agreed that I wouldn’t do anything about
it. /
One leader‟s decision to avoid using HRT was based on her assessment of the
literature she had read on the topic.

/..... having read literature and so forth on it [HRT] I would prefer where
possible to just have a healthy diet and keep the exercise up and try to manage
it as much as I can and just see if I can manage my way through it than go on
sort of medication with the potential risks and things. /

Another commented on her assessment of the WHI study and how the findings
supported her thoughts regarding the use of HRT.
/..... that didn’t really surprise me [findings of the WHI study]. It is very hard
to do population studies that are so controlled that you can come up with,
statistics that are meaningful, so I tend to be very skeptical of those sorts of
numbers, but there is more and more evidence piling up that excessive use of
HRT is, you know, and that doesn’t surprise me. You are asking your body to
continue with a process that it has had enough of. It doesn’t need that any
more, and now you are demanding that it continues on. And to be continuing
through until you are 60 or 65...../
Having a pragmatic approach to medication appeared to be a factor in one leader‟s
decisions about treatment options.

/ I've got a pretty pragmatic approach to medication. If something comes up
and I need it I'm not particularly for or against in advance. If, if, you know, if
the symptoms were causing me problems, then I'd probably go and see the
doctor and see if there's something he can do about it that isn't going to cause
something worse..../
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Although one leader had heard a number of adverse reports about the use of HRT, she
said it was her own experience of having an unpleasant reaction to HRT that
influenced her decision to discontinue the treatment.
/ I didn’t not take HRT because of the issues from these studies and things. I
think if it had helped me I would have taken it and kept going, but I remember
taking it and thinking, ‘Oh God! I feel like I’m having a period every day with
it’, sore breasts and...../

Another leader claimed to be informed about HRT and had ongoing concerns about
the risks that may be associated with its use.

/ I've read a lot about it. I know a lot about it and I mean the balls out isn't it
in regards to how good it is for you, otherwise it can actually be impacting you
in other health issues and things...../

A number of leaders talked specifically about their reluctance to use medications or
drugs and their preference for using alternative approaches and therapies to manage
symptoms.
/ I’m now looking at, herbal, I mean, I have never taken anything medically,
anything...../ But I have just, only this week in fact, because I am hopeless at
remembering to take things; that is my problem, started taking a few things,
like, the Evening Primrose and the fish oil. Whether it makes any difference I
have no idea...../

/ I actually take no medication at all and so I am not someone who likes
popping pills. So I think I would probably look at alternate natural type of
dietary and potentially lifestyle changes before I would look at taking a drug. /

/.....my own way of dealing with things in terms of night sweats and things like
that is, I'd take things like evening primrose oil, and black cohosh and those
sorts of things as part of the 4000 vitamins I now take to keep my body moving.
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I think I would suggest a whole lot of things before I would say, medical
intervention, HRT and that's before HRT got a bad name...../
/ I decided I was going to not do anything about this. I certainly wasn’t going
to be taking anything like antidepressants or anything like that./.....she [ the
GP] asked did I want antidepressants and I said, ‘No’ and that was it. We left it
at that. I sought alternative therapies...... I was taking alternative treatments,
which seemed to be okay. / /..... going to naturopaths and what have you, and
they would make preparations. /

/..... hot flushes started first and that's when I had the homeopathic, and that
actually worked really quite well for me the homeopathic.....//..... really helped
manage those....took them [hot flushes] down to a very, very low level. /

Another leader had her own unique approach to managing her night sweats. When
asked by her GP if she needed any medication:

/ I said 'no I can control my temperature by waving my foot around in the air
and that's fine’, and so there was never any discussion of any medication. I
never asked for any...../

In contrast to those who preferred non-pharmacological approaches to alleviate
symptoms, one leader expressed her concerns about alternative approaches.

/.....all of the alternative approaches are basically chemicals, anyway. They are
just badged differently, ‘Oh it’s natural!’ ‘Oh yeah, whoopee-do’. Well, heroin
is natural, too; it comes out of a poppy plant. //..... I’m not into that space of
finding alternatives delivered by people who are often not qualified and
haven’t got a clue.....I’m not interested in putting something into the system
that I don’t understand and don’t know. It is my science background. /

A number of participants discussed the circumstances under which they may choose
to use HRT.
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For one leader, using HRT would be an option if her symptoms caused her discomfort
or began to impact on her capacity to achieve what she wanted.

/.....if it was causing me something like headaches or, something that was quite,
a discomfort during the day or started impacting on what I wanted to achieve,
yeah, I'd probably be lining up and giving it a go and seeing what
happened...../

For another, mood swings and a potential loss of credibility would be the catalyst for
using HRT.

/ I think it would be if I got some of the mood swings and I became someone
I’m not. // I don’t see any evidence that I’m suffering any mood swings and
therefore I maintain my credibility with the people around me and that is all
that I’m worried about, but if I was going through deep depression or things
that were changing the way I might be perceived, then I would consider that
[HRT] then. // I think it would be if I got some of the mood swings and I
became someone I’m not. /

Although she did not envisage using HRT herself, one leader expressed her belief that
she did not expect others to be martyrs and not use HRT if they felt they needed it.

/..... if you need that sort of thing that's fine, that's what you should do. I don't
expect people to be martyrs and you know, 'Thou shalt not take HRT’. /

In contrast, one leader expressed strong concerns about what she considered was the
inappropriate promotion of HRT use.
/ Women [in the past] were being encouraged to use post-menopausal
hormones whether they needed them or not. /

Although she said she had concerned about choosing appropriate treatment options,
one leader did not feel that she had access to current information about the pros and
cons of HRT use.
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/..... maybe my information is out of date and maybe I haven’t sorted it out so
much, but from time to time I think about ‘Oh HRT, right, I had better see what
the latest bit of information is and what we should and shouldn’t do’ and
probably that information is somewhere, but I never really feel that there is a
place that I can get the latest ‘what’s happening today?’ and the pros and
cons. /

Deciding between the risks and benefits would reportedly be factors in determining
appropriate treatment options for one leader.

/ I mean it is like everything else you do in life. You have to look at whether you
go for short term gains or you think long term. I suppose in many ways it
depends on what kind of a person you are and what kind of a risk taker you
are. I think I’ve always been a bit of a risk taker and I would be going for the
immediate warning. ..... if it was something that was definitely proved to be
cancer causing or something, then obviously you would look for an alternative.
But, I think that if you are not managing, if you are not coping, and that seems
to be the better option...../

Several leaders had used or were currently using HRT to manage symptoms. A
number used HRT for short periods either because of unwanted side-effects; because
they did not find it effective or because they decided they could manage without it.

One leader was prescribed HRT to help manage heavy periods but found she had an
adverse reaction. She decided to soldier on without it.
/..... the doctors then put me onto hormone replacement therapy, but that didn’t
agree with me and I went off it very quickly, because I used to get very sore
breasts and that sort of thing. So I just took myself off it. I thought, ‘No, I’ll just
soldier on.’ I really just thought, ‘I’ve got to carry on through this because I’m
not going to take hormone replacement therapy. It doesn’t suit me.’ I didn’t
bother looking at alternatives or anything else. // I think I probably just took
myself off it [HRT] and thought, ‘I’ll just get on with it.’/
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Another participant was persuaded to use a very low dose HRT to manage symptoms
after finding alternative treatments ineffective.

/.....very low dose, the HRT, but I felt that was stopping me. I didn't like doing
it. I'd tried all the herbal things and everything but I didn't want to take in
HRT but I was not able to function really, I was so tired and that made it
difficult at work and you've got to put on a bit of a face you know, at work.
You have to, you have to be seen as functioning and you're being paid to
function and all of those sort of sorts of things and I went through a period
there where I just couldn't function.// It's not something I..... I didn't stay on for
a long time. I went off it again and then I went on it again at another period,
the lowest dose you could have, for about another 6 months...../

Although HRT provided benefits in the short term, one participant said she did not
necessarily believe she would use it indefinitely.

/ The quality of life, the quality of job, able to manage, and understanding that
it may not be something that you are going to do forever.// I was reluctant to
[go off HRT] while I was still at a busy job, but as soon as there was the
opportunity I thought, ‘I don’t need to be having these. I can manage without
them.’ I know a number of my friends did that at the same time. We used to talk
about the second menopause wave that some of them were getting. /

The experience of symptoms after ceasing HRT was also discussed by another leader.

/ I know I went off cold turkey..... I went cold turkey and then everything came
back with a vengeance.// Even though I had stopped menstruating, you know, I
was through menopause, but everything came back with a vengeance. /

When asked why she came off it:
/ Well, because I thought, ‘Well, I’m through menopause, I don’t need it.’ I
really hadn’t researched how you go off it, so I went back on it and then it
might have been a couple of years later I weaned myself off. /
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Another leader who eventually ceased HT discussed having a recurrence of the night
sweats.

/ I did start with night sweats again, but I.....// I got through it. I would have
had more minor symptoms at that stage. // I can’t even recall whether there
was any of that low feeling. If there was, it wasn’t important then. /

One talked about the influence of her peer group on her attitude to HRT.

/..... all of us, I mean, there are sort of like 8 or 10 of us in that group, and I
can’t remember anybody being anti-HRT. /

I’m dead or I’m on HRT.

A number of participants chose to use HRT to address their symptoms. For some, this
decision was taken despite the risks they (or others) believed may be associated with
its use because of the perceived benefit of the treatment.
/ I can remember people saying to me, ‘Oh it’s terrible being on HRT. You
shouldn’t be on HRT, it is so dangerous’ and blah-blah-blah. I said, ‘Do you
know what? I took a choice. I’m dead or I’m on HRT.’ I didn’t want to die.
That’s how extreme I felt it was. I really could not have continued living that
way because I mean it was horrible. /

/ Well, you have got to map the risks and rewards of all these things, as they
say, as even my HRT doctor says. /

Two leaders described how they had been inspired to use HRT after hearing a
prominent Perth gynecologist and author speak publicly about managing menopausal
symptoms.

/ I was feeling very unloved and overburdened, unnecessarily I thought until I
met Dr Margaret Smith and she just turned my life around by putting me on
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HRT// I really never ever had focused or had heard a lot about what could be
real symptoms of menopause and wasn't even recognising that that might have
been the case. / I heard Margaret Smith on the radio. //..... she was directing
her comments to busy women and saying 'you can change your life. You can
learn to cope. You just need to take charge of it yourself and do a few things
like go to your doctor'. // I probably went to my GP and said ‘I’ve got to see
this woman'. I then went and heard her speak to a group of women at a
fundraising luncheon and I said to her ‘How do I get to see you, and how soon
can I see you?' So I never looked back and apart from the medication she put
me on I've got to say her personally she personally was a great influence on
positive reinforcement...../

The second leader described a similar experience.

/ I went to a lecture quite early on in the piece that Margaret Smith gave. /
/.....and that influenced me in terms of, ‘You don’t have to put up with these
symptoms; there is something you can do about it.’ So I did look into HRT
really quite early in the piece.// I can remember it so it was quite meaningful
at the time.....// I think it was more meaningful coming from a woman than
some of the, male gurus./ I suppose I trusted Margaret Smith.// She made a lot
of sense to me. /

After some initial difficulty getting information and advice from doctors about HRT,
one leader reported that once the treatment was established, everything was perfect.

/ I think it was about a year and a bit before I actually even got the first HRT,
but that then took another six months for me to find the right place.//
Everything was perfect; I mean, just everything. I was normal. That was the
thing. I was normal. I felt completely normal. I could deal with the things that I
wasn’t able to deal with. /

She goes on to talk about how she believed her behaviour changed after starting HRT.
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/ .....certainly at board level, a complete evidence of change. I implemented so
many things. All of those areas that I was trying to do things and then
somebody would say ‘no’ and I would cry, I managed to change that whole
really culture and way of dealing with everything from recruitment through to
firing and everything in between. /

Hot flushes and a waning libido were eventually the catalyst for one leader to use
HRT.

/ ..... the two overriding symptoms that have really troubled me are hot flushes
and loss of libido./ / The hot flushes were getting absolutely beyond a joke. I
remember, what finally pushed me over the edge. I was at dinner and sweat
was dripping down my chopsticks at a Chinese restaurant, and everyone was
looking at me laughing.//. I thought, ‘This is ridiculous. This has gone beyond a
joke.’ So I went and did something about it. So it got that bad before I was
driven to do HRT. // I mean, what I really wanted to cure was the hot flushes
and it [HRT] did. . //.It was the hot flushes, yes, that was the real trigger. I let it
go on too far. I mean, perhaps awareness is a really interesting point. /

Another leader was not sure whether the benefits she experienced in using HRT were
due to physical or psychological factors.

/..... I did, [find HRT effective] and whether it was a psychological thing or
whether it was physical, I’m not sure. My belief is that it was physical in that it
just gave me that, you know, more level sort of stabilising. /

Leaders who were able to use HRT for extended periods of time reported very
positive outcomes.
/ She [the GP] treated the symptoms. She said, ‘Let’s try this’ and ‘we’ll try out
this dose’, and that was what I stuck with. It was all fine, and I went back to see
her probably a few months later and I was able to report a transformation. // I
think I was sleeping better. I certainly didn’t have the sweats, but I suppose the
most powerful change was this kind of lifting of the mood. I just kind of felt that
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it was almost palpable. It was amazing...... // It was absolutely amazing. // I
would have felt that I would have coped better [on HRT]. I certainly wouldn’t
have been battling. I was more sort of energetic. I mean, a lot of my work
wasn’t at work. I had to do a lot of things after hours.// So, if you are feeling a
bit low and you are going and meeting new people and you are trying to kind of
be the face of an organisation, it becomes a bit of a struggle. So my sense is
that all of that changed and I went into that with a lot more energy. /

A successful career and better relationship with her husband were attributed to the
benefits of HRT according to one participant.

/..... I then went on to have a very successful career and have had enormous
energy; able to do it, felt well, felt fit. I would have to say that I have probably
worked at the most difficult job and position, hours and that sort of thing. So I
just attribute, my ability to cope with a lot of things has been to my use of HRT.
My relationship with my husband, everything improved. /

She talked further about her determination to continue using HRT even when family
members tried to persuade her that she did not need it.
/.....I’ve just been on HRT ever since. Even though my older sister said 'you
don't need that sort of intervention, we're of good stock, we don't need it'. But I
have said to all of them 'the risks may be there, talked about risks in the paper,
but I have decided that I'm going to be in charge of my life and I've now been
16 years in (organisation) and very productive energetic sort of contribution
to (…) in this State.// I just knew it [HRT] was making a change...../

For a number of leaders, the benefits they associated with using HRT outweighed the
possible risks.
/ I have no qualms about using it. I don’t care whether I get a risk of heart
attack or a risk of increased breast cancer or of the vagina or whatever. // So,
what was best for me? I have no qualms about using it; absolutely not. /
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/ I don't like taking anything actually, but I mean, horses for courses at times
and sometimes, what's the lesser of the evils. I was always. ‘I’m never going to
take HRT' but...... //..... you'd get one lot of information and then another lot of
information and I think common sense tells me if you can not take any kind of
artificial chemicals into your body that's got to be better for you than doing it
but to me it was like 'I can't function so therefore I will [take HRT]. /

One leader reflected on how she felt she may have managed had she not chosen to use
HRT.

/ I think I would just have been worn out, worn out quicker than I was. I think I
would have been worn out. /

A number of participants commented on their reactions to the negative publicity
regarding the use of HRT, following the release of the Women‟s Health Initiative
(WHI) report in 2002.

/ I was reluctant to go off the HRT and even when that first lot of research
came out which questioned whether I should be still on it, I went and saw my
GP and had a long chat with her and said, ‘Look, I’m reluctant to do
anything.’ I said, ‘Oh yeah.’ I think it was a bit like a crutch./ I think when that
first lot of research came out I wasn’t totally convinced and I kept my thinking
that when I retired I would. I think that she was suggesting that I might come
off before I actually did, but I said, ‘Look, I don’t want to risk it. I feel I need to
just keep an even keel until I finish off at work and so on.’ So I think she was a
very well informed and good GP for women. /

/ ..... we [a group of friends] were talking about the going off them [HRT]
because we were all at that point and we were all concerned about the
research. So there was some talk around about that time. /
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Some leaders expressed doubt about the validity of the research.

/ Well, I think it is a tough one. I mean, I would have to be convinced that the
research on HRT was as sound as it is supposed to be. I think there are
questions about that. /

/ I doubt the validity of that study [WHI study]. I discussed that with my doctor.
I didn’t read the report. I only read what was available in the newspaper, and I
was very skeptical on the way it was reported. // Doctors are a lot more
comfortable about prescribing antidepressants.// Well, you know, you have a
choice. Obviously you have to be guided in making your choice and to me it
was effective. I don’t have a medical background to say any more than that. I
can only go through myself. /

Another leader said that despite the negative publicity, she always returned to HRT
because of its positive affect on her life.

/ Look, on the odd occasion when there's been bad publicity, I might have
stopped for 5 or 6 weeks, but I always returned because I thought,.' that is what
has turned my life around'...../

Leaders related different experiences regarding the change in attitudes to the use of
HRT.

/ ..... there is an anti. None of my friends take HRT. I see one particular friend
of mine in England, and she was this fabulous fun sexy great woman, and she is
now a sad miserable grumpy, and almost lost her sexuality. /

/.....all of us, I mean, there are sort of like 8 or 10 of us in that group, and I
can’t remember anybody being anti-HRT. /
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Superordinate Theme Three: Keeping Up Appearances

For many leaders, maintaining the appearance of control that they believed was
expected of them in a leadership role was paramount. In addition, a number of
participants reported holding the perception that they (or women in general) may be
unfavourably judged if they allowed others to become aware that they were
perimenopausal or experiencing symptoms.

Fronting up and putting on a bit of a face.

A number of leaders talked about their own perceptions about the way they felt they
should appear when in the workplace.

/......you have to front up and you've got to be seen as capable and competent
and in control and all of those sorts of things and .you've got to look right too
at work. You're expected to look neat and tidy and presentable all the time and
I think the days are gone where you had to be power dressing, that's all gone
fortunately, but you still, to be dripping wet..... /

/.....you've got to put on a bit of a face at work. You have to be seen as
functioning and you're being paid to function and all of those sort of sorts of
things and I went through a period there where I just couldn't function. /
/ I would have been more conscious of being more, seemingly even at work
than I might have been personally. /

One leader reflected on the expectations she believes women place on themselves and
are conditioned by others, to accept.

/.....there's just a little bit of a fine line. It's a little bit of 'give yourself
permission to have this' as well. We can tend to be superwomen when you're in
a senior role and you're expected....., women are conditioned to all of that as
well. We've got partners and family and all of that sort of stuff and a lot of
women have family at home when they’re doing this so that would be even
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harder I think. /

In addition to the perceived consequences of negative perceptions or judgments on
career prospects or credibility, one leader talked about the importance of maintaining
the appearance of control so that those reporting to her felt comfortable about seeking
her advice and support.

/.....it's more like the impact on them rather than the impact on me. I like to feel
as though people feel comfortable about coming to talk to you or feel they can
cope if they feel that I can cope. If they feel that I'm not coping I don't think
that's good for them and you're there to support other people//.....they need
more leadership, they need to look to you as being a stronger role model and
all of those sorts of things.// It's about them, it's not about me. It's not about me
feeling embarrassed ‘cause I don't think I am particularly embarrassed it’s
about how they would feel about coming to me that would worry me. // I see my
role of there to coach them and to support them and to, to get them competent
enough and develop them if they think that you’re down or you've got issues or
you've got something then..... they're good people, they're nice people who
have a sense of care about you as well and they’d feel like they were imposing
on me.../

Show your weakness and you are lost!

A number of leaders reflected on how they and other women (in general) may be
concerned about revealing any indication that their symptoms may affect their
performance and the possible ramifications for them in terms of their career
prospects.
/..... if you are in a management position, you don’t necessarily want people to
know intimate things about you because that can be a problem/ I think there is
that professionalism there, yeah, of not letting them [colleagues] know. /

/ There might be some subtle pressure I guess to not be seen to let something
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like menopause have an impact on your performance at work. /

/..... it could be a problem in terms of promotion, from a generic sense. I can
imagine that women would think, ‘Oh no, I can’t tell them about that because
that might influence their decision about whether I can manage this or manage
that.....’/

/.....professionally, women are reluctant to publicly acknowledge any weakness
in their coping because people, in particular in a male dominated profession,
are very quick to say 'oh well it's a woman's thing and you know, they're
suffering and they need to be understood and we need to overlook them for the
next promotion or whatever'..... So that's why women are, in those very
competitive areas, to be seen to be coping and to admit that there are down
days is not good for their professional promotions. /

One leader gave a description of how she believed she needed to appear in order to
maintain an aura of competence.
/..... it is difficult because you don’t want to show anything that you are not as,
in your armour. /

Another leader describes how she was warned about the ramifications of revealing
any sign of weakness in her particular workplace.

/ I got told when I first [joined the organisation] I had [other colleagues]
explain to me how you look for one another’s weaknesses. That is the way the
game is played. / So show no weakness; show your weakness and you are lost. /

One leader described how in her line of business others were inclined to look for your
weaknesses and talked about her efforts to avoid putting herself at risk if she felt her
symptoms may have made her more vulnerable to an attack.
/ I’ve seen, just because of my line of business, where they look for your
weaknesses and they go for your weaknesses, so you can’t show any weakness.
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So if I thought that maybe I wasn’t..... If ever I think maybe I’m not 100 per
cent, I take great care not to put myself in a situation where it is going to
show// And because I was very lucky, it was only for short periods. I could just
cut back for those short periods. I could still work. I could do paperwork or
whatever, but just not put myself in the situation where you are the centre of;
you know, in my line of work, an attack. /

One participant discussed her perception that being open about physical things was
more acceptable than disclosing problems of an emotional or intellectual nature.

/..... if I had hot flushes, things like the very evident physical things like that, I
did have a laugh about it because what else can you do, but the more subtle
things like anxiety and loss of memory would have been harder, well,
particularly anxiety, to share, I guess.// ..... there was certainly in my mind a
distinction between the really physical signs and then the more emotional
signs. I felt I had to hide the more emotional.....// Yes, it is okay to break your
leg but it is not okay to get a bit fed up. /

She provides further insight into how she believes she needs to behave in order to
maintain her credibility with her male colleagues.

/ You know, you want to be.....Well, I had to be the same [as her male
colleagues] as I could possibly make myself. I mean, that is how I always felt.
You have got to be like them. /

Another leader also talked about her perceived need to present herself in a certain
way in order to be the face of the organisation.

/..... if you are feeling a bit low and you are going and meeting new people and
you, you know, are trying to kind of be, the face of an organisation, it becomes
a bit of a struggle.// I think I would have tended to hide any feelings, any
irritability or whatever. /
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Several leaders made comments about how they believed women generally may be
judged within the workplace.

One leader suggested that a women was more likely to be judged based on her
explicit behaviour rather than because she was perimenopausal.
/ I think that is a perception that people have that ‘Oh well, someone will use
that against me,’ but I’ve never in my whole life ever heard a conversation that
says, ‘Oh well, she has got this issue or that issue’ and if she is very moody,
then it might well be the moody bits that make people uncomfortable.// No, it’s
not the fact, but it is just how it is manifesting itself, and if people don’t
understand that, then they only take it on face value that, ‘Oh gee, she’s a
moody bitch and no one likes dealing with her.’ Then that’s an issue. I mean, I
have sat on lots and lots of selection panels of senior women where it is a table
full of men and me where we are selecting people for a particular job and I’ve
never heard any remark ever. /

Another leader provided a different perspective, believing that women are judged
more harshly than men particularly if they are deemed not to be coping or functioning
optimally.

/ I think that for women, and older women, it is a problem because age does
matter when women are concerned much more than men in the professional
areas, and if there's any indication that we are failing or resorting to
assistance or whatever, it is very harshly judged. /
One leader talked about the judgments she believes are made about women‟s
behaviour generally.

/ I think already women are judged by being over-emotional about things
anyway, so that if you deal with something in that female.....Well, it’s not even
that. It’s actually probably in that female PMT way when we are a bit
irrational..... You know, you have got to fight that in management or in the
business world throughout, I think, and be aware of that, even the PMT if you
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have strong PMT. Because I had bad PMT anyway in the olden days, so I knew
about PMT, but having it all the time is another case. /

One participant believed there would be few concessions made for women at this
stage of life just as is the case for working mothers.

/ In this environment there are not that many professional women anyway, and
you always very much welcome their participation. So I don’t think of women
in terms like that [being perimenopausal]. I think the only thing that I could
liken it to is being a working mother where there is stigma attached to that and
there are expectations and there is not a lot of leniency. So I think it is
probably things like that where you have got outside influences that do impact
on your working life, but I think particularly from a male perspective there
would almost be no thought about that. I can’t say for sure, but I think that
certainly my board would be, ‘Well, we pay you to do a job and we expect you
to do it and you work around whatever those issues in your life happen to be.’/

Another leader who had worked in a predominantly male environment had some
comments regarding factors she believed affect the way men might respond towards
women having hot flushes in professional settings.
/ It is very hard in today’s society that a lot of men don’t know where to look,
don’t know what to do, because we have taken away the ability for them to
have a little jibe and a little joke because someone will get upset about it,
whereas I reckon that if I can put the humour out there to start with, then they
all know they can have a little jibe back and we all get on with business. /

Another gave her insights into how she believed men may perceive the plight of
perimenopausal women in the workplace.
/ I think probably men have thought, ‘Well, women have gone through it for
years’ you know, ‘and they have got on with it. Why can’t they do that now?’ It
is just like, ‘Get on with it’ you know. /
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Women and men may react differently in the presence of someone experiencing a hot
flush, according to one leader.

/ I think they [women] are probably more uncomfortable than the men that I
bring attention to it [hot flush]. That might be the case //..... in a professional
sense, I am just trying to think. No, I think they laugh like the men and laugh
sort of at/with me, but won’t admit it themselves...../

One leader believed that being menopausal and exhibiting certain behaviour may
jeopardise a woman‟s chances of promotion. She related her observation of this
happening to two women she knew.

/ I have seen sort of pretty dynamic women who get to that stage and that
would be their next stage, but somehow they haven’t got to that next stage and I
believe it is because..... The two women I’m thinking about both have been
menopausal and I think that their behaviour may have put doubt in the mind for
them to get the next step. Not that they turned it down, but they missed out. You
know, something, their behaviour changed or maybe they dealt with something
irrationally or whatever and therefore, ‘Oh, I don’t think we will do that
because, you know, Mary, see how she reacted to such and such. You know, she
really blew that up. Well, we don’t want that on the board or at that level.’/

Superordinate Theme Four: It’s Lonely at the Top

Many leaders described the sense of isolation they experienced while in leadership
roles. This was often associated with their desire to maintain an aura of confidence
and capability as reported in the preceding section. In addition, many talked about the
lack of peer support and opportunities to socialize and share information due to the
time constraints often associated with their high work demands.
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No one to talk to.

One leader describes how she manages the sense of isolation she experiences being in
a management position. She also points out that peers with whom she may feel more
comfortable talking to may not be thick on the ground.

/ I think in a management position you are more isolated anyway from staff, so
you are looking at people in line with you, or perhaps even above you, as a
mentor. They may not be thick on the ground. // So there is that issue and then
the separate issue, of course, is whether you have got people that you connect
with and that you want to share things with. /

Another leader talked about how she believed her time at work restricted her
opportunities for talking with friends.

/ I think for me, one of things that has really struck me as being an issue is that
we have no one to talk to. It is very isolating being a woman if you are in a
management position because you predominantly spend most of your hours at
work. /..... so it doesn’t really leave any room at all for chatting. I’m not really
a chatty person, I suppose, because I have always had a job like this where it
has been very focused, and so on. I’m not a coffee person, so I think it is a real
issue for someone like myself because you are quite isolated and you don’t get
to talk about things that other women are experiencing...... So we really don’t
communicate. We don’t have a forum to communicate when you are working. /
/ I have a group of women my age...... There are six of us...... //. The only time
that I really do that [talk about personal issues] is when I do get with these
girlfriends of mine a couple of times a year. /

Having no peers she could relate to was also an issue for another leader

/ I had no peers I could relate to and all that sort of thing. /

Another also reported an absence of women peers in her workplace. She made the
point that, in her experience, women are in the minority in senior positions.
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/..... in senior positions, you know. Most of the people I deal with are men. /

Talking to those on a peer level would be preferable to talking to a report according
to another leader. She also describes how she might be more inclined to talk with
friends about the extent to which symptoms were impacting upon her capacity to
manage effectively at work.

/ I think it is when you're in the leadership role, if you've got a collegial group,
on like a peer level, where you're more likely to talk, I mean I’m not that
hierarchical really, but it does tend to work a bit like that. I thinks it's that I
wouldn't be comfortable talking with somebody who reported to me about not
feeling like I could cope. I wouldn't talk to them about that. I'd talk to my
friends about ‘this is really impacting on my work. I'm so frigging tired I can't
get out of bed. I'm feeling like I can't manage properly at work. I feel like I'm
not doing it'. I wouldn't do that to a 'report'...../

A no-go zone!

A number of leaders talked about the taboo some believed was associated with
talking about personal issues like perimenopause with colleagues. One described this
as a no-go zone even with other professional women.

/ Professional women tend to be quite good support for each other I think, but I
still think that that [discussing perimenopausal symptoms] is a no-go zone.//
..... there is lots of support about being a working woman, how hopeless your
husbands are; how much teenage children give you the shits; how you don’t get
paid fairly. I mean, I think the issues that would be covered in ‘The West
Australian’, they are the ones that would be talked about, but certainly I can’t
think of a professional woman I’ve had a discussion with about menopause.// It
just seems a totally taboo subject. /

The distinction between discussing work stuff and personal stuff is also highlighted by
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another leader.
/..... if you talk about work stuff, that’s easy, but talking about personal stuff is
very difficult unless you are really close. /

One leader reported that the subject of perimenopause had not been discussed at any
seminar she had attended.

/..... never talk about anything like that at any of the seminars and things that I
have been to. The only time people might talk about it is if they went to, say,
something with Margaret Smith which is about menopause or something. /

One leader suggested that there might be a greater degree of tolerance in regard to
women experiencing mood changes, if people were to talk about perimenopause.
/ The trouble is that because people won’t talk about it, then people aren’t
tolerant, because they just think ‘she’s having a snooty mood’ or ‘she is in a
bad mood today.’ And because there is no way of anyone actually saying,
‘Well, yeah, just give me a bit of space in the next two days’, they won’t even
ask other women to give them a bit of space. Instead they just get ratty and I’ve
always found that hard because then you don’t know how to react. /

Two leaders talked about the barriers to offering advice about personal stuff in the
workplace.

One who had found HRT helpful was reluctant to push her views about it on women
colleagues.

/..... there's a lot of negative publicity about it [HRT] and they weren't sure that
that was for them and it's not something you want to push on women
colleagues...../

She reflected on what she would like to say to colleagues about her experience of
using HRT to manage perimenopausal symptoms.
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/.....still now if I pick up a colleague, or one of my peers, they may not be
driving, they have very quiet lives compared to mine. There's an enormous
difference and I would just like to say to them, ' you've missed out - you've
missed, you're missing life! There's so much life to be lived.’ /

She goes on to say how she would approach a colleague she thought may be
experiencing perimenopausal symptoms:

/ I'd be very sympathetic and I would very gently. Pose the situation or the
proposition that maybe they ought to consider HRT. /

The other also talked about the need to be cautious about offering advice on personal
issues.
/ If I knew her better I would say, ‘You probably would benefit from......’ but
people have to be receptive to that. You have got to be so careful, don’t you?
Especially if you talk about work stuff, that’s easy, but talking about personal
stuff is very difficult unless you are really close. //..... people are becoming
much more, I think, open to discussion, but it is really a tricky one, isn’t it? /

Recommendations for Other Women in Similar Circumstances

At the end of the interview, leaders who had not done so during the course of the
interview were asked for their opinions in response to Research Question Four: What
are the recommendations for educating and supporting women in similar
circumstances? Although a number of participants provided general comments about
the issues confronting women in leadership roles, only a few were able to offer
specific advice or recommendations about interventions or strategies that may assist
other leaders who may be experiencing perimenopausal symptoms.

One leader talked about the value of mentoring and advocacy for women generally.
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/ It is really hard to generalise, but there are a lot of women’s support groups
now where a lot of women are realising how nice it is to be a mentor or an
advocate, particularly advocacy. I don’t like the term ‘mentoring’ much, but
the greatest value older women can do is to actually offer an opinion that a
younger woman will be suitable for a job, and be an advocate for her. The
organisations that are getting a lot of women coming through the system are
those where they have got advocates and that is because they have been open
enough that people have learnt to trust them, and I think that is part of the
thing we have to deal with. // I’m seeing it a lot now as I get rung up a lot for
suggestions on who might be a good woman to have on a board. So I can be an
advocate for some of the women who have not yet broken out of the not-forprofits. It is important that we do that and it is really important that the women
that are in the system now offer those names forward. /

A number of participants indicated that they believed women need information in
order to make informed decisions.

/ I think for other women, they need the information in order to make the
judgment. / / And perhaps they need some good stories from women. /

/ I just think that there is a need for women to be guided through it in a more
general..... the education on it, the general education on it, but also how to deal
with it in the workforce has not been addressed. It is sort of, not a taboo
subject, but’ Well, so what? Just get on with it’ and I guess that is sort of the
attitude I have taken too, because it is how I sort of deal with it myself..... /

/..... what I'd recommend to other people is, try to develop some awareness and
really to be able to take enough time to at least look at what's actually
happening here and ‘why am I like that?’ I didn't really connect the two
things...../

The absence of advocates in the community who could give a positive lead to women
in regard to the benefits of using HRT made another woman sad.
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/..... it's sad that there are not more advocates out there in the community who
can give a positive lead to women and say ' give it [HRT] a go because it's
turned my life around and maybe, you know, there are opportunities for you to
turn your life around instead of resorting to saying ‘ I'm depressed, my
husband's being horrible to me or, he doesn't see it, my point of view’, and
turning to antidepressants which we know are not a good thing to, not a good
option to be pursuing. /

A more informed medical profession was needed according to one participant.

/ I think the medical profession actually is probably what needs.....the general
medical profession are those who need to be more informed in order to inform
us accurately. /

Other Issues Raised and Comments Made by Participants

A number of comments were made that did not relate directly to the research
questions. A number of the following comments have been reported earlier in relation
to themes associated with the research questions. It is considered appropriate to
include these in the following section with reference to the broader issues they
encompass.
One leader described how she believes she may once have reacted to other women
who may have been experiencing perimenopausal symptoms in the workplace. She
believed she may previously have lacked insight into the possible problems faced by
such women.

/ If I find them difficult to deal with, I might try and find a few ways around it,
and that maybe where I could come up against a woman who is menopausal
and not really quite understanding her issues. /
Another leader described how she believed that women‟s self-perceptions generally
differ from those of men.
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/.....a lot of women aren’t self-confident about their own abilities, whereas men
will brave their way through. If they can spell the title, they will think they are
90 per cent towards getting the job and that will be their only qualification they
have got is they can spell it or think they can spell it, whereas the women will
want to be sure that they absolutely 100 per cent understand it, or they are full
of self-doubt. And I’ve never understood that, never understood it. /

A number of leaders talked about situations in which they had observed the
experiences of other menopausal women.

/..... a friend who does not work and has not worked for years and years and
years was saying, ‘Oh, I’m always tired and this is happening and I’m feeling
bloated and I’m putting on weight’ and so forth. I felt that because her life is
very different and she doesn’t have the same sort of stresses imposed on her life
or the commitments to a sort of working life, maybe she doesn’t cope with it as
well because there are no sort of extra-curricular things in her life as a
distraction...../

Broader issues associated with the cultural aspects of ageing and the denial of the
legitimacy of perimenopause as a transit through life was also raised by one
participant.

/ There is the other thing, too, about menopause. It was something I remember
thinking about, and that is the whole cultural thing about ageing and perceived
loss of sexuality and all of those sorts of things.//..... and I think a bit of denial
about it actually happening as opposed to, I suppose embracing it as part of
women’s transit through life that, ‘This is what happens’. And much the same
thing for men, too, when they get to that age and whatever happens, they grasp
that they are not going to get higher up the thing or whatever, and they have
similar sorts of issues. Yeah, if we didn’t have this single minded focus on
achievement and how you have got to perform, you know, and the idiocy of
things like having to be there at a breakfast at 7.00 in the morning and work
through to half past seven at night. /
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When asked how she thought a woman‟s personal experience of the menopausal
transition might affect the way she managed other perimenopausal women in the
workplace one leader expressed her doubts about making generalizations.
/ My answer would be, 'Depends on the woman’ and I think there would be
women who have very severe symptoms who would not be sympathetic to
anyone else ....//.....and there would be women who basically breeze through it
with virtually no problems, who would be highly empathetic and so I'm not
convinced that experiencing it makes you better or worse at helping other
women.....//.....it's much more about your own values.....// I'd need to be
convinced that having the experience makes you empathetic....../

She went on to provide some insights into the ways in which she believed women
support each other in the workplace.

/ I think there's a whole lot of gender stuff in there around how women support
each other in the workplace because you can have highly feminised workplaces
that are really vicious to each other, so I've said this place [her workplace] is
women friendly and the women support each other but you can have the same
number of women here and you wouldn’t want to lean forward because that'd
give the opportunity for them to put the knife in your back...../

One leader reflected on the manner in which she hoped she would offer support to
others in her workplace if she believed it was required.

/ What I would hope is that my relationship with others be open enough that
people can come and tell me what's going on; that if I noticed it I’d have no
problem in asking ‘are you Ok? Is there anything that you need? Have you
thought about.....?/
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Summary
The findings presented above represent a discrete account of the participants‟
narrative, with the researcher‟s comments limited to paraphrasing, comparing and
contrasting the participants‟ remarks. The development of superordinate themes
completes the interpretative process of data analysis.

The following chapter will discuss the findings of the study and how they relate to the
extant literature. The issues raised that may subsequently inform further research and
provide the basis for educational and support strategies for other women in similar
circumstance will also be presented.
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Chapter Five: Discussion

Introduction

Discussion of the findings will follow the format established in the previous chapter.
A brief discussion of the participants‟ comments regarding the symptoms checklist
will be followed by a discussion of the Superordinate Themes which relate to
Research Questions One, Two and Three. The chapter will conclude with discussion
of issues raised in response to Research Question Four and other issues raised by the
participants that were not directly related to the research questions but of significance
to this study.

In accordance with the established protocol, italic script will be used to denote the
words and phrases used by the participants and as originally cited in the previous
chapter.

In addition to discussion regarding individual symptoms, a number of participants
made general comments related to the checklist and definitions supplied prior to the
interview. These comments reflect aspects of the leader‟s understanding and
awareness of the nature and onset of perimenopause and are therefore considered
important in providing a deeper understanding of the broader issues that may affect
female leaders at this time of their lives. These comments will now be discussed.

Participants’ Comments Regarding the Symptoms Checklist

Existing evidence reveals that women are often ill-informed about both the nature and
onset of perimenopausal symptoms (Lyndaker & Hulton, 2004; Twiss et al., 2007). It
was therefore expected that female leaders approached to take part in the study may
have disparate levels of understanding about aspects of perimenopause. In
consideration of this, all prospective participants received the symptoms checklist and
definitions of the terms perimenopause and menopause prior to the interview. This
information provided a basis on which women could determine their own eligibility
for the study and was also intended to act as a catalyst for discussion. The checklist
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was not intended to be definitive, but rather as a guide to indicate the possibility of a
hormonal basis for a perceived change in the nature or type of symptoms experienced.

Although all participants checked at least one symptom, some were unsure about
whether certain symptoms were in fact associated with perimenopause. This
uncertainty was consistent with the findings of Twiss et al. (2007) that women are
less inclined to recognise perimenopausal symptoms such as joint pains that are not
usually associated with the menstrual cycle or menstruation.

The majority of participants however, reported finding the checklist useful as a
catalyst for discussion and for some, as a prompt, reminding them about symptoms
they had experienced in the past and often not associated with perimenopause. In
addition, consistent with the findings of Lyndaker and Hulton (2004) and Twiss et al.
(2007), a number of participants indicated that they were not familiar with the term
perimenopause and did not know that perimenopause could precede menopause by
several years or that symptoms were often at their worst at this time.

Several participants expressed regret that they had not recognised at the time, that
symptoms they were experiencing may have been the result of hormonal fluctuations.
A number indicated that better knowledge and awareness may have enabled them to
make more informed decisions about treatment options. One participant said she
wondered if her decision to retire from a job she had previously enjoyed had not been
influenced by symptoms she later recognised as having been associated with
perimenopause. Other leaders reflected on the distress or disruption they had
experienced as a result of uncharacteristic or aberrant behaviour that they had not
recognised as possibly being associated with perimenopause. This was consistent
with the findings of Boughton and Halliday‟s (2008) that uncertainty about the nature
and origin of symptoms caused women to experience distress and placed many at a
disadvantage in regard to seeking appropriate advice and support. Boughton and
Halliday also reported that many of the women in their study who experienced
symptoms that they did not recognise as being associated with perimenopause
believed they were losing their sanity or experiencing psychiatric problems.
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A number of participants, who did seek medical advice for symptoms they initially
suspected may have been hormonally based, were reportedly sent for blood tests
ostensibly to ascertain menopausal status. This is a concern because it is outside the
recommendations of the AMS (2010 d) which advises doctors not refer women for
blood tests for this purpose because the results may be unreliable. They recommend
that doctors make their diagnosis based on clinical signs and symptoms such as those
on the symptoms checklist. In addition, telling a woman she is not menopausal is
misleading if the doctor does not also explain that although the woman may not have
reached actual menopause, she is likely to be in the menopausal transition and
experiencing perimenopausal symptoms. Failing to clearly explain this may leave the
woman more distressed and confused about other possible causes of her symptoms.
For example, Prior (2006) found that misdiagnosis often led women to erroneously
believe they were suffering from conditions such as fibromyalgia or chronic fatigue.
Changing attitudes towards the use of HRT may be another obstacle to women‟s
receiving timely advice and treatment for symptoms. Research indicates that since the
release of the WHI findings in 2002, doctors are less likely to raise the issue of
perimenopause with women. Twiss et al. (2007) reported that doctors are now more
inclined to wait until women‟s symptoms become more distressing or until they raise
the issue themselves. In addition, Simon and Reape (2009) report that health care
professionals may lack an understanding of the pertinent issues and overestimate the
risks associated with the use of HRT.

It is also possible that health care professionals recognise that women associate being
menopausal with getting old and may react with some indignation to a suggestion that
symptoms they may be experiencing may be associated with the menopausal
transition. Research suggests that in Western societies, menopause is associated with
negative beliefs and images (Hunter, 2003). Marvan et al. (2008) cite studies that
suggest that women associate a loss of status and physical attractiveness with
menopause. Anecdotally, women often do not contemplate menopause until they are
nearing their fiftieth birthday and in this regard, may associate this life stage with
becoming old. Educating women to understand that the hormonal changes associated
with perimenopause may precede actual menopause by several years and may even be
experienced by relatively young women in their late thirties or early forties, may help
164

to reduce this stigma. Lyndaker and Hulton (2004), recommend that women should
be educated about perimenopause during their 30s so that they are able to recognise
symptoms and seek appropriate and timely advice.

Summary

Providing participants with the symptoms checklist and definitions of the terms
perimenopause and menopause provided a basis for discussion of issues associated
with the recognition and attribution of symptoms. Although no attempt was made
within the current study to ascertain the participant‟s prior understanding of the
terminology or nature and onset of symptoms, it was evident that a number of
participants had been unaware of the term perimenopause; the age at which symptoms
may first manifest or the range of symptoms that may be associated with fluctuating
hormone levels. It is a concern that even amongst a group of intelligent and well
educated women, there is still some apparent lack of clarity about these issues.

Discussion of individual symptoms identified on the checklist provided insights into
the broader psychosocial issues associated with the leaders‟ experience of
perimenopause. The commonalities and differences within the reported experiences
provide the basis for the development of the four Superordinate Themes which will
now be discussed.

Superordinate Themes

The four emergent superordinate themes are as follows:


Distraction, disruption, discomfort and distress



Soldiering on or taking control



Keeping up appearances



It‟s lonely at the top
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Each of these superordinate themes will now be presented.

Superordinate Theme One: Distraction, Disruption, Discomfort and Distress

As discussed above, all leaders checked at least one symptom on the checklist and all
reported some degree of distraction, disruption, discomfort or distress associated with
the experience. Although the degree to which particular symptoms affected their lives
varied, the commonality of the experience amongst participants was considered to
constitute the first of the emergent Superordinate Themes: Distraction, disruption,
discomfort and distress, which is comprised of the following second-order themes:


Disturbed and interrupted sleep



Hot, sweaty and red in the face



I mourn the loss of my libido



Don‟t wear white!



Irritable, anxious and feeling low



A bit more forgetful and less on the ball



Erratic, loony and emotionally driven extreme behaviour

Each of these second-order themes and their implications for women in leadership
roles will now be discussed.

Disturbed and interrupted sleep.

The most frequently checked symptom on the checklist was sleeplessness. Of
particular interest in regard to this finding was the confidence with which many of the
leaders attributed the change in their sleep patterns to perimenopause and the
emphasis many placed on this in their discussion. This was not surprising considering
that sleep disturbances are reportedly twice as likely during perimenopause (Baber,
2009). In addition, Simon and Reape (2009) reported that insomnia may affect the
majority of women during perimenopause and was considered by their study
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participants to be the most problematic symptom, often compromising their ability to
do their jobs effectively. Other studies also found that disrupted sleep reportedly
affected daytime functioning, decreased quality of life and concerns about not getting
a good night‟s sleep often increased anxiety in perimenopausal women (Arigo et
al.,2007; Polo-Kantola et al.,2001; Simon & Reape, 2009). Furthermore, the literature
refers to a range of health problems that can be exacerbated by or attributed to a
reduction in sleep quality including problems with cognition and depression (Godfrey
et al., 2009; Motivala et al., 2009; Hudson, 2004).

It was not surprising therefore, that the impact of having disrupted sleep reportedly
took its toll on a number of leaders. Several reported that coping with sleep
disruptions caused irritability and mood swings as well as increased levels of anxiety
and tiredness during their working day. One leader described her tiredness as
debilitating and reported that she was unable to function at this time. She
subsequently resorted to HRT because she believed her lack of sleep was affecting
her work performance.

Of particular concern for women contending with the demands associated with
leadership, is the possibility that the problems they experience with disrupted sleep
may continue for a number of years. According to Crandall (2008), up to 10% of
women may experience disrupted sleep patterns associated with perimenopausal and
menopausal changes for up to 12 years. It was not surprising therefore, that some
participants reported having had disrupted sleep for a number of years.

It is conceivable that having disrupted sleep for extended periods of time, may
adversely affect leaders‟ health, well-being and potentially, job performance. Simon
and Reape (2009) reported that some of their study participants lost up to three hours
sleep per night. This must constitute a substantial burden for leaders who may already
have to contend with the disadvantages frequently associated with working in
environments that continue to place extremely high demands on women and
frequently offer less support for them than for their male colleagues.
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Hot, sweaty and red in the face.

Vasomotor symptoms such as night sweats and hot flushes are the most frequently
reported perimenopausal symptom affecting between 70% and 85% of women
(Rymer & Morris, 2000; Baldo et al., 2003). It is not surprising therefore, that the
majority of leaders checked one or both of these symptoms.

While night sweats frequently affected sleep quality, hot flushes reportedly caused a
range of problems for those whose work involved high profile face to face or public
interactions. Participants talked about the discomfort, distraction and embarrassment
they experienced as a result of the flushing and/or increased perspiration. A number
reported that they felt dirty or sweaty as a result of their hot flushes. For others,
experiencing a hot flush in a public situation, meeting or while giving a presentation
was more or less problematic depending on whether they believed others would
notice and who was present at the time.

Leaders talked about the strategies they employed to minimize the impact of flushing
and sweating. Some managed this by paying particular attention to the clothing they
wore including layered dressing and found that this was sufficient to ameliorate the
effects of the fluctuations in body temperature. The need to consider what clothing to
wear and how to manage the work environment in order to feel comfortable was a
significant issue for a number of leaders and represented yet another distraction
within their busy lives.

The extent to which having a hot flush in public caused embarrassment varied
depending on the situation. A number of leaders reported that although they were not
particularly embarrassed by their flushing, the presence of men or subordinate staff
caused them to be less open about the experience. One leader said she would be
reluctant to reveal that she was having a hot flush if she believed others might use it
against her. Others reported that they used humour to alleviate any potential
embarrassment in the event of a hot flush, regardless of the gender or status of those
present. Similarly, in one of the few studies in this area, Reynolds (1999) describes
how her participants used humour to defuse potentially embarrassing situations
associated with experiencing a hot flush. Interestingly, one leader said she thought
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that in a meeting with men and women, the other women may be more uncomfortable
than the men in the event of her making a joke about having a hot flush.

In contrast, although a number of participants discussed how their response to the
experience of a hot flush may vary depending on the gender of those present, two of
the leaders who worked predominantly with men were not uncomfortable about
acknowledging or even drawing attention to themselves when experiencing a hot
flush. One did however say that she made a distinction between the physical signs
(like hot flushes) and what she described as the more emotional signs or
perimenopause saying she felt she had to hide the later.

It appears that for a number of leaders, being recognised as perimenopausal was of
less concern than the prospect of having significant others judge them as being less
capable or more emotional. In this regard, a number of leaders indicated that they
were more concerned that the distraction associated with experiencing a hot flush
may cause them to appear embarrassed or nervous (which they claimed they were
not) or in some way lead to significant others misinterpreting their body language.
This also reflects Reynolds‟s (1999) finding that the women in her study were
concerned about losing their poise in the event of having a hot flush at a meeting or in
the presence of a socially powerful group.

Of particular relevance for women in leadership roles is the reported relationship
between hot flushes and stress. Research indicates that stress may exacerbate hot
flushes both in terms of the number experienced and their intensity (Cutson &
Meuleman, 2000). It is possible therefore, that for leaders whose work is demanding,
more frequent or more intense hot flushes may be both the cause and effect of
increased levels of stress.

In summary, for female leaders who are endeavouring to present an image of poise
and competence, the discomfort, sweating and reddening of the skin that often
accompanies a hot flush has the capacity to be a distraction that may well undermine
confidence and compromise performance.
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I mourn the loss of my libido.

Loss of libido and sexual function, and associated urogenital changes are frequently
experienced by women during perimenopause (Wren, 2009; MacLennan, 2009).
Although often not directly impacting work performance, symptoms that compromise
female leader‟s intimate relationships may conceivably have an adverse effect on
their quality of life and sense of well-being and this may subsequently affect their
professional lives as leaders.

Less sexual feelings was the fourth most frequently noted symptom on the checklist,
however little discussion was initiated by the participants in regard to this and other
associated issues. Urogenital symptoms such as vaginal dryness, uncomfortable
intercourse, loss of bladder control, and urinary frequency were also often noted on
the checklist but rarely raised by the participants as an issue for discussion. A few
participants indicated that they believed that certain urogenital symptoms and loss of
libido were an inevitable consequence of ageing.

Although one leader said she mourned the loss of her libido during perimenopause, it
is possible that other participants felt such issues, although having an impact on their
personal lives, did not directly affect their professional roles and therefore were not
pertinent to the study topic. McBride et al. (2010) asserted that women often do not
report certain urogenital symptoms either because they consider them unimportant or
because they feel embarrassed. Whilst it is possible that a number of leaders did feel
uncomfortable about discussing these issues in any detail, some did mention that
vaginal dryness was an issue. One leader said she would have no concerns about
raising this issue with her doctor if the symptom became more problematic while
others indicated that they may be reluctant to talk about the issue with a male GP.
Several leaders reported that they were able to manage this symptom by using nonprescription products from the pharmacy.

In addition to their own embarrassment about discussing certain issues with their
doctor, Kingsberg (2009) found that women were often also embarrassed on behalf of
their doctor. She suggested that this concern may have been warranted as health
professionals often admitted to being embarrassed at the prospect of discussing such
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matters with their patients and clients. It was not surprising that Kingsberg
recommended improvements in patient-physician communication and better
education of both the women concerned and the health professionals responsible for
providing them with advice and support.

It is unfortunate that many of the urogenital symptoms experienced during
perimenopause have the capacity to be more than just an uncomfortable nuisance.
Women experiencing urogenital symptoms are often at a greater risk of developing
problems with incontinence as well as fungal and bacterial infections (Doyle, 2006).
These problems may constitute yet another burden for women trying to cope with
highly demanding leadership roles. In addition, unlike many perimenopausal
symptoms, urogenital symptoms may persist and even increase after menopause
condemning many women to ongoing problems that may impact both their physical
and psychosexual health (Doyle, 2006).

It is of concern that although these symptoms can often be addressed safely and
effectively with low dose vaginal oestrogen preparations (Doyle, 2006), few of the
participants (when asked) said that they had been offered this treatment by their GP.
It would appear that if confident, educated women are ill-informed or reluctant to
raise their concerns about urogenital problems, it could be even less likely that
women generally would feel comfortable discussing these kinds of issues.

In summary, health professionals are best placed to provide timely information and
advice about urogenital health, libido and sexual function with women whom they
consider may be perimenopausal. It would seem therefore that it may be particularly
important for health professionals to take a proactive role in this regard as
recommended by Kingsberg (2009) and MacBride (2010), rather than waiting for the
woman to raise the issue herself. It is also important that women are informed about
the broader ramifications for health and general wellbeing of urogenital problems
during perimenopause and into post menopause. For women at mid-life who are not
using HRT, good health care should include the doctor broaching the subject of
vaginal health and recommending treatments such as vaginal oestrogen products that
are low risk and highly beneficial for maintaining vaginal health (Smith, 2010).
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Don’t wear white!

Another issue that has the potential to adversely affect women in leadership roles
both directly and indirectly, is heavy or irregular menstruation which often occurs
during perimenopause. Unlike the period following menopause, which is
characterised by a lack of menstruation, the period of perimenopause is frequently a
time when a woman‟s periods may become heavier and less regular. A number of
leaders talked about having erratic or unusually heavy periods which they believed
had the capacity to undermine their sense of wellbeing and confidence. One leader
talked about feeling she needed to take precautions much of the time just in case her
period started unexpectedly. Others talked about not wearing white skirts or trousers
at this time and being concerned about meetings or lectures that went on for more
than a few hours.

For leaders with busy and demanding work schedules, concerns about the
consequences of unexpected or heavy periods may be yet another distraction that has
the potential to undermine confidence and wellbeing. Furthermore, as well as the
emotional impact of heavy or unpredictable periods, women experiencing heavy
periods are at risk of becoming anaemic and this has been shown to affect aspects of
both physical and cognitive performance (Garside et al., 2008 ; Szromba, 2009).

Irritable, anxious and feeling low.

As discussed, many of the symptoms of perimenopause have the capacity, both
directly and indirectly, to compromise a woman‟s physical and mental health.
Maintaining emotional health and stability are critical in roles that require high levels
of decision making and leadership. For a number of participants, perimenopause
reportedly heralded changes in (otherwise stable) emotional and psychosocial
behaviour. Symptoms identified by participants included depression, unloved
feelings, anxiety, irritability, mood swings, problems with concentration and poor
memory.
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Changes in mood were frequently reported and a number of leaders talked about their
efforts to manage mood swings and irritability. Some talked about taking it out on
their families while endeavouring to maintain an aura of coping at work. A number of
leaders also reported feeling more anxious at this time although none were confident
that this was related to hormonal changes. Feeling low however, was more frequently
attributed to perimenopause, with one leader describing this feeling as resembling
permanent PMT (pre-menstrual tension).

The confidence a number of leaders expressed in the relationship between their low
mood and hormonal changes gained further support amongst those who were
subsequently prescribed HRT. These leaders reported that they were able to detect a
change in the way they felt following the use of HRT, with one leader describing this
change as a lifting of her mood.

These findings are consistent with research which indicates that women are more
vulnerable to experiencing anxiety and depression during perimenopause (Soares,
2003). Studies also indicate that HRT, and in particular oestrogen, may improve some
aspects of psychological and cognitive function (Morrison & Tweedy, 2000;
McIntyre et al., 2005). The capacity of HRT to lift mood in perimenopausal women
in addition to ameliorating (or eradicating) other symptoms such as hot flushes is well
documented. It is therefore perhaps not surprising that a study by McIntyre et al.
(2005), found a statistically significant increase in the prescribing rates of
antidepressants following the release of the WHI report in July, 2002. Although
further investigation may be required to ascertain a causative relationship, this finding
is controversial because this increase in prescriptions for antidepressants coincided
with a statistically significant (and similar magnitude) decrease in prescriptions for
HRT.

Although only one participant in the current study reported having been prescribed
antidepressants, anecdotal evidence suggests that clinicians may now find prescribing
antidepressants to perimenopausal women more palatable than prescribing HRT. This
is of concern for a number of reasons. Firstly, although certain antidepressant
medications such as selective serotonin reuptake inhibitors (SSRIs) have been shown
to ameliorate hot flushes (Loprinzi, Stearns & Barton, 2005), they are much less
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effective in this regard than HRT (Wolfman, 2005; MacLennan, 2009). Secondly, the
use of antidepressants either to treat hot flushes or low mood in perimenopausal
women is a concern if women are not being informed that such medications may have
side-effects including sexual dysfunction (Baldwin et al., 2008) and an increased risk
of bone loss and subsequently, osteoporotic fractures (Saag, 2007; Rosen, 2009).

Furthermore, it is a concern that the reported increased rate of prescription of
antidepressants for women as reported by McIntyre et al. (2005) has similarities to the
over-prescription of Valium for women in the middle of last century. Discussing this
issue and the ramification of the negative publicity regarding the use of HRT, Smith
(personal communication, May, 2010) made the following comment:

We have gone back 50 years to the time when women were treated with
barbiturates and other heavy sedatives and then Serapax or Valium because
hormone therapy was not available or even thought of.

It is possible that there may be psychosocial (as well as physical) implications for
women who are prescribed antidepressants for symptoms that may be more
effectively and perhaps, more appropriately treated by low-dose, short-term HRT.

This is yet another area where the education of women and their health care
professionals is critical if women are to be afforded the opportunity to make informed
decisions about treatment options.

A bit more forgetful and less on the ball.

Another controversial issue involves the relationship between hormonal changes and
cognitive function. Although there has been much debate about this issue, recent
research supports the premise that hormonal fluctuations affect aspects of cognition
and memory. In particular, the effects may be at their worst for a short period during
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late perimenopause and may involve aspects of cognitive function such as verbal
memory (Greendale al., 2009).

Although one leader attributed her lack of strategic thinking to hormonal changes,
others who said they were a bit more forgetful or less on the ball at this time were less
inclined to attribute these changes to perimenopause. Only a few leaders ticked
problems with concentration and/or poor memory .This outcome was surprising in
that research indicates that around 60% of perimenopausal women report having
problems with memory and concentration at this time (Luetters & Huang, 2007;
Greendale et al., 2009). Discussion with the participants revealed that most of those
who did notice changes in cognitive function attributed these to the normal process of
ageing.

As mentioned earlier, a lack of awareness about the possibility of hormonally
mediated cognitive or emotional changes may lead some women to suspect a more
sinister reason for their symptoms (Boughton & Halliday, 2008). Leaders who notice
changes in aspects of their cognitive function need to be informed that this is not
necessarily an indication of a progressive age related decline but may occur for a
short period during late perimenopause, after which time the problem may
spontaneously resolve (Greendale et al., 2009).

It is vital that female leaders are provided with an opportunity to discuss any concerns
about changes in cognitive function during perimenopause in a non-threatening and
non-judgmental environment. Interventions of this nature may assist women leaders
to more effectively manage this time of their lives without making significant
decisions (including ones related to their careers) based on misconceptions about the
symptoms they may be experiencing.

Erratic, loony and emotionally driven extreme behaviour.

Of particular interest in this study was the extent to which leaders reported
experiencing what many described as uncharacteristic behaviour during
perimenopause. The use of terms such as loony, erratic and irrational by leaders to
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describe their behaviour indicates a deeper level of effect than is suggested by the
terms anxiety, irritability and mood swings which are proffered on the symptoms
checklist. One leader talked about her emotionally driven extreme behaviour and
another talked about losing her courage. It was also interesting that a number of
leaders reported a lack of insight at the time the uncharacteristic behaviour was
manifesting. This was significant for many who expressed some consternation when
reflecting back on their past behaviour. It was often only after commencing HRT and
noticing a change in their emotional state that participants were able to evaluate the
extent to which their earlier behaviour had been affected. For example, one leader
who did not take HRT until leaving her employment, questioned whether the change
in her emotional state that she had experienced while still in a leadership role may
have precipitated her decision to take early retirement.

The confidence with which many of the leaders attributed the changes in their moods
and emotional behaviour to hormonal fluctuations is supported by the research.
Studies indicate that hormone fluctuations such as those often associated with the premenstrual and post-natal periods as well as during perimenopause can significantly
affect emotional health, well-being and quality of life (Li, et al., 2000; Dennerstein, et
al., 2002; Soares & Zitek, 2008). In fact, a number of leaders likened the experience
to an extended and often severe period of premenstrual tension (PMT).

Although some early research (Huber et al., 1999; Robinson, 2001) suggests that mild
forms of psychosis and even an increase in the incidence of schizophrenia may be
related to perimenopausal changes, a search of the relevant data bases found no
reference to the extreme changes in emotional and psychosocial behaviour described
by a number of the leaders in this study. Anecdotally, erratic behaviour during the
menopausal transition is not unexpected and many women can relate stories about
their own or other‟s reflections regarding uncharacteristic or erratic behaviour at this
time of their lives. Although it is questionable whether timely awareness may have
enabled any of the leaders to adjust their reportedly uncharacteristic behaviour, one
leader lamented the fact that no-one had made her aware at the time. She said she
believed this would have been helpful.
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For some leaders, particularly those working for large international corporations or in
politics, feeling vulnerable and manifesting any sign of emotional instability was
considered to be a threat to their credibility and potentially, to their leadership
prospects. As one leader said: It is okay to break a leg, but it is not okay to get a bit
fed up. For this reason, it is important that opportunities are provided for women in
leadership roles to talk about these sorts of issues in non-threatening environments. In
addition, raising awareness about the possibility of this kind of manifestation of
perimenopause may ensure that women are able to address the problem at the time it
is occurring rather than, perhaps, making career (and other) decisions that they may
later regret.

Summary

It is evident that at the very least, perimenopausal symptoms can be disruptive and at
their most extreme, have the potential to undermine a leader‟s capacity to maintain
optimum work performance. It is unfortunate that the period of perimenopause when
symptoms may be at their most severe so often coincides with the time in a female
leader‟s life when she is striving to maintain and perhaps advance her career.

Female leaders who may be ill-informed and unsuspecting may be experiencing
symptoms that have the capacity to undermine their confidence, performance and
quality of life. This lack of timely awareness was raised by a number of leaders who
claimed that recognition of symptoms was often retrospective. Furthermore, as with
the similarly successful and highly educated women in Simon and Reape‟s (2009)
study, many of the leaders in the current study were unclear about the risks and
benefits associated with the use of effective treatments such as HRT.

As discussed earlier, research shows that women in general are ill informed about
what to expect at this time of their lives. Women in leadership roles may be at a
further disadvantage because the nature of their work often isolates them from other
women and opportunities to share pertinent information about issues such as
perimenopause. This issue of isolation forms the basis of Superordinate Theme Four
and will be discussed later in the chapter.
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It is evident once again that women (particularly those in demanding roles) will
continue to be disadvantaged if they (and their doctors) are denied timely and
effective education about the nature and onset of perimenopausal symptoms and the
most effective and appropriate treatment options.

Superordinate Theme Two: Soldiering On or Taking Control


Just get on with it!



Time out.



Seeking support



I like my doctor



I just don‟t like taking tablets



Im dead or I‟m on HRT

A number of factors reportedly influenced the decisions leaders made in regard to the
management of their symptoms. Some indicated that the way they approached this
time of their lives reflected the determination that had enabled them to achieve their
leadership status. For others, decisions about managing symptoms were associated
with their core beliefs about the use of medications or preference for natural
therapies.

Just get on with it!

Many of the leaders approached the management of their perimenopausal symptoms
with the same determination and professionalism that they applied to other aspects of
their leadership roles. One leader said she believed she lost much of her softness at
this time while others used terms such as pushing through or soldiering on to describe
the way they managed unpleasant symptoms. Others described how adopting a just
get on with it attitude took its toll on other aspects of their lives including their
relationships with family members. One leader said she did not believe someone in
her position should have off days and others described how their sense of being
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motivated or professional prevented them from taking sickies or time off to seek
professional advice about symptoms.

It is questionable whether such attitudes were beneficial to the leaders either in terms
of their health and well-being or their capacity to maintain optimum work
performance at this time. Endeavouring to maintain an aura of professionalism while
contending with troublesome symptoms must constitute an added burden for anyone
in a demanding leadership role.

Time out.

In contrast to the apparent impost often associated with the demands of a leadership
role, some leaders discussed how their status also afforded them a degree of
autonomy and flexibility. For some this enabled them to take time out both as a means
of managing their symptoms and of avoiding scrutiny at times when they may have
felt particularly vulnerable. A number of leaders talked about working from home; re
arranging appointments or avoiding confronting situations at times when symptoms
were problematic.

The degree to which leaders were able to take advantage of flexible working
arrangements varied with many saying that the high work loads associated with their
role made it difficult to take time off or avoid contact with others. Leaders in highly
competitive corporate roles may have less flexibility than those in government or notfor-profit organisations in which there may be a more developed culture of ensuring
some degree of work/life balance.

Seeking support.

Although many of the participants described a number of factors that they believed
limited their opportunities to talk to significant others about issues associated with
perimenopause, those who were able to talk to friends, colleagues, family members or
health professionals found this to be a useful coping strategy.
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In particular, a number of leaders who may otherwise have been quite isolated by
their leadership roles described how they were able to achieve a degree of peer
support by forming a social group outside their respective workplaces which they
referred to as their Menopause Support Group. Although they did not all work
together, they were peers in regard to their age and leadership status. They described
how they met regularly and were able to offer each other advice and support as they
entered and travelled through perimenopause. All indicated that this particular
affiliation had been helpful at the time and was a source of both information and
support for those involved. The success of this affiliation may provide some insight
into the most effective ways to ensure that other female leaders are afforded similar
opportunities for garnering support. It may be significant that the women did not all
work together and were able to meet on neutral territory that provided a nonthreatening and supportive environment.

The experiences of this particular group of leaders is in contrast to the experiences of
other study participants who found that aspects of their leadership role often isolated
them from possible sources of advice and support. As previously mentioned this issue
of isolation is at the core of Superordinate Theme Four: It’s lonely at the top and will
be discussed later in the chapter.

I like my doctor.

During the interviews, many of the participants discussed aspects of their relationship
with their doctor and how this influenced the way they managed their symptoms.
Although most indicated that they liked their doctor and felt comfortable talking
about various symptoms, this was not always the case. One described feeling less
comfortable discussing certain issues with a male doctor and others had difficulty
establishing a relationship with a new doctor when their usual doctor was no longer
available. Even for leaders who believed they had a good relationship with their
doctor, it was apparent that for some there was poor communication around the issue
of perimenopause.
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Participants were not asked directly about the gender of their doctor, however most
mentioned that their current doctor was a woman. One leader said she believed it was
important for women to establish a good relationship with a female doctor because
they may not receive the same level of support around the issue of perimenopause
from a male doctor. Although a number of leaders indicated that they may be more
reticent about discussing certain issues with a male doctor, a number of those who
had female doctors also indicated that there were issues such as libido, vaginal health
or sexual function that they felt less comfortable discussing.

Participants discussed various aspects of the advice they had received from their
doctor in regard to the treatment of perimenopausal symptoms. A number gave
accounts of receiving advice which appeared to contradict that provided on the AMS
website (www.menopause.org.au). For example, one leader who had commenced
using HRT for troublesome symptoms, talked about discontinuing its use after
experiencing unwanted side-effects including breast tenderness. It is now
recommended that doctors experiment with different doses and modes of hormone
delivery in order to find the treatment that reduces the incidence of symptoms such as
hot flushes while avoiding side-effects such as breast tenderness or breakthrough
bleeding (MacLennan, 2009). Furthermore, as previously mentioned, a number of
leaders talked about being advised (contrary to AMS recommendations) to have
blood tests purportedly to ascertain perimenopausal status when in fact the fluctuating
levels of hormones associated with perimenopause mean that blood testing is
frequently inconclusive at this time.

These findings suggest that it is likely that unless a general practitioner has
undertaken post graduate training such as that offered by the AMS, he or she may be
less effective at identifying, assessing and treating perimenopausal patients
effectively. The AMS website lists doctors throughout Australia who have undertaken
this training and women should be made aware of this information.
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I just don’t like taking tablets.

Although there is limited empirical evidence for the efficacy of complementary or
alternative medicines (CAMs) to treat perimenopausal symptoms (Cutson &
Meuleman, 2000; Hunter, 2003; Hickey et al., 2005; MacLennan 2009) a number of
leaders reported achieving some relief from symptoms using these kinds of products.
Other leaders talked about the benefits of maintaining their general health at this time,
through diet, exercise and relaxation techniques such as yoga. Leaders used terms
such as ride it out in regard to coping with symptoms rather than resorting to the use
of products many referred to as medications.

A number of leaders expressed their reluctance to use pharmaceutical products
generally while some were concerned specifically about the use of HRT. This
concern was not surprising in light of the negative publicity about HRT which has
resulted in many women choosing to discontinue using this treatment (MacLennan,
2009; Simon & Reape, 2009). Other leaders reported that their preference for nonpharmacological approaches was based less on concerns about the possible adverse
effects of treatments such as HRT than on their belief that menopause was a natural
process and (as one stated) should not be tampered with. This attitude was consistent
with the findings of Bosworth et al. (2005) who reported that women who thought of
menopause as natural were less likely to use HRT and more likely to discontinue
using it after the highly publicized findings from the WHI report in 2002. They also
found that women who thought about and understood the risk/benefits of HRT were
more likely to start and less likely to discontinue using this treatment.

Although many of the participants said they had endeavoured to gather information
about the safety and efficacy of the various treatment options, it was evident that
some were reliant on the information promulgated in the media. Furthermore,
according to MacLennan (2009) many health professionals continue to promote
therapies including hormonal preparations (often referred to as bio-identical
hormones) for which there is little quality control or evidence of efficacy or safety.
MacLennan also claims that the risks associated with the use of HRT “have been
inflated by the popular press and those purveying alternative therapies (p. 121).”
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Although tighter restrictions on the promotion of alternative medicines have been
recommended (MacLennan, 2009), the onus continues to be on health professionals
to ensure they are well-informed about the efficacy and safety of the products they
recommend. It is also imperative, given the research suggesting a critical period for
initiating HRT, that women are provided information in a timely manner to enable
them to undertake treatment early enough to achieve the most benefit.

I’m dead or I’m on HRT.

A number of participants talked about using HRT to take control of their symptoms.
With the exception of one leader who experienced unpleasant side-effects (as
discussed above) all participants who subsequently used HRT for extended periods
of time found it effective for reducing their symptoms and many reported significant
improvements in the quality of their lives. Some also stated that the use of HRT had
improved their ability to cope with the demands of their leadership roles. The benefits
associated with the use of HRT were summed up rather dramatically by one leader
who said I’m dead or I’m on HRT.

Furthermore, although a number of leaders reported that their doctor had encouraged
them to consider ceasing to use HRT after the recommended 5 years, some said they
had ignored this advice and continued the treatment because it had greatly
improvement their overall quality of life. Many of the study participants who initiated
HRT prior to 2002 had been using it for longer than 5 years, some only discontinuing
use after retirement and one was still on HRT after almost two decades.

Summary

Participants chose different strategies to manage perimenopausal symptoms. In many
cases, leaders indicated that their decisions to either soldier on or take control of
symptoms reflected their general philosophical approach to the use of medications.
Participants, who chose to soldier on, often reported using behavioural strategies,
lifestyle changes and natural approaches to symptom management. Others indicated a
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preference for taking control of their symptoms, with some choosing interventions
such as medically prescribed hormone therapy.

Although there has been wide criticism of aspects of the WHI findings (Wren 2009;
MacLennan, 2009) many women (and their doctors) may continue to be uncertain
about the risks and benefits associated with HRT. In regard to the findings of this
study, the decisions participants made about the management of their symptoms
would be expected to reflect the broader community‟s changing attitudes and
uncertainty about treatment options. Not surprisingly, the majority of leaders who had
used HRT for extended periods of time had begun doing so prior to 2002 while of
those who reportedly entered perimenopause after 2002 only one was using HRT at
the time of interview. According to MacLennan (2009) HRT remains “the best
researched and most effective management of both menopausal symptoms and the
long-term consequences of estrogen deficiency (p. 116).” A number of eminent
women‟s health specialists have recently raised their concerns about the ramifications
for women of what they describe as unbalanced reporting about the risks associated
with the use of HRT (McLennan, 2009; Smith, 2010; Wren, 2009).
According to MacLennan (2009), “The risks of HRT have been inflated by the
popular press and those purveying alternative therapies (p.121).” He provides the
following recommendation:

The message is that the latest data on HRT do not warrant the fear and ultraconservative approach adopted in 2002. Long-term therapy is appropriate for
women with long-term symptoms who are aware of the potential risks of their
regimen in their personal circumstances. (p. 121)

The change in attitude to the use of HRT may have left many leaders with few
effective options for managing troublesome symptoms. It is not inconceivable that
under such circumstances, some leaders may find it difficult to soldier on without the
benefits of HRT. It is also possible that some may choose to relinquish their
leadership roles or decide not to contest promotional opportunities as a consequence.
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Once again, it is clear that education of women and health professionals about the
risks and benefits associated with the various treatment options is critical if women
are to be effectively supported through the menopausal transition. There appears to be
no substitute for effective doctor-patient communication about current treatment
options. In addition, the onus must be on health professionals to ensure that the
information they dispense is up-to-date and that they are proactive in discussing
perimenopausal changes with their women patients as they enter mid-life.

Superordinate Theme Three: Keeping Up Appearances


Fronting up and putting on a bit of a face.



Show your weakness and you are lost!

Maintaining a confident and professional demeanour was of great importance to the
majority of leaders. In particular, leaders discussed two areas of concern: firstly the
need to be present and appear to be fully functional at all times and secondly, the
need to avoid appearing weak or vulnerable at any time.

Fronting up and putting on a bit of a face.

Leaders talked about having to front up and be seen as capable, competent and in
control at work. This reportedly included being able to function and to look neat and
tidy and presentable all the time. A number of leaders talked about the lengths they
would go to in order to ensure they would be able to maintain (what they considered)
the appropriate image at work. Strategies included being highly organised and
maintaining an appearance of coping that they may not have managed to maintain in
their private lives. There was often a sense of resignation as well as determination.
One leader described herself as a get on with it sort of person while another talked
about becoming more matter of fact about her work and other issues at this time.
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Several aspects of experiencing perimenopausal symptoms (such as hot flushes) that
had the potential to undermine this image were mentioned. For example the
distraction often associated with being dripping wet as the result of hot flushes was
seen by some as a potential threat to their ability to maintain an image of
professionalism either because it caused them to lose concentration or because they
believed it made them appear flustered or somehow less competent. Although most
participants believed they were largely able to maintain their professional image
while in the workplace, the effort often required to achieve this clearly constituted an
additional impost on the health and well-being of these leaders at this time in their
careers.

Show your weakness and you are lost!

Showing any degree of vulnerability was perceived by many leaders as a threat to
their leadership status. A number of leaders talked about not wanting to be recognised
as menopausal or experiencing perimenopausal symptoms because they felt they
might be judged as less capable or competent. One leader talked about believing that
others may make negative judgements about any woman who was seen to be needing
to resort to assistance (such as using HRT). Another participant who worked in a
predominantly male industry talked about how she made a distinction between
revealing the physical versus the more emotional symptoms of perimenopause,
believing she had to hide the later.

Another leader spoke about the importance of maintaining an aura of coping and
approachability for the benefit of reports or other (usually subordinate) colleagues.
This leader believed that revealing any level of personal vulnerability (such as that
associated with having a hot flush) had the potential to compromise the level of
confidence she believed others needed to have in her as a leader. Maintaining an aura
of confidence was considered to be important if others were to continue to feel
comfortable about seeking her guidance or support.

It was interesting to note that one leader who worked in a female-dominated
workplace was more concerned about ensuring that those reporting to her continued
186

to feel confident in seeking her counsel while a number of leaders who worked in
male-dominated professions were more concerned about the impact on them
personally of being judged as less than competent. Although maintaining an aura of
professionalism was important in both cases, the primary reason for doing so differed.
This finding is consistent with the findings of a study by Gardiner and Tiggermann
(1999) which, although somewhat dated, may unfortunately continue to be relevant
for women in Australian workplaces today. Their research indicated that women
adopt different leadership styles depending on the gender balance of their
organisation. They found that women were less inclined to adopt the traditionally
more feminine interpersonally orientated leadership styles when working in maledominated environments than when working in more gender-balanced or femaledominated environments. Furthermore, they cite a study by Eagly and Johnson (1990)
which showed that women working in male-dominated environments were more
concerned about maintaining authority and position. Gardiner and Tiggermann noted
that in Australia the majority of women in leadership roles worked in male-dominated
environments and were therefore likely to be subject to a number of pressures and
expectations that women in more gender balanced organisations did not face.
Furthermore, they also noted that this gender imbalance often caused women leaders
to feel more visible within the workplace and that this often engendered a sense of
vulnerability.

It is unfortunate that this gender imbalance continues to be a factor in Australian
workplaces (EOWA, 2009). In these environments, female leaders manifesting the
outward signs of perimenopause or being distracted by symptoms that may impact on
emotional or intellectual function could conceivably experience a heightened sense of
visibility and vulnerability. This may be particularly the case for female leaders
working in positions that place them under constant public scrutiny. Two leaders
commented on the difficulties they and other women faced when their roles involved
high profile exposure in the public arena. Both discussed how this increased their
perceived need to maintain an aura of coping and competence at all times.

Leaders described the strategies they used to avoid placing themselves in the public
arena when they felt that perimenopausal symptoms (such as hot flushes) may have
put them at a disadvantage. One leader who worked in a highly competitive male187

dominated environment, also talked about how she believed she had to avoid showing
any vulnerability and that she felt she needed to be in her armour in the workplace.

Another leader talked about her perceived need to be like the men she worked with
which reflected the findings of Mavin (2008) who talks about the “continuing
pervasiveness of heroic masculinism” (p. 76). This she says, requires that women
adopt stereotypically male attributes, thereby risking censure from both male and
female colleagues. Mavin suggests that this expectation that women should adapt
their behaviour in this way may actually dissuade women from seeking positions of
leadership. Furthermore she says that it is evident that “women‟s presence in the
world of men is conditional on their willingness to modify their behaviour to become
more like men or to be perceived as more male than men” (p. 76).

Although one leader said she believed there were negative connotations within the
pervading culture, about menopause being a time of aging and loss of sexuality, none
of the leaders expressed concerned that being recognised as menopausal may have led
others to also perceive them (personally) as being old or ageing. It may be that a
certain level of maturity is considered acceptable, and even perhaps desirable for
anyone (male or female) when holding a position of leadership. A search of the
literature failed to uncover any research into current perceptions about the
relationship between age and leadership. It is evident however that with the average
age of board director being between 51 and 70 years of age as discussed earlier (Kang
et al., 2007), a degree of maturity is the norm and most likely expected of those in
leadership roles. It is possible that the leaders in the current study did not perceive
that there was a disadvantage for women in being recognised as menopausal and
therefore, by association, „old‟, as long as this was not considered to be synonymous
with being less capable or competent.

Summary

It would appear that although many of the leaders indicated that they were not
concerned if others identified them as being menopausal (as made evident by having
a hot flush in a public setting) most were concerned about losing their poise and being
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judged as less capable or competent as a result of their symptoms. It was also evident
that a number of leaders made a distinction between the physical and emotional
symptoms associated with perimenopause. As one leader put it ... it is okay to break
your leg but it is not okay to get a bit fed up.
Leaders‟ efforts to avoid the possibility of being judged as emotionally or
intellectually compromised because of perimenopausal symptoms often required the
development of strategies to maintain their poise and aura of coping. These strategies
ranged from choosing clothing to minimise the effects of hot flushes to avoiding
public exposure at times when symptoms may have increased their sense of
vulnerability.

Although such strategies were effective for some leaders, others indicated that the
demands of their particular work made it difficult to accommodate the physical and
emotional impost of certain symptoms. It is likely that women leaders in high profile
roles involving frequent interface with the public, may find it particularly difficult to
consistently maintain an aura of coping and competence while contending with
troublesome perimenopausal symptoms. These women may be more inclined to
relinquish their leadership roles than their counterparts in less high profile roles, if
they are unable or unwilling to access effective treatment (such as HRT) for their
symptoms.

Superordinate Theme Four: It’s lonely At the Top


No one to talk to



A no-go-zone!

A number of aspects of being in a leadership role reportedly contributed to a sense of
isolation for some participants. This was often related to the time demands associated
with being in a leadership role and in many cases, the absence of female peers within
the workplace.
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No one to talk to.

In Australia, women in leadership roles continue to be in the minority in almost every
sphere of industry (EOWA, 2009). It was not surprising therefore, that the majority of
participants were either employed in male-dominated work environments or were
required to report to boards which were male-dominated. According to Gardiner and
Tiggermann (1999), women in mostly male workplaces often found that they were
isolated from their male peers and therefore often unable to access both formal and
informal support networks that men take for granted. With little change in the gender
balance in Australian workplaces, this lack of supportive networks is still likely to be
a major factor for most female leaders. Leaders experiencing perimenopausal
symptoms may be particularly disadvantaged in these environments because they may
lack opportunities to garner information and support from other women. In addition,
the perceived need to maintain an image of approachability and/or competence (as
previously discussed) may increase the sense of isolation for many female leaders.

As discussed earlier, those leaders who were able to establish peer support networks
found this extremely valuable. Unfortunately, the majority of study participants
reported that these kinds of opportunities were limited. For example, one leader who
characterised the company she worked with as being dreadful with its women,
described how this added to her level of anxiety particularly as she lacked female
peers she could relate to and from whom she could seek support. Another talked
about being isolated away from (subordinate) staff by virtue of her leadership status
and therefore needing to seek support and mentorship from those in line or above
whom she said may not be thick on the ground. The same leader also commented that
in addition, there was a need to be able to connect with others and be prepared to
share information with them. In this regard, she only felt comfortable talking about
perimenopausal issues with colleagues who were also considered friends.

Other aspects of being in a leadership role may also cause women to feel isolated. For
example, a number of participants talked about the long hours they worked and how
this restricted the time available for socializing and sharing information outside the
workplace. One leader felt that being in a management position restricted the time
available to chat with others which caused her to feel isolated and prevented her from
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talking about things that other women may have been experiencing. She said there
was no forum to communicate for women leaders (like her) in the workplace.

Finally, in contrast to the perception that a more gender balanced or feminised
workplace may be more supportive of women one leader indicated that she believed
that women are not always supportive of each other in all circumstances in the
workplace. She suggested that a supportive work environment has more to do with
the personalities of those involved than their gender.

A no-go-zone!

Even when there were other professional women to talk to, a number of leaders did
not believe it was appropriate to discuss personal issues such as perimenopause. One
leader describes this as a no-go-zone and another as a totally taboo subject. Similarly,
another leader said that for her, any discussions of issues such as perimenopausal
symptoms with female colleagues would be fairly brief and superficial.

Interestingly, another leader made the observation that a lack of understanding may
reduce people‟s tolerance to the mood changes often associated with perimenopause.
She said that others may react better if they were aware of the reasons for the change
in behaviour of a female colleague rather than believing she was simply in a bad or
snooty mood.

Summary

Although leadership may be an isolating experience for both men and women, it is
apparent from the extant literature such as Gardner and Tiggermann, 1999, and the
findings of this study, that women leaders are further disadvantaged because they are
often in the minority and frequently excluded from the networks that their male peers
use to garner support. For women experiencing troublesome perimenopausal
symptoms, this lack of support may have particular significance if it prevents them
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from accessing opportunities to normalise their experience or share advice about
symptom management.

In addition to being thin on the ground, as one leader put it, the long working hours
may further limit the opportunities for many female leaders to access and share
information and support both within and outside the workplace. Furthermore, a
number of study participants reported that aspects of their experience of
perimenopausal symptoms caused them to feel more physically and emotionally
vulnerable. This increased sense of vulnerability may be further exacerbated by their
isolation.

Recommendations and Other Issues Raised by Participants

The majority of leaders discussed the need for more comprehensive education of
women in regard to the recognition and management of perimenopausal symptoms. It
was also suggested that health care professionals should be better informed in order to
be more effective in offering appropriate and timely advice. One leader specifically
mentioned that she believed women are more likely to receive good advice and
effective treatment if they are able to establish a good relationship with a female
doctor.

Although several leaders mentioned the potential benefits of effective mentoring and
advocacy for female leaders generally, there was often the perception that there may
be barriers to discussing personal stuff in these kinds of forums. A number of leaders
also mentioned that it may not be appropriate to proffer advice (particularly when
unsolicited) about perimenopause or coping with symptoms to colleagues.

An anticipated outcome of this research was that participants would provide specific
advice or recommendations that may benefit other leaders in similar situations. It was
therefore surprising that very few suggestions were put forward during the interviews.
After reviewing the findings however, it became clear that the issues that contribute
to the feeling of isolation that many female leaders described may also restrict the
opportunities available for garnering support and information. It was also apparent
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that the need to maintain an aura of coping and poise appeared to be at odds with the
concept of having open discussion within the workplace, about issues associated with
perimenopausal symptoms. Within this context, leaders may have found it difficult to
envisage specific interventions or strategies that may have provided support to others
in similar circumstances.

One leader did however mention that she thought that good stories from women may
be a valuable way to provide other female leaders with information and advice that is
relevant to their unique situation. The sharing of personal experiences by female
leaders may assist in reducing the stigma associated with this issue and enable others
to gain the insight and support necessary to more effectively manage this time of their
lives and as one leader said, survive wonderfully.
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Chapter Six: Conclusion

The findings of the study will now be summarised and conclusions drawn. In
addition, the limitations of the study will be outlined and recommendations for
effective interventions and further research will be presented.

At the outset of this study, several issues considered to be at the core of this research
were outlined:


Most women will experience perimenopausal symptoms.



Many women are ill-informed about the nature, onset and effective management
of perimenopausal symptoms.



Perimenopausal symptoms have been shown to cause a range of physical and
emotional symptoms for women in the workplace.



The work environment has been shown to exacerbate the effects of
perimenopausal symptoms.



Perimenopausal symptoms may constitute an added burden for women
contending with certain demands reportedly associated with leadership.



The age at which women are likely to be undertaking leadership roles often
coincides with the age at which many may be experiencing perimenopausal
symptoms.



A loss of confidence in the use of HRT may have left some women leaders with
limited treatment options for problematic symptoms.

Although there is research supporting the tenet of each of these core issues, few
studies have investigated the effects of perimenopausal symptoms on women in
leadership roles. This study sought to explore this phenomenon by providing a
representative group of women leaders with an opportunity to relate their experience
of perimenopausal symptoms; how they managed their symptoms; the factors that
influenced their decisions regarding treatment options and their recommendations for
other women in similar circumstances. Information was gathered through in-depth,
semi-structured interviews with 17 women leaders.
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Interpretative phenomenological analysis (IPA) was chosen for this study because of
its capacity to ensure that participants‟ responses were not limited by narrow
predefined parameters (Smith et al., 2009). The following four Superordinate Themes
were subsequently identified, each reflecting both the commonalities and differences
within the reported experiences of the participants:


Distraction, disruption, discomfort and distress



Soldiering on or taking control



Keeping up appearances



It‟s lonely at the top

These emergent themes reflected the particular set of circumstances that confronted
the women leaders who participated in this study. Many of the issues raised provide
new and often unanticipated insights into how women leaders may experience
perimenopausal symptoms and the implications in regard to their professional roles.
For example, participants reported that experiencing perimenopausal symptoms while
contending with the demands associated with a leadership role was often distracting,
and for some, a source of physical and emotional distress which had the capacity to
undermine confidence and work performance. Although perimenopausal symptoms
have the capacity to adversely affect women in general, a number of factors
associated with both the status and work demands experienced by women in
leadership roles may exacerbate their experience of symptoms and compromise their
capacity to maintain optimum leadership performance.

Furthermore, a number of leaders in this study indicated that there may be
ramifications for women who display any signs that perimenopausal symptoms may
be having an adverse affect on their level of performance or capacity to do their work.
This may contribute to the reluctance many leaders expressed in regard to publicly
acknowledging their symptoms or discussing their experience with their peers.

Of particular significance in this study was the concurrence of the age at
perimenopause with the age at which women may be undertaking leadership roles.
Many of the study participants described having to contend with troublesome
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perimenopausal symptoms while also facing a range of challenges specifically
associated with being a female in a leadership role. For example, many described the
isolation they experienced in regard to working in largely male-dominated
environment. The gender imbalance that continues to be a factor for women leaders in
Australian workplaces has been shown to increase the stress levels of many women
leaders who may feel overly visible and vulnerable as a result.

The lack of female peers also reportedly limited the opportunities for female leaders
to seek advice and support in relation to both professional and personal issues. In
addition, a number of study participants indicated that the time demands associated
with leadership roles also limited opportunities for socializing outside the workplace.
This may have further restricted opportunities for gathering information, advice and
support from other women and health professionals.

Another issue that may be of particular significance for women in leadership roles is
the change during the past several years, in attitudes to the use of HRT. A number of
studies indicate that negative publicity has caused many women to avoid using HRT
(Holloway, 2009; Simon & Reape, 2009; Wren, 2009). This is disturbing because
HRT remains the most effective treatment available for the management of
perimenopausal symptoms (MacLennan, 2009) and recent reports indicate that for
many women, low-dose HRT commenced around menopause and used for up to five
years may actually be beneficial and pose few health risks (MacLennan, 2009; Wren,
2009).

The changing attitude to the use of HRT was evident within this study with leaders
who entered perimenopause in the pre-WHI era were more inclined to use HRT than
those who entered perimenopause more recently. Furthermore, many of the leaders
who used HRT to manage symptoms reportedly believed that the treatment enabled
them to continue to manage the demands of their work and, for some, to achieve a
better quality of life. The change in attitude to the use of HRT may mean that some
women leaders are less comfortable about using this treatment and therefore left with
few effective options to manage troublesome symptoms.
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Women generally need to have access to information that will enable them to make
informed decisions about treatment options. Health professionals including mental
health counsellors such as those employed in employee assistance programs, are well
placed to provide this kind of information and support. Simply raising the possibility
that physical and emotional changes may be the result of the hormonal fluctuations
often associated with perimenopause, may enabled women to take control and
actively manage their symptoms. This information may also greatly reduced their
anxiety that certain symptoms may herald the onset of some more sinister illness or
indicate the beginnings of an age-related decline in cognitive function.

It has been suggested that raising awareness about the possible impact of
perimenopausal symptoms on the work performance of female leaders may in some
way further disadvantage women. Although there is the possibility that this may be
the case, it is imperative that women are informed about the nature and onset of
possible symptoms so that they can make the most appropriate decisions about how
they manage this time of their lives.

It is evident that women in leadership roles within Australian workplaces are likely to
be in the age range in which they may experience perimenopausal symptoms. Many
will be ill-informed about the nature and onset of symptoms and the effective
treatment options available. In addition, the demands of their professional roles may
restrict their opportunities to gather and share information with their peers and health
professionals. Furthermore, women leaders may have to contend with the added
burdens associated with working in male-dominated environments where they are
often isolated from other women and the support networks that may be available to
their male colleagues. It is likely that the combination of these factors may constitute
a major challenge for women who are striving to maintain optimum performance in
leadership roles in Australian workplaces.

This study provides a number of insights into a previously unexplored phenomenon.
The findings indicate that certain perimenopausal symptoms have the capacity to
adversely affect women undertaking leadership roles. Denying that this may be an
issue for some women leaders may be counterproductive and contribute even more to
the sense of isolation that many of the study participants reportedly experience around
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this issue. This study provides a clear mandate for the development of strategies that
provide opportunities for leaders to share information and concerns with their peers,
about perimenopausal symptoms and other issues that may be unique to women in
leadership roles in Australian workplaces. Providing the kind of information and
support that enables perimenopausal women to take on and continue to meet the
challenges associated with a leadership role, will be of benefit to the women, the
business world and the community in general.

Limitations of the Study

As outlined in Chapter Three, the intention of this study was to explore the lived
experiences of a particular group of women in order to develop a greater
understanding of the phenomenon under investigation. The study participants
represent a unique group of women who shared a relatively unique set of
circumstances related to their working lives. In this regard, the findings of the study
are not intended to be transferable to other populations but may nevertheless be used
to inform the direction and nature of further research and guide the development of
effective interventions for women in similar circumstances.

Further Research

The value of conducting further research into the effects of perimenopausal
symptoms on women in leadership roles is significant. The findings of this research
provide the basis for a number of possible research projects.

Firstly, it would be valuable to investigate the current level of awareness among
women in general regarding the nature and onset of perimenopausal symptoms, the
various sources of information and support and their attitudes to the treatment options
available. Secondly, further investigation is warranted into the needs of women in
leadership roles in regard to the development of effective mentoring and support
programs. Although there are a number of initiatives directed at enhancing the
opportunities for women to access mentoring programs in relation to work
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performance and skills, it is clear that there are barriers to open discussion of issues
associated with the impact of hormonal fluctuations associated with perimenopause.
Finding the appropriate strategies and approaches to overcome some of the stigma
associated with this issue will be a challenge. Investigating effective ways to
incorporate awareness raising and educational strategies into existing occupational
health and safety and professional development programs through business
organisations and professional groups may provide the impetus for a change in
attitude to an issue that has hitherto been avoided.

Another area for further investigation is the level of knowledge regarding the onset
and nature of perimenopausal symptoms and the efficacy and appropriateness of
treatment options amongst health professionals. It appeared in the leader‟s responses
that information from health professionals was often limited and at times inconsistent
with the advice provided by the AMS which is the peak medical body in Australia in
regard to this issue. It would also be useful to investigate the degree to which the
various undergraduate and postgraduate medical and counselling programs focus on
providing this information to students.

Further research into these issues would contribute greatly to the body of knowledge
in this area and subsequently the development of effective interventions directed at
improving the circumstances of women leaders at this time of their lives.

Recommendations.

There are three recommendations based on the findings of this study. Firstly, it is
evident that there is a need for more timely and comprehensive education of women
in general in regard to the onset and nature of perimenopausal symptoms. It is
recommended therefore, that women should be advised that perimenopausal
symptoms may begin several years before actual menopause and can adversely affect
their physical and emotional well-being. Education needs to be directed at women in
their 30s and 40s before they enter perimenopause. Secondly, special consideration
needs to be taken in regard to the particular circumstances of women in leadership
roles. This unique group of women should be provided with opportunities to access
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information and support through existing occupational health and safety, mentoring
and professional development programs in a manner that is non-threatening and
respectful of the potentially sensitive nature of the issue. Thirdly, there needs to be an
increased onus placed on health care professionals including occupational health and
safety personnel, mental health counsellors and medical practitioners to provide the
information and support that will benefit women approaching mid-life (and
particularly those in leadership roles). This information should enable women to be
prepared for the onset of perimenopause, recognise perimenopausal symptoms and
make informed decisions about the management of their symptoms. Above all, this
should be done in a timely and sensitive manner.

It is also evident that health care professionals are not always well informed about the
health needs of women at mid-life. This information should be provided to students
and through the professional organisations responsible for the ongoing education of
health professionals. A greater onus should be placed on these professional
organisations to ensure that their members are provided with up to date, peer
reviewed information.

In addition, health care professionals need to provide women with the information
and support that will enable them to maintain their postmenopausal health and wellbeing thereby improving their opportunities to extend their productive working lives
if they so choose.
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CONSENT FORM

Respondent:
I hereby consent to participate in a study to be undertaken by Philippa Gavranich,
Professional Doctorate (Health Science) student, University of Notre Dame
Australia.
I have read the information sheet and understand what my participation in the study
will involve. I understand that I may withdraw my consent and discontinue my
participation at any time. I agree to the interview being tape recorded, transcribed,
and the information being used for the purpose of the study, dissertation presentation
at the University of Notre Dame Australia, and subsequent presentations including
conferences, public forums or media releases. I understand that I have the right to
review, edit or erase the recording or transcript of the recording of the interview prior
to its inclusion in the study.

Signature............................................................................

Date.............................................

Researcher:
I hereby certify that I have provided the respondent with the appropriate information
about the nature of the study and the extent of her participation. I have also explained
how the information will be used and that confidentiality will be strictly respected. I
have answered any questions that have been raised, and have witnessed the above
signature.

Signature..................................................(Philippa Gavranich)

Date............................................
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INFORMATION SHEET FOR STUDY PARTICIPANTS
This study is part of a Professional Doctorate (Health Science) being undertaken by
Philippa Gavranich, student, University of Notre Dame Australia. The purpose of this
study is to investigate the perceived impact of perimenopausal symptoms on women in
leadership roles. In particular, it will explore how they cope with symptoms, the factors
that influence their decisions regarding treatment option and their recommendations
for educational and support services that may assist other women in similar
circumstances.


Participants will be volunteers who have been informed about the study and consider
themselves eligible.



Information will be gathered from participants during a tape-recorded, 60 minute, one-onone interview conducted by the researcher in a private setting.



Participants may withdraw consent and discontinue participation at any time during the
interview.



Transcribed information from the recorded interview will be used for the purpose of the
study and dissertation presentation at the University of Notre Dame Australia and possibly
in subsequent presentations and papers.



The information gathered will be treated in the strictest confidence, in accordance with the
requirements of the University Research Ethics Committee.



Transcripts will contain no information that will enable identification of the interviewee or any
other party.



Participants will be given the option of reviewing the transcript of their interview.



All tape-recordings and transcripts of interviews with participants will be held in a locked
cabinet in a secure location, until the completion of the study to ensure the integrity of the
data.



On completion of the study, all transcripts will be held in a secure location at the University
of Notre Dame Australia for five (5) years.



Participants will be provided with an executive summary of the research findings at
completion of the study.



Participants will be provided with a list of contacts and resources that may answer any
questions regarding the subject under investigation.



Participants may contact the researcher, Philippa Gavranich on her mobile: 0418 901864 or
by E-mail: pgavranich@student.nd.edu.au at any time if they have any concerns or queries.
Alternatively, participants may contact research supervisors Prof. Helen Parker at
hparker@nd.edu.au or Dr Sue van Leeuwen at Sue@leadershipwa.org.au or the Executive
Officer of the Ethics Committee, University of Notre Dame Australia (08) 9433 0555 if they
have any concerns or complaints about the process used in information gathering, the study
or any aspect of their involvement.

Philippa Gavranich
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Information about terms used in this study

There is often some confusion about the terms 'menopause' and 'perimenopause'. The
term 'natural menopause' refers to the permanent cessation of menstruation resulting
from the normal loss of ovarian follicular activity. Natural menopause is recognized to
have occurred after 12 consecutive months of amenorrhea (no periods), for which there
is no other obvious pathological or physiological cause. Menopause is therefore actually
a point in time which is known with certainty only in retrospect a year or more after a
woman has had her last natural period. The average age at which women reach
menopause is 51 years.
It is estimated that around 80% of Australian women at mid-life, experience
symptoms associated with changing levels of reproductive hormones. These symptoms
are often most severe during the period of perimenopause which may begin as early as
15 years before, and for a year or more after actual menopause.
For more information about perimenopause and menopause see the website for
the Australasian Menopause Society at www.menopause.org.au and their
recommended links.
For the purpose of this study, the term 'leadership role' will be defined as follows:
A role in which an individual may exert influence over other people for the
purpose of achieving organisational goals.
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Symptoms Checklist
The following ‘checklist’ is a composite of lists available from the
Australasian Menopause Society (AMS) website and the ‘Symptoms
Checklist’ used by the Rosalie Golan Centre for Women’s Health in
Subiaco (WA). Please indicate if you have experienced any of these
symptoms.
Symptom Checklist
Hot flushes
Light headed feelings
Headaches
Irritability
Depression
Unloved feelings
Anxiety
Mood swings
Sleeplessness
Unusual tiredness
Unusual backache
Unusual joint pains
Unusual muscle pains
New facial hair
Dry skin
Crawling feelings under the
skin
Less sexual feelings
Dry vagina
Uncomfortable intercourse
Urinary frequency
Poor memory
Palpitations
Loss of bladder control
Breast soreness
Fluid retention
Abdominal bloating
Migraine
Sugar craving
Problems with concentration
&/or memory
Night sweats
Unusually heavy periods

√
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